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Abstract
Models and applications for measuring the impact of health
research: update of a systematic review for the Health
Technology Assessment programme
James Raftery,1* Steve Hanney,2 Trish Greenhalgh,3 Matthew Glover2
and Amanda Blatch-Jones4
1Primary Care and Population Sciences, Faculty of Medicine, University of Southampton,
Southampton General Hospital, Southampton, UK
2Health Economics Research Group (HERG), Institute of Environment, Health and Societies, Brunel
University London, London, UK
3Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
4Wessex Institute, Faculty of Medicine, University of Southampton, Southampton, UK
*Corresponding author j.p.raftery@soton.ac.uk
Background: This report reviews approaches and tools for measuring the impact of research programmes,
building on, and extending, a 2007 review.
Objectives: (1) To identify the range of theoretical models and empirical approaches for measuring the
impact of health research programmes; (2) to develop a taxonomy of models and approaches; (3) to
summarise the evidence on the application and use of these models; and (4) to evaluate the different
options for the Health Technology Assessment (HTA) programme.
Data sources: We searched databases including Ovid MEDLINE, EMBASE, Cumulative Index to Nursing
and Allied Health Literature and The Cochrane Library from January 2005 to August 2014.
Review methods: This narrative systematic literature review comprised an update, extension and
analysis/discussion. We systematically searched eight databases, supplemented by personal knowledge,
in August 2014 through to March 2015.
Results: The literature on impact assessment has much expanded. The Payback Framework, with
adaptations, remains the most widely used approach. It draws on different philosophical traditions,
enhancing an underlying logic model with an interpretative case study element and attention to context.
Besides the logic model, other ideal type approaches included constructionist, realist, critical and
performative. Most models in practice drew pragmatically on elements of several ideal types. Monetisation
of impact, an increasingly popular approach, shows a high return from research but relies heavily on
assumptions about the extent to which health gains depend on research. Despite usually requiring
systematic reviews before funding trials, the HTA programme does not routinely examine the impact of
those trials on subsequent systematic reviews. The York/Patient-Centered Outcomes Research Institute and
the Grading of Recommendations Assessment, Development and Evaluation toolkits provide ways of
assessing such impact, but need to be evaluated. The literature, as reviewed here, provides very few
instances of a randomised trial playing a major role in stopping the use of a new technology. The few trials
funded by the HTA programme that may have played such a role were outliers.
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Discussion: The findings of this review support the continued use of the Payback Framework by the HTA
programme. Changes in the structure of the NHS, the development of NHS England and changes in the
National Institute for Health and Care Excellence’s remit pose new challenges for identifying and meeting
current and future research needs. Future assessments of the impact of the HTA programme will have to
take account of wider changes, especially as the Research Excellence Framework (REF), which assesses the
quality of universities’ research, seems likely to continue to rely on case studies to measure impact. The
HTA programme should consider how the format and selection of case studies might be improved to aid
more systematic assessment. The selection of case studies, such as in the REF, but also more generally,
tends to be biased towards high-impact rather than low-impact stories. Experience for other industries
indicate that much can be learnt from the latter. The adoption of researchfish® (researchfish Ltd,
Cambridge, UK) by most major UK research funders has implications for future assessments of impact.
Although the routine capture of indexed research publications has merit, the degree to which researchfish
will succeed in collecting other, non-indexed outputs and activities remains to be established.
Limitations: There were limitations in how far we could address challenges that faced us as we extended
the focus beyond that of the 2007 review, and well beyond a narrow focus just on the HTA programme.
Conclusions: Research funders can benefit from continuing to monitor and evaluate the impacts of the
studies they fund. They should also review the contribution of case studies and expand work on linking
trials to meta-analyses and to guidelines.
Funding: The National Institute for Health Research HTA programme.
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Plain English summary
This review updates a previous review of methods for assessing the impact of programmes such as theNational Institute for Health Research Health Technology Assessment (HTA) programme. This review
confirmed the earlier finding that the Payback Framework was, and remains, the main method used
internationally. This work also reviewed the wider literature to develop a taxonomy of different underlying
approaches to measuring impact. On the basis that it is robust, flexible and remains the most widely used
approach internationally, we found that the Payback Framework remained an appropriate approach for
the HTA programme to use.
Three extensions to the Payback Framework were examined in more detail, the first in relation to
expressing impact in terms of its monetary value. Studies using the approach generally show big returns
from investment in health research. A first attempt to apply this to the HTA programme found
similar results.
As the results of randomised trials mainly impact on clinical guidelines through systematic reviews, we
checked how often trials funded by the HTA programme were included in systematic reviews undertaken
after these trials were published. We found that around one-quarter of such trials were included in later
reviews by the Cochrane Collaboration. We recommended that the programme consider what its impact
might be on systematic reviews and clinical guidelines for each trial it publishes.
The third extension considered whether or not, and to what extent, trials funded by the HTA programme
successfully stopped the spread of new technologies that had failed to show benefit; we found that this
was rare. Around one-quarter of trials funded by the programme could be considered ‘first in class’, but
many were variants of existing technologies rather than entirely new. Areas for further research include
exploring the benefits to the HTA programme of, considering the impact on systematic reviews and clinical
guidelines from each trial it publishes, and second, monitoring the extent to which the trials it funds are
‘first in class’.
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Scientific summary
Background
In 2007, the Health Technology Assessment (HTA) programme published a review of approaches and tools
for measuring the impact of health research programmes [Hanney S, Buxton M, Green C, Coulson D,
Raftery J. An assessment of the impact of the NHS Health Technology Assessment Programme. Health
Technol Assess 2007;11(53)]. We sought to update and extend that review in light of considerable
advances in the field in recent years. Internationally, there has been a growing interest in assessing the
impact of programmes of health research. Recent developments in the UK create a new context for
considering impact assessment. These include the increasing recognition that much research is wasteful,
the pressure on higher education institutions to demonstrate accountability and value for money, the
expansion in routine collection of research impact data through national databases, such as researchfish®
(researchfish Ltd, Cambridge, UK) and the large-scale assessment of research impact in higher education
through peer review of case studies in the Research Excellence Framework (REF).
Objectives
Our objectives were to (1) identify the range of theoretical models and empirical approaches to measuring
the impact of health research programmes; (2) develop a taxonomy of models and approaches, highlighting
their underlying assumptions and their strengths and limitations for different purposes; (3) summarise the
evidence on the application and use of these different models; and (4) evaluate the different options for
taking impact assessment forward in the National Institute for Health Research (NIHR)/HTA programme.
In this we built on the previous HTA review, published in 2007, which covered the literature up to 2005.
Methods
The study design was a narrative systematic review, consisting of three linked phases: an update, an
extension and an analysis/discussion. In the update phase, we systematically searched eight databases from
2005 (in August 2014); hand-searched selected journals; undertook reference checking and citation
tracking of reviews and other key sources published since 2005; and drew on other studies known to the
authors. We included conceptual or methodological studies describing models and approaches, and
examples of empirical applications. We excluded studies that speculated about future impact or addressed
solely the implementation of guidelines. Two assessors checked each potential paper for inclusion for
relevance. Using a structured data extraction sheet, we extracted a standard data set from each paper,
including source, model(s) or approach(es) used, factors associated with impact, and strengths and
limitations. We charted these data on spreadsheets and produced a narrative overview of key findings.
In the extension phase, we explored a wider literature, with a view to theorising the range of different
approaches to impact assessment. We used relevant papers from the main search described above and
added selected studies published before 2005 if they provided theoretical insights for our taxonomy. Our
analysis identified five ‘ideal types’ of philosophical perspectives underpinning impact models, although we
acknowledged that most models in practice drew pragmatically on elements of more than one ideal type.
The ideal types were positivist (which maps broadly to unenhanced logic models), constructionist
(which links to interpretative and interactionist models), realist (which underpins models that emphasise
context–mechanism–outcome–impact links), critical (which refers to participatory models of research)
and performative (which informs many Co-production or co-creation models). The Payback Framework,
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for example, includes an underlying logic model drawing out causal links between funded research
programmes and subsequent impact. It has been enhanced with interpretative elements (a detailed
narrative of how, and by whom, the study was set up, conducted and its findings disseminated). The
Payback Framework’s emphasis on how context affects the success of impact efforts also reflects elements
of a realist philosophy.
In the analysis phase, we drew together the findings from the different components of the review and
considered some higher-order questions.
Results
The literature on impact assessment has much expanded since 2005. It now includes a potentially
confusing array of models that draw on different epistemological assumptions about the link between
research and impact. Our search identified an initial sample of 513 potentially relevant sources, which was
later reduced to a final sample of 161 papers including over 20 different models and with 110 empirical
applications of these models.
The Payback Framework remains the most widely used model for evaluating the impact of funded health
research programmes; it has been extensively applied, and sometimes adapted and refined by various
research groups. Twenty-seven out of the 110 empirical studies of impact published since 2005 were
based at least partly on the Payback Framework. Other robust models that show promise in capturing the
diverse forms of health and non-health impacts from research include the Canadian Academy of Health
Sciences framework, the research impact framework and various approaches to considering the monetised
impacts of health research.
Different models and approaches rest on different assumptions. Some logic models imply a more or
less linear link between a funded programme of research and its subsequent impacts, although most
contemporary logic models acknowledge, and seek to capture, multiple intervening influences on this link.
Social scientists tend to take a ‘complex systems’ approach, arguing that an emphasis on ‘hard’ (that is,
measurable and attributable) impacts is misplaced and that more attention should be given to the
relationships and ‘productive interactions’ occurring in a multistakeholder network. The most widely used
models (notably the Payback Framework) are eclectic and pragmatic, supplementing an underlying logic
model with attention to the key relationships and interactions at different stages in the chain of causation.
Such approaches enable factors in the organisation of research to be identified that seem to be associated
with an increased possibility of achieving impact, for example collaboration to set research agendas
relevant to needs of the health-care system.
We identified three emerging literatures that have particular potential to inform the HTA’s assessment
of the impact of its future research programmes: (1) approaches to measuring monetised impact;
(2) approaches to assessing the contribution of randomised controlled trials (RCTs) to systematic reviews
and meta-analyses; and (3) approaches to assessing the contribution of RCTs to stopping treatments that
are ineffective. The case study approach to impact assessment in the 2014 REF, published just as this
report was going to press, also deserves attention.
Discussion
Summary of options and recommendations
The findings of this review support the continued use of the Payback Framework by the HTA programme.
The fact that the programme’s funding, like the rest of NIHR, comes from the funds allocated to the
Department of Health, means that a major part of the impact must be concerned with meeting the needs
of the NHS. Changes in the structure of the NHS, the development of NHS England and changes in the
National Institute for Health and Care Excellence’s remit pose new challenges relating to identifying, and
meeting, current and future research needs.
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The social science literature highlights the importance of building and maintaining relationships between
different stakeholders in the design and conduct of research (including sponsors, researchers, citizens and
policy-makers) in order to build a shared understanding of research priorities and create interest and
engagement in particular programmes of work (hence, improve dissemination and impact after these
are complete).
Logic models that assume a more or less direct link between a programme of work and its subsequent
impact (e.g. funding a clinical trial of a drug or procedure, which influences a guideline, which, in turn,
influences clinical practice and thence patient outcomes) may be appropriate for the bulk of HTA-funded
research, especially systematic reviews and trials. These models, however, may need to be modified and/or
supplemented by other approaches when the research programme addresses such issues as organisational
change or the collaborative development of research partnerships, such as Collaborations for Leadership in
Applied Health Research and Care.
Future assessments of the impact of the HTA programme will have to take account of wider policy
changes, notably the REF, which may continue to rely on peer review of case studies as a measure of
impact. Besides searching the REF case studies to identify examples of work funded by the HTA
programme, a recommendation for future research is to explore how case studies of impact from
programmes such as the HTA should be structured in the future. The selection of case studies, such as in
the REF, but also more generally tends to be biased towards ‘good news’ stories. Other fields indicate that
much can be learnt from failures.
The adoption of researchfish by most major UK research funders also has implications for future
assessments of impact. Although the routine capture of indexed research publications has merit, the
degree to which researchfish will succeed in collecting other, non-indexed outputs and activities remains to
be established.
One option for the HTA programme is to plan how best to meet the data requirements of future impact
assessments, both those undertaken by the programme but also external assessments such as the REF.
The likely data requirements of future assessments of impact and of the REF need to be planned for,
and included, either in management information systems or in special projects.
We recommend a review of case studies and their application to health research, including the 2014 REF,
combined with independent preparation of case studies of new HTA projects. This review should include
both successful and unsuccessful projects. It should also include cases regarding the monetisation of
impact and the linking of trials to systematic reviews and guidelines. Particular case studies might contrast
the tracing forward/backward methods of linking particular research projects to policy changes.
Research is required on the role of ongoing electronic data collection of the kind involved with
researchfish. This should assess the strengths and weaknesses of this approach, the extent of bias, such as
towards indexed publications, and the extent of researchers’ compliance and their concerns about
this approach.
Research is also required on optimal methods for assessing the impact of randomised trials on systematic
reviews and guidelines. The York/Patient-Centered Outcomes Research Institute’s methods currently
being piloted by the HTA programme should be evaluated along with the scope for use of Grading of
Recommendations Assessment, Development and Evaluation. This research should also address ways of
assessing the value of randomised trials and meta-analyses that show no statistically significant difference
between interventions.
In relation to NIHR more widely, research is required on the appropriate measures of impact for its research
programmes and initiatives other than the HTA programme.
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Conclusions
Research funders can benefit from continuing to monitor and evaluate the impacts of the studies they
fund. Besides continuing to use the Payback Framework, they might consider how best it might assist data
collection relating to estimating impact in monetary terms. They might also routinely assess the impact of
the trials it funds on subsequent systematic reviews and clinical guidelines.
Financial constraints on health services mean that health research must demonstrate societal impact and
value for money. Methods for doing so have developed considerably in the last few years. Although not
without caveats, these methods should be applied routinely to help safeguard the effectiveness and
cost-effectiveness of research programmes.
Funding
Funding for this study was provided by the HTA programme of the NIHR.
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Chapter 1 Introduction
Assessing the impact of health research has become a major concern, not least because of claims thatthe bulk of research currently undertaken is wasteful.1 As publicly funded research is often organised
in ‘programmes’, assessment of impact must consider a stream of projects, sometimes interlinked. The
Health Technology Assessment (HTA) programme, as the name implies, is such a programme, funding
mainly a mix of systematic reviews and randomised controlled trials (RCTs). In a previous review, Hanney
et al.2 assessed the impact of the first 10 years of the NHS HTA programme from its inception in 1993 to
June 2003 and identified factors that helped make an impact, including, first, the fact that the topics tend
to be relevant to the NHS and to have a policy customer and, second, the strengths of the scientific
methods used coupled with strict peer review.2,3 That assessment included a review of the literature
published up to 2005 on the methods for assessing the impact from programmes of health research.
Evidence explaining why this research is needed now
Internationally, there has been a growing interest in assessing the impact of programmes of health
research, and recent developments in the UK have created a new context for considering impact
assessment. Besides the claim that much research is wasteful, other factors include pressure on higher
education institutions to demonstrate accountability and value for money, the expansion in routine
collection of research impact data and the large-scale assessment of research impact in higher education
through case studies in the Research Excellence Framework (REF).
Aim
To review published research studies on tools and approaches to assessing the impact of programmes of health
research and, specifically, to update the previous 2007 systematic review funded by the HTA programme.2
Objective
Our objective was to build on the previous HTA review2 (published in 2007, covering the literature up to 2005) to:
1. identify the range of theoretical models and empirical approaches to measuring impact of health research
programmes, and collate findings from studies assessing the impact of multiproject programmes
2. extend the review to examine (1) the conceptual and philosophical assumptions underpinning different
models of impact and (2) emerging approaches that might be relevant to the HTA programme, such as
studies focusing on monetised benefits and on the impact of new trials on systematic reviews
3. analyse different options for taking impact assessment forward in the National Institute for Health
Research (NIHR)/HTA programme, including options for drawing on routinely collected data.
Structure of the report
Chapter 2 describes the methods used for the review, Chapter 3 reports the findings from the updated
review, Chapter 4 presents a broader taxonomy of impact models, Chapter 5 provides the findings on the
monetary value of the impact of health research, Chapter 6 reports on the impact of trials on systematic
reviews, Chapter 7 summarises the impact of trials on discontinuing the use of technologies and Chapters 8
and 9 provide a discussion of the main findings, including options for NIHR/HTA to take research impact
assessment forward and draw conclusions from the report, and discuss recommendations for future
impact assessment.
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Chapter 2 Methods
The work was organised into three streams: the first stream focused on updating and extending theprevious 2007 review;2 the second stream involved an extension of the literature in relation to the
conceptual and philosophical assumptions on different models of impact and their relevance to the HTA
programme; and the third stream considered the different options for taking impact assessment forward in
the NIHR/HTA programme.
This chapter provides an account of the methods common to these streams of work. Where there were
differences because of the type of review conducted, further explanation is provided under the relevant
work stream.
Review methods
Given the nature and scope of the reviews included, a range of methods were used to identify the
relevant literature:
1. systematic searching of electronic databases
2. hand-searching of selected journals
3. citation tracking of relevant literature
4. literature known to the team (i.e. snowballing)
5. bibliographic searches of other reviews
6. bibliographic searches of references in identified relevant literature.
Search strategies
Although different search strategies were conducted for the different elements, details of the individual
search strategies can be found below (see Appendix 1 for full listing of the search strategies used).
Update to the previous review methods
The previous assessment of the impact of the HTA programme2 was informed by a review of the literature
on assessing the impact of health research. It found an initial list of approximately 200 papers, which was
reduced to a final ‘body of evidence’ of 46 papers: five conceptual/methodology, 23 application and 18
combined conceptual and application (please refer to the original Hanney et al.2 report for a full list of
these references). (In that review, as in the current one, ‘paper’ refers generically to the full range of
publications, including reports in the grey literature.) The discussion included an analysis of the strengths,
and weaknesses, of the conceptual approaches. The Payback Framework, the most widely used approach,
was considered the most appropriate framework to adopt when measuring the impact of the HTA
programme, notwithstanding the limited progress made in various empirical studies in identifying the
health and economic benefit categories from the framework.
The first question for the updated review was: ‘what conceptual or methodological approaches to
assessing the impact of programmes of health research have been developed, and/or applied in empirical
studies, since 2005?’.2
The second question was: ‘what are the quantitative findings from studies (published since 2005)
that assessed the impact from multiproject programmes (such as the HTA programme)?’.
DOI: 10.3310/hta20760 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 76
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Raftery et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
3
Search strategy development
The information scientist (Alison Price) evaluated the search strategy run in the previous report.2 We used
the same search strategy, but checked to identify any new medical subject headings and other new
indexing terms. We also reviewed Banzi’s search strategy,4 a modified version of our original strategy. The
review by Banzi et al.4 searched in only two bibliographic databases (MEDLINE and The Cochrane Library),
whereas we searched a larger number (see Databases searched). By not including the EMBASE database,
Banzi et al.4 may have missed some relevant indexed journals. For example, the journal in which the Banzi
review was published, Health Research Policy and Systems, was indexed in EMBASE and not in MEDLINE
until later. We included EMBASE indexing terms, as applied to the Banzi et al.4 paper, in our expanded
EMBASE search strategy.
Any new and relevant indexing terms were evaluated and added to the revised search strategies.
The search strategies used text words and indexing terms to capture the concept of the impact of health
research programmes. The search results were filtered by study and publication types. The new terms
increased the sensitivity of the search, while the filters improved the precision and study quality of
the results.
Databases searched
The searches were run in August 2014 for the publication period from January 2005 to August 2014 in
the following electronic databases: Ovid MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations,
EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), The Cochrane Library,
including the Cochrane Methodology Register, HTA Database, the NHS Economic Evaluation Database
(NHS EED) and Health Management Information Consortium (HMIC), which includes grey literature such as
unpublished papers and reports (see Appendix 1 for a full description of the search strategies).
Other sources to identify literature
A list of known studies, including those using a range of approaches in addition to the Payback Framework,
was constructed by SH. This list was used to inform aspects of the database search and help identify which
journals to hand-search. These journals were Health Research and Policy and Systems, Implementation
Science, International Journal of Technology Assessment in Health Care and Research Evaluation.
A list of key publications was constructed and the references were searched for additional papers. The list
consisted of major reviews published since 2005 (that were already known to the authors, and/or were
identified in the search) and key empirical studies.4–19
For studies reporting on the development and use of selected conceptual frameworks, we took the main
publication from each as the source for citation tracking using Google Scholar (Google Inc., Mountain
View, CA, USA). The list was supplemented by citation tracking of selected key publications, although we
considered only post-2005 citations of any papers that were published before that date.
Inclusion/exclusion criteria
We included studies if they described:
1. conceptual or methodological approaches to evaluating the impact of programmes of health research
2. the empirical evaluation of the impact of a particular programme of health research.
Studies were excluded if they provided only speculation on the potential impact of proposed (future)
research [including recent studies on the value of information (VOI)], discussed the impact of research
solely in the context of wide and intangible benefits (such as for the good of society and for the overall
benefit of the population), or only considered impact in terms of guidance implementation. These
inclusion/exclusion criteria repeated those used for the original review that aimed to identify appropriate
approaches for retrospective assessment of the impact from the first decade of the HTA programme. VOI
studies were not seen as relevant for such a review. Similarly, our review focused on the impact of specific
METHODS
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pieces and programmes of research; it was beyond the scope of this study to consider the impact of
guidelines based on multiple studies from different programmes of research. Therefore, our focus was on
the implementation of that specific research and not on the implementation of guidelines in general.
Our focus on programmes of research highlights the perspective of funders who are interested in
identifying the impact of the body of work, at some level of aggregation. We also expanded the use of the
term ‘programme’ to included empirical studies focusing on bodies of research conducted by research
centres or groups, or a collection of studies around a common theme and conducted in a way that the
researchers collectively might view as a programme.
In the 2007 report, we distinguished ‘first, studies that start with a body of research and examine its
impact and, second, those that consider developments within the health sector, especially policy decisions,
and analyse how far research, from whatever source, influenced those developments’.2 The latter category
of studies, which would have been large, was excluded to allow us to focus on studies that worked
forwards to trace the impact from specific programmes of research. Since 2005, there have been further
major reviews of studies of policy-making and how research evidence is used.5,8,20,21 We examined these
reviews to help identify studies to include. Again, we did not include studies that explored how research
was utilised by policy-makers unless the focus was on the impact made by a specific body of research.
In relation to studies setting out options for research impact assessment, we generally included the study if
it made some proposal based on the review or analysis, and if the proposed approach could, at least in theory,
have a reasonable chance of being used to assess impact of health research programmes.8 We also included
reviews that usefully collated data on issues such as the methods and conceptual frameworks used in studies.5
Steve Hanney and AY independently went through the papers and applied the criteria (set out above) to at
least the abstract of each paper identified. The studies were classified using the same criteria as previously
applied; ‘includes’, ‘possible includes’ and ‘interest papers’, with scope for iteration. Agreement on
inclusion was resolved by discussion by SH and AY. Where agreement could not be made, the final
decision was made through further discussion with JR and/or TG.
Data extraction
We constructed a data extraction sheet based on a simplified version of the one previously used.2 It
covered basic details such as author, title and date; type of study; conceptual framework and methods
used in impact assessment; categories of impacts assessed and found; identification of whether or not the
study attempted to assess the impact from each project in a multiproject programme; conflicts of interest
declared; strengths and weaknesses; factors associated with impact; and other reviewer comments and
quotes (see Appendix 2 for full details).
The data extraction sheet was applied to the papers by SH, TG, MG, JR and AY. Each member of the team
considered the list of ‘includes’, avoiding papers on which he/she had been an author. As anticipated,
some papers were removed following more detailed examination at the data extraction stage.
Extension of the literature methods
The second stream formed four parts:
1. exploring the conceptual and philosophical assumptions of models of impact
2. monetary value on the impact of health research
3. the impact of randomised trials on systematic reviews
4. the impact of randomised trials on stopping the use of particular technologies.
The methods for each part are discussed below.
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Conceptual and philosophical assumptions of models of impact
This stream aimed not merely to update the previous review but to extend its scope. Although much has
been published in the past 10 years on different models of impact, less attention has been paid to
theorising these models and critically exploring their conceptual and philosophical assumptions. We sought
to identify, and engage theoretically with, work from the social sciences that questioned the feasibility and
value of measuring research impact at all.
For this extension, we captured key papers from the main search described above and added selected
studies published before 2005 if they provided important relevant insights. A modified data extraction
sheet was developed (see Appendix 2).
For the theoretical component, we grouped approaches primarily according to their underlying
philosophical assumptions (distinguishing, for example, between ‘positivist’, ‘constructivist’, ‘realist’,
and so on) and, within those headings, by their theoretical perspective. We compared the strengths and
limitations of different philosophical and theoretical approaches using narrative synthesis.
This stream also sought to tease out any approaches from the sample of papers identified in the updated
review that might be especially relevant to the HTA programme. We were already aware of some papers
on monetisation of research impacts, quantifying the contribution of RCTs to secondary research and to
discontinuation of ineffective technologies. These three topics were themes in our searches and analysis.
Monetary value on the impact of health research
We considered approaches to monetising the value of the health gain arising from medical research.
We reviewed key recent developments in this field, in the context of prior knowledge of several recently
published studies, including the Medical Research: What’s it Worth report,22 which was widely cited to
support medical research funding in the Government’s 2010 Spending Review.23 We also included work by
members of the review team (SH and MG), and others, on the monetised benefits from cancer research,
and studies from Australia.24–26 These studies also provided the context for an analysis to examine a subset
of research supported by HTA.27 An additional, complementary, thorough search of the literature was
performed using Buxton et al.28 as a starting point.
The purpose of this additional search was to identify studies since 2004 that have used any methods
to attempt to value (in monetary terms) the benefits (health and cost savings) of a body of health research
(e.g. disease-specific level, programme level, country level) and link that with an investment in the body
of research.
Economic returns from health research can be considered in two categories: (1) the population health
gains from improvements in mortality and morbidity, which can be monetised using various approaches
(cost savings or increases in cost of delivery of new technologies can be incorporated into this
monetisation); and (2) the wider economic benefits that contribute to gross domestic product (GDP)
growth through mechanisms such as innovation, new technologies and patents – ‘spill-over’ effects.
The focus was on identifying studies that have at least included a component concerned with the first
category of returns. Although the main literature review was limited to programmes of health research,
this extension included studies that considered other units of analysis, such as by disease.
Search strategy
A supplementary search to the main review was run in October 2014 to ensure that no relevant papers
were omitted. Searches of the following databases were performed: Ovid MEDLINE, EMBASE, The
Cochrane Library, NHS EED and the HMIC from January 2003 to October 2014 (see Appendix 1 for full
details of the database searches).
METHODS
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Studies were included if they contained a component that quantified the returns from investment in
medical research, by attaching a monetary value to hypothetical or realised health gains of conducted
research. Studies that discussed or estimated the value of conducting future research to eliminate decision
uncertainty (expected VOI) were excluded.
Impact of randomised trials on systematic reviews
The importance of summarising available evidence before conducting new trials and using new trials to
update and correct systematic reviews has long been argued29 and was embraced by the HTA programme
from its start.30 Impact on policy, such as guidance from the National Institute for Health and Care
Excellence (NICE), relies, where possible, on systematic reviews rather than on individual trials. Although
some 70% of HTA-funded trials cite a preceding systematic review, little work has been done on the
impact such trials have on updating and correcting systematic reviews.31 This element of the review tried to
identify examples of attempts to do this, and explore literature relating to how the contribution of a
randomised trial to a subsequent systematic reviews might be established.
Search strategy
Alison Price conducted a supplementary search to the main review in October 2014. The search identified
54 articles (see Appendix 1 for search terms). Two were added based on the review of citations. In
addition, the literature on VOI was reviewed, as variants of this rely heavily on systematic reviews.
The identified articles comprised those that were descriptive, those relating to the use of systematic
reviews in designing future trials and relating to VOI (and its variants).
Impact of randomised trials on stopping the use of particular technologies
This considered the impact that single randomised trials might have in stopping the use of particular
technologies. Examples of such trials funded by the HTA programme include trials of water softening
for eczema,31 and larvae for wound healing.32 Their negative findings were probably definitive, but
conventional methods might not capture their full impact. We explored the relevant literature with a focus
on trials that were ‘first in class’ or ‘biggest in class’.
Search strategy
Alison Price conducted two supplementary searches to the main literature review in March 2015 on the
following databases: Ovid MEDLINE without Revisions from 1996 to March 2015, week 2; EMBASE from
1996 to 2015, week 10; and Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations.
The first search (using Ovid MEDLINE) identified 52 articles (see Appendix 1 for full details of the database
searches) and the second search (again using Ovid MEDLINE) identified 55 articles.
Data extraction
If there was more than one version of a report, only one version was included. For example, we included
only one 2012 report from the Higher Education Funding Council for England (HEFCE) outlining plans for
the assessment of the impact of research conducted in UK higher education through means of the REF.33
Similarly, the same criteria applied to annual sets of publications of research impact from funders such
as the Medical Research Council (MRC) and the Wellcome Trust.
Rather than having two lists of partially overlapping papers relating to Chapters 3 and 4, we merged the
two emerging lists into one list of papers. Thus, the numbers in Chapter 3 represent the numbers for both
the updated review plus key papers from those described in Chapter 4.
EndNote X7 (Thomson Reuters, CA, USA) reference management database was used to store the relevant
papers obtained from the different sources used.
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Chapter 3 Updated systematic review
The purpose of the current review was to update the previous review,2 including a summary of the rangeof approaches used in health research impact assessment, and to collate the quantitative findings from
studies assessing the impact of multiproject programmes. First, we present a summary of the literature
that is reported in the large number of studies. Second, we describe 20 conceptual frameworks, or
approaches that are the most commonly used and/or have the most relevance for assessing the impact
of programmes such as the HTA programme. Third, we briefly compare the 20 frameworks. Fourth, we
discuss the methods used in the various studies, and describe a range of techniques that are evolving.
Fifth, we collate the quantitative findings from studies assessing the impact of multiproject programmes,
such as the HTA programme, and analyse the findings in light of the full body of evolving literature.
Review findings
The number of papers identified though each source is set in Table 1. A total of 513 records were
identified, of which 161 were eligible; databases directly identified only 40 of these 161 (see Appendix 3,
Table 14, for a brief summary of each of the 161 references) (Figure 1).
TABLE 1 Type of sources used to identify relevant literature
Source used to identify the literature Number of records identified
Database 40
Hand-search 14
Reference list 41
Citation track 23
Known to the team/snowballing 43
Total 161
Records screened
(n = 513)
Records excluded
(n = 332)
Full-text articles
assessed for eligibility
(n = 181)
Studies included in 
main review
(n = 161)
Full-text articles
excluded, with reasons
(n = 20)
Records identified through
database searching
(n = 297)
Additional records identified
through other sources
(n = 216)
FIGURE 1 Flow diagram of identified studies.
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Summary of the literature identified
From the initial searching and application of the inclusion criteria, the number of publications identified
this time was approximately three times the 46 included in the ‘body of evidence’ for the 2007 review.2
Using wider criteria, we ended up with a list of 161.
We classified 51 as conceptual/methodological papers (including reviews), 54 as application papers and
56 as both conceptual and application papers (these are classified and reported in Appendix 3, Table 14,
under column ‘Type’). The 51 conceptual and methodological papers not only reflect an increase in the
discussion about appropriate frameworks to use but also reflect the wider criteria used in the extension to
the update, including some pre-2005 publications. Thus, a simple comparison between the 51 conceptual
papers in the update and the five in the previous review would not be appropriate.
The papers come predominantly from four English-speaking nations (Australia, Canada, the UK and the
USA), with clusters from the Netherlands and Catalonia/Spain. We also identified an increasing number of
health research impact assessment studies from individual low- and middle-income countries, as well as
many covering more than one country, including European Union (EU) programmes and international
development initiatives.
Some of the studies on this topic are published in the ‘grey literature’, which probably means they are
even more likely to be published in local languages than they would be if they were in the peer-reviewed
literature. This exacerbates the bias towards a selection of publications from English-speaking nations that
arises from the inclusion of publications if they are available only in English.
Appendix 3 (see Table 14) lists the 161 included studies with a brief summary of each. We note basic data
such as lead author, year, type of study (method, application, or both) and country. The last item has
become more complicated with the increase in the range of studies conducted. We prioritised the location
of the research in which impact was assessed rather than the location of the team conducting the impact
assessment. Similarly, for reviews or other studies intended to inform the approach taken in a particular
country, it is important to identify the location of the commissioner of the review, if different from the
team conducting the study. We also recorded the programme/specialism of the research in which impact
was assessed, and the conceptual frameworks and methods used to conduct the assessment. A further
column covers the impacts examined and a brief account of the findings. The final column offers
comments, and quotes, where appropriate, on the strengths and weaknesses of the impact assessment
and factors associated with achieving impact.
We also identified a range of papers that were of some interest for the review, but the papers did not
sufficiently meet the inclusion criteria (see Appendix 4 for further details of these papers).
The included studies demonstrate that the diversity and complexity of the field has intensified. It has long
been recognised that research might be used in many ways, even in relation to just one impact category,
such as informing policy-making.34,35 Within any one impact assessment, there can be many different ways
and circumstances in which research from a single programme might be used. Furthermore, as a detailed
analysis of one of the case studies described in Wooding et al.36 illustrated, even a single project or stream
of research might make an impact in various different ways, some relying on interaction between the
research team and potential users and some through other routes.
The diversity in the approaches is also linked to the different types of research (basic, clinical, health
services research, etc.) and fields, the various modes of research funding (responsive, commissioned, core
funding, research training), and the diverse purposes and audiences for impact assessments. These are
considered at various points in this review.
UPDATED SYSTEMATIC REVIEW
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The 51 conceptual/methodological papers in Table 14 (see Appendix 3) illustrate the diversity. Some of
these 51 papers developed new conceptual frameworks and some reviewed empirical studies and used the
review to propose new approaches. Others analysed existing frameworks trying to identify the most
appropriate frameworks for particular purposes. RAND Europe conducted one of the major streams of
such review work. These reviews include background material informing the framework for the Canadian
Academy of Health Sciences (CAHS),37 an analysis commissioned by the HEFCE to inform the REF,38 and a
review commissioned by the Association of American Medical Colleges.9
Such reviews represent major advances in the analysis of methods and conceptual frameworks, and each
compares a range of approaches. They often focus on a relatively small number of major approaches.
Although Guthrie et al.9 identified 21 frameworks, many are not health specific and they vary in how far
the assessment of impact features in the broader research evaluation frameworks.
Our starting position was different, and aimed to complement this stream of review work. We collated and
reviewed a much wider range of empirical studies, in addition to the methodological papers. We not only
identified the impacts assessed, but also considered the findings from empirical studies, both to learn what
they might tell us about approaches to assessing research impact in practice and also to provide a context
for the assessment of the second decade of the HTA programme.
In selecting the conceptual frameworks and methods on which to focus, we thought it was important to
reflect the diversity in the field as far as possible, but at the same time focus on analysis of approaches
likely to be of greatest relevance for assessing the impact of programmes such as the HTA programme.
Conceptual frameworks developed and/or used
We identified a wider range of conceptual frameworks than in the previous review. How the 20 frameworks
were used can be seen later (see Table 2). We have grouped the discussion of conceptual frameworks into
three main sections. The data are presented in ways that allow analysis from several perspectives. First,
we present a historical analysis that helps to identify which frameworks have developed from those included
in the 2007 review. Second, we order the frameworks by the level of aggregation at which they can be
applied. Having briefly introduced each of the frameworks we then present them in tabular form under
headings, such as the methods used, impacts assessed, strengths and weaknesses. Finally, in our analysis
comparing the frameworks we locate each one on a figure with two dimensions: categories of impacts
assessed and focus/level of aggregation at which the framework has primarily been applied.
The three main groups of frameworks are:
1. Post-2005 application, and further development, of frameworks described in the 2007 review, and
reported in the order first reported in 2007 (five frameworks).
2. Additional frameworks or approaches applied to assess the impact of programmes of health research,
and mostly developed since 2005 (13 frameworks). (These are broadly ordered according to the focus
of the assessment, starting with frameworks that are primarily used to assess the impact from the
programmes of research of specific funders, then frameworks that are more relevant for the work of
individual researchers and, finally, approaches for the work of centres or research groups.)
3. Recent generic approaches to research impact developed and applied in the UK at a high level of
aggregation, namely regular monitoring of impacts [e.g. via researchfish® (researchfish Ltd, Cambridge,
UK)] and the REF (two frameworks or approaches).
Post-2005 applications of frameworks described in the 2007 review
Five are listed as follows:
1. the Payback Framework39
2. monetary value approaches to estimating returns from research (i.e. return on investment, cost–benefit
analysis, or estimated cost savings)
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3. the approach of the Royal Netherlands Academy of Arts and Sciences (2002)40
4. a combination of the frameworks originally developed in the project funded by the UK’s Economic and
Social Research Council (ESRC) on the non-academic impact of socioeconomic research41 and in the
Netherlands in 199442 [this became the Social Impact Assessment Methods through the study of
Productive Interactions (SIAMPI)]
5. detailed case studies and follow-up analysis, on HTA policy impacts and cost savings: Quebec Council of
Health Care Technology assessments (CETS).43,44
The Payback Framework
The Payback Framework consists of two main elements: a multidimensional categorisation of benefits and a
model to organise the assessment of impacts. The five main payback categories reflect the range of benefits
from health research, from knowledge production through to the wider social benefits of informing policy
development, and improved health and economy. This categorisation, which has evolved, is shown in Box 1.
Although a detailed account of the various impact categories is available elsewhere,2 key recent aspects of
the framework’s evolution relate to headings number 2 and 5 in Box 1.
BOX 1 Example of the multidimensional categorisation of paybacks of the Payback Framework
1. Knowledge
l Journal articles, conference presentations, books, book chapters and research reports.
2. Benefits to future research and research use
l Better targeting of future research.
l Development of research skills, personnel and overall research capacity.
l A critical capacity to absorb and appropriately utilise existing research, including that from overseas.
l Staff development and educational benefits.
3. Benefits from informing policy and product development
l Improved information bases for political and executive decisions.
l Other political benefits from undertaking research.
l Development of pharmaceutical products and therapeutic techniques.
4. Health and health sector benefits
l Improved health.
l Cost reduction in delivery of existing services.
l Qualitative improvements in the process of delivery.
l Improved equity in service delivery.
5. Broader economic benefits
l Wider economic benefits from commercial exploitation of innovations arising from R&D.
l Economic benefits from a healthy workforce and reduction in working days lost.
R&D, research and development.
Source: adapted from Donovan and Hanney.45
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In the ‘Benefits to future research and research use’ category, the subcategory termed ‘A critical capacity
to absorb and appropriately utilise existing research, including that from overseas’ had proven difficult to
operationalise in applications of the Payback Framework. However, a more recent evidence synthesis46
incorporated this concept into a wider analysis of the benefits to the health-care performance that might
arise when clinicians and organisations engage in research. Although the evidence base is disparate, a
range of studies was identified that suggested when clinicians and health-care organisations engaged in
research there was a likelihood of improved health-care performance. Identification of the mechanisms
through which this occurs contributes to the understanding of how impacts might arise, and increases the
validity of some of the findings from payback studies in which researchers claim that research is making an
impact on clinical behaviour in their local health-care systems.
In the ‘Broader economic benefits’ category, recent developments emphasise approaches that monetise
the health gains per se from research, rather than assessing the economic benefits from research in terms
of valuing the gains from a healthy workforce.26 Nason et al.47 applied the Payback Framework in a way
that highlighted the economic benefits category and identified various subcategories.
The payback model is intended to assist the assessment of impact and is not intended necessarily to be a
model of how impact arises. It consists of seven stages and two interfaces between the research system and
the wider environment, with feedback and also the level of permeability at the interfaces being key issues:
developments do not necessarily flow smoothly, or even at all, from one stage to the next (Figure 2).
As noted in the 2007 review,2 although the framework is presented as an ‘input–output model’, it ‘also
captures many of the characteristics of earlier models of research utilisation’ such as those of Weiss34 and
Kogan and Henkel.49 The framework recognises that research might be utilised in various ways. It was
devised to assess the impact of the Department of Health/NHS programme of research, a programme in
which development was informed by Kogan and Henkel’s earlier analysis of the department’s research and
development.49 That analysis had promoted the idea that collaboration between potential users and
researchers was important in encouraging the commissioning of research that was more likely to make an
impact. Partly, the development of the Payback Framework was a joint enterprise between the Department
of Health and the Health Economics Research Group.50 The inclusion in the updated review of the findings
from the application of the framework to the assessment of the first decade of the HTA programme
illustrates the context within which the framework seems best suited.
The conceptual framework informs the methods used in an application; hence, documentary analysis,
surveys and case study interview schedules are all structured according the framework, which is also used to
organise the data analysis and present case studies in a consistent format. The various elements were
devised both to reflect and capture the realities of the diverse ways in which impact arises, including as a
product of interaction between researchers and potential users at agenda-setting and other stages. The
emphasis on examining the state of the knowledge reservoir at the time of research commissioning enables
some evidence to be gathered that might help explore issues of attribution, and possibly the counterfactual,
because it forces consideration of whatever other work might have been going on in the relevant field.
One of the limitations of the Payback Framework, and various other frameworks, arises because of the
focus on single projects as the unit of analysis, when it is often argued that many advances in health care
should be attributed to a body of work. This ‘project fallacy’ is widely noted, including by many who apply
the framework. In some studies applying the framework, for example to the research funded by Asthma
UK,51 the problem was acknowledged in the way in which case studies that started with a focus on a
single project were expanded to cover streams of work. Although some studies have been able to apply a
version of the framework to demonstrate considerable impact from single studies,52 this has tended to be
in particular types of research – in this case, intervention studies.
Some studies applied the framework in new ways, as noted in Table 14 (see Appendix 3). This might lead
to welcome innovation, but also to applications that do not recognise the importance of features such as
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the interfaces between the research system and the wider environment and the desirability of capturing
aspects such as the level of interaction prior to research commissioning.
Despite the challenges in application, 27 of our 110 empirical studies published since 20052,36,47,51–74
claim their framework is based either substantially or partly on the Payback Framework (Table 2).
In addition, the Payback Framework also informed the development of several other frameworks, especially
the framework from the CAHS.7 Furthermore, the framework based on the review by Banzi et al.4 built
on both the Payback Framework and the CAHS’s Payback Framework. The Payback Framework also
contributed to the development, by Engel-Cox et al.,63 of the National Institute of Environmental Health
Sciences (NIEHS) framework.
TABLE 2 Empirical studies using the 20 selected frameworks/approaches
Framework/approach (in order presented
in text of Chapter 3)
Empirical studies applying the framework or drawing on aspects
of it
Payback Framework Action Medical Research, 2009;54 Anderson, 2006;55 Aymerich et al.,
2012;56 Bennett et al., 2013;57 Catalan Agency for Health Technology
Assessment and Research, 2006;58 Bunn, 2010;59 Bunn and Kendall,
2011;60 Bunn et al., 2014;61 Cohen et al., 2015;52 Donovan et al.,
2014;62 Engel-Cox et al., 2008;63 Expert Panel for Health Directorate of
the European Commission’s Research Innovation Directorate General,
2013;53 Guinea et al., 2015;64 Hanney et al., 2007;2 Hanney et al., 2013;51
Kalucy et al., 2009;65 Kwan et al., 2007;66 Longmore, 2014;67 Nason et al.,
2011;47 NHS SDO, 2006;68 Oortwijn, 2008;69 Reed et al., 2011;70 RSM
McClure Watters et al., 2012;71 Schapper et al., 2012;72 Scott et al.,
2011;73 The Madrillon Group, 2011;74 and Wooding et al., 201436
Monetary value Deloitte Access Economics, 2011;25 Guthrie et al., 2015;27 Johnston et al.,
2006;75 MRC, 2013;76 Murphy, 2012;77 and Williams et al., 200878
Royal Netherlands Academy of Arts and
Sciences and others
Royal Netherlands Academy of Arts and Sciences 201079
Social impact assessment model through the
study of productive interactions
Meijer, 2012;80 and Spaapen et al., 201181
Quebec Council of Health Care Technology’s
assessments
Bodeau-Livinec et al., 2006;82 and Zechmeister and Schumacher,
201283
CAHS Adam et al., 2012;84 Aymerich et al., 2012;56 Cohen et al., 2015;52
Graham et al., 2012;85 Saskatchewan Health Research Foundation,
2013;86 and Solans-Domenèch et al., 201387
Banzi’s research impact model Laws et al., 2013;88 and Milat et al., 201389
National Institute of Environmental Health
Sciences’s logic model
Drew et al., 2013;90 Engel-Cox et al., 2008;63 Liebow et al., 2009;91
Orians et al., 200917
Medical research logic model (Weiss) Informed various approaches rather than being directly applied
National Institute for Occupational Health and
Safety’s logic model
Williams et al., 200992
The Wellcome Trust’s assessment framework Wellcome Trust, 201493
VINNOVA Eriksen and Hervik, 200594
Flows of knowledge, expertise and influence Meagher et al., 200895
Research impact framework Bunn, 2010;59 Bunn and Kendall, 2011;60 Bunn et al., 2014;61
Caddell et al., 2010;96 Kuruvilla et al., 2007;97 Schapper et al., 2012;72
and Wilson et al., 201098
Becker Medical Library model Drew et al., 2013;90 and Sainty, 201399
continued
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Monetary value approaches to estimating returns from research (i.e. return
on investment, cost–benefit analysis or estimated cost savings)
These approaches differ in the scope of the impacts that are valued and the valuation method adopted. In
particular, since 2007 further methods have been developed that apply a value to, or monetise, the health
gain resulting from research. Much of this work assesses the impacts of national portfolios of research, and
is thus at a higher level of aggregation than that of a programme of research. Most of the studies of this
are, therefore, not included here in Chapter 3, but are described in Chapter 5, which looks specifically at
such developments. Nevertheless, three studies25,27,75 from this stream do assess the value of a programme
of work and so are included in the update. Of the three, Guthrie et al.27 and Johnston et al.75 are the
clearest applications of this approach to specific research programmes.
Furthermore, many econometric approaches to assessing research impact do not relate to the impact of
specific programmes of research. However, an increasing number of frameworks have been developed
that propose ways of collecting data from specific projects or programmes that can be built up to provide
a broader picture of economic impacts. For example, Muir et al.107 developed an approach for measuring
the economic benefits from programmes of public research in Australia. Other work includes the
development of frameworks by the UK department responsible for science; the Department of Business,
Innovation and Skills (BIS) and, earlier, the Department for Innovation, Universities and Science108
developed frameworks under which the department collects data on economic benefits from each
research council’s programmes of research, including the MRC.76 The impacts include patents, spin-offs,
intellectual property income; and data collection overlaps with the approach of regular collection of data
from the MRC described below (see Regular monitoring or data collection).76
A further category in the BIS framework is data on the employment of research staff. The classification of
such data as a category of impact is part of a wider trend, but is controversial. However, in political
jurisdictions, such as Ireland47 or Northern Ireland,6 it might be appropriate to consider the increased
employment that comes as a result of local expenditure of public funds leveraging additional research
funds from other sources.
To varying degrees the assessment of economic impacts can form part of wider frameworks, including
the Payback Framework, as in the two Irish examples above, and the VINNOVA approach described by
Eriksen and Hervik94 (see VINNOVA).
TABLE 2 Empirical studies using the 20 selected frameworks/approaches (continued )
Framework/approach (in order presented
in text of Chapter 3)
Empirical studies applying the framework or drawing on aspects
of it
Societal quality score (Leiden University
Medical Centre)
Meijer, 2012;80 and Mostert et al., 2010100
Research performance evaluation framework Schapper et al., 201272
Realist evaluation Evans et al., 2014;101 and Rycroft-Malone et al., 2013102
Regular monitoring Drew et al., 2013;90 MRC, 2013;103 MRC, 2013;76 and Wooding
et al., 2009104
REF (informed by Research Quality Framework) Cohen et al., 2015;52 Group of Eight and Australian Technology
Network of Universities, 2012;105 and the HEFCE, REF Main Panel A,
2015106
SDO, Service and Delivery Organisation.
Studies in bold indicate that more than one approach substantially informed the approach eventually adopted/developed by
the study (in these cases, the other approaches are not shown unless they too are one of the 20 selected frameworks).
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The approach of the Royal Netherlands Academy of Arts and Sciences
The report from the Royal Netherlands Academy of Arts and Sciences79 updated the evaluation framework
previously used by the academy to assess research, not just impact, at the level of research organisations
and groups or programmes. The approach combines self-evaluation and external peer review, including a
site visit every 6 years. The report listed a range of specific measures, indicators or more qualitative
approaches that might be used in self-evaluation. They included the long-term focus on the societal
relevance of research, defined as ‘how research affects specific stakeholders or specific procedures in
society (for example, protocols, laws and regulations)’.79 The report proceeds to give the website for the
Evaluating Research in Context (ERiC) project, which is described in Spaapen et al.109 as being driven partly
by the need, and/or opportunity, to develop methods to assist faculty in conducting the self-evaluation
required under the assessment system for academic research in the Netherlands.
A combination of the frameworks originally developed in 2000 in the project
funded by the UK’s Economic and Social Research Council on the non-academic
impact of socioeconomic research and in the Netherlands in 1994 (this became the
Social Impact Assessment Methods through the study of Productive Interactions)
In 2000, a team led by Molas-Gallart,41 working on the project funded by the UK’s ESRC on the non-
academic impact of socioeconomic research, developed an approach based on the interconnections of three
major elements: the types of output expected from research; the channels through which their diffusion to
non-academic actors occurs; and the forms of impact. Later the team combined forces with Spaapen, whose
early work with Sylvain42 on the societal quality of research had long been influential in the Netherlands,
and, collectively, they led the SIAMPI approach.110 This overlaps also with the development of the SciQuest
method by Spaapen et al.109 that came from the ERiC project described in The approach of the Royal
Netherlands Academy of Arts and Sciences.
Its authors described SciQuest as a ‘fourth-generation’ approach to impact assessment. The previous three
generations were characterised, they suggested, by measurement (e.g. an unenhanced logic model),
description (e.g. the narrative accompanying a logic model) and judgement (e.g. an assessment of whether
the impact was socially useful or not). The authors suggested that fourth-generation impact assessment
is fundamentally a social, political and value-oriented activity and involves reflexivity on the part of
researchers to identify and evaluate their own research goals and key relationships.
SciQuest methodology requires a detailed assessment of the research programme in context and the
development of bespoke metrics (both qualitative and quantitative) to assess its interactions, outputs and
outcomes. These are then presented in a unique research embedment and performance profile, visualised
in a radar chart.
In addition to these two papers,109,110 the study by Meijer80 was partly informed by SIAMPI (see Appendix 3).
Detailed case studies and follow-up analysis on Health Technology Assessment policy
impacts and cost savings: Quebec Council of Health Care Technology assessments
In the 2007 review,2 we described a series of studies of the benefits from HTAs conducted by the CETS.43,44
They conducted case studies based on documentary analysis and interviews, and developed a scoring
system for an overall assessment of the impact on policy that went from 0 (no impact) to +++ (major
impact). They also assessed the impact on costs. Bodeau-Livinec et al.82 assessed the impact on policy of
13 HTAs conducted by the French Committee for the Assessment and Dissemination of Technological
Innovations. Although they did not explicitly state that they were using a particular conceptual framework,
their approach to scoring impact appears to follow the earlier studies of CETS in Quebec.
Zechmeister and Schumacher83 assessed the impact of all HTA reports produced in Austria at the Institute
for Technology Assessment and Ludwig Boltzmann Institute for HTA aimed at use before reimbursement
decisions were made or decisions for disinvestment. Again, they developed their own methods, but the
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impact of these HTA reports was analysed partly by descriptive quantitative analysis of administrative data
informed by the Quebec studies.43,44
Additional frameworks or approaches applied to assess the impact of
programmes of health research and mostly developed since 2005
Many other conceptual frameworks have been developed to assess the impacts from programmes of
health research, mostly since 2005. Some studies have combined several approaches. Below we list
13 frameworks that have also been applied at least once. Some frameworks combine elements of existing
frameworks, an approach recommended by Hansen et al.111 This means that in the list of studies that
have applied different conceptual frameworks (see Table 2), there are some inevitable overlaps. Scope
exists for different interpretations of exactly how far a specific study does draw on a certain framework.
An important consideration in deciding how much detail to give on each framework has been its perceived
relevance for a programme such as the HTA programme.
The 13 conceptual frameworks are presented as follows: first, frameworks applicable to programmes that
have funded multiple projects; second, frameworks devised for application by individual researchers;
third frameworks devised for application to groups of researchers or departments within an institution;
and, finally, a generic evaluation approach that has been applied to assess the impact of a new type of
funded programmes. Inevitably, it is not this clear-cut and there are some hybrids.
Canadian Academy of Health Sciences
The CAHS established an international panel of experts, chaired by Cyril Frank, to make recommendations
on the best way to assess the impact of health research. Its report, Making an Impact: A Preferred
Framework and Indicators to Measure Returns on Investment in Research,7 contained a main analysis,
supported by a series of appendices by independent experts. The appendices discuss the most appropriate
framework for different types of research and are analysed in Table 14 (see Appendix 3).37,112–114
The CAHS framework was designed to track impacts from research through translation to end use. It also
demonstrates how research influences feedback upstream and the potential effect on future research.
It aims to capture specific impacts in multiple domains, at multiple levels and for a wide range of audiences.
As noted in several of the appendices, it is based on the Buxton and Hanney Payback Framework (see
Figure 2).39 The framework tracks impacts under the following categories, which draw extensively on the
Payback Framework: advancing knowledge; capacity building; informing decision-making; health impacts;
broader economic; and social impacts.7,115 The categories from the Payback Framework had already been
adopted in Canada by the country’s main public funder of health research, the Canadian Institutes of
Health Research, for use in assessing the payback from its research.
The main difference in the categorisation from that in the original Payback Framework is the substitution
of ‘informing decision-making’ for ‘informing policy and product development’. The CAHS return on
investment version,7 allows the categorisation to include decisions by both policy-makers and individual
clinicians in the same category, whereas the Payback Framework distinguishes between policy changes and
behavioural changes, and does not specifically include decisions by individual clinicians in the policy
category. Therefore, the CAHS framework explicitly includes the collection of data about changes in clinical
behaviour as a key impact category, but in studies applying the Payback Framework any assessments that
can be made of behavioural changes by clinicians and/or the public in the adoption stage of the model
help form the basis for an attempt to assess any health gain.
The CAHS’s logic model framework also builds on a Payback logic model, and combines the five impact
categories into the model showing specific areas and target audiences where health research impacts can
be found, including the health industry, other industries, government and public information groups.
It also recognises that the impacts, such as improvements in health and well-being, can arise in many
ways, including through health-care access, prevention, treatment and the determinants of health.
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The Canadian Institutes of Health Research divided its research portfolio into four pillars. Pillars I–IV cover
the following areas: biomedical; clinical; health services; and social, cultural, environmental and population
health. The CAHS team conducted detailed work to identify the impact from the different outputs arising
in each of these areas.
The team also developed a menu of 66 indicators that could be collected. It was intended for use across
Canada, and has been adopted by the Canadian Institutes of Health Research and in some of the provinces,
for example by Alberta Innovates: Health Solutions (AIHS), the main Albertan public funder of health research.
AIHS also further developed the framework into a specific version for their organisation and explored how it
would be implemented and developed. Implementation had to do with standardising indicators across
programmes to track progress to impact. It was developed to improve the organisation’s ability to assess its
contributions to health systems impacts, in addition to the contributions of its grantees.85 The CAHS
framework has also been applied in Catalonia by the Catalan Agency for Health Information and Quality.84
Banzi’s research impact model
Banzi et al.,4 in a review of the literature on research impact assessment, identified the Payback Framework
as the most frequently used approach. They presented the CAHS’s payback approach in detail, including
the five payback categories as listed above. Building on the CAHS report, Banzi et al.4 set out a list of
indicators for each domain of impact and a range of methods that could be used in impact assessment.
The Banzi research impact model has been used as the organising framework for several detailed studies
of programmes of research in Australia.
A number of the applications have suggested ways of trying to address some of the limitations noted in
the earlier account of the Payback Framework. For example, the study by Laws et al.88 applied the Banzi
framework to assess the impact of a schools physical activity and nutrition survey in Australia. They found
it difficult to attribute impacts to a single piece of research, particularly the longer-term impacts, and
wondered whether or not the use of contribution mapping, as proposed by Kok and Schuit may provide
an alternative way forward (see Chapter 4 for a description of Kok and Schuit116).
National Institute of Environmental Health Sciences’s logic model
The US NIEHS developed and applied a framework to assess the impact from the research and the
researchers it funded. Engel-Cox et al.63 developed the NIEHS logic framework and identified a range of
outcomes by drawing on the Payback Framework and Bozeman’s public value mapping.117 These outcomes
included translation into policy, guidelines, improved allocation of resources, commercial development;
new and improved products and processes; the incidence, magnitude and duration of social change;
health and social welfare gain and national economic benefit from commercial exploration and a healthy
workforce; and environmental quality and sustainability. They added metrics for logic model components.
The logic model is complex; in addition to the standard logic model components of inputs, activities,
outputs and outcomes (short term, intermediate, long term), there are also four pathways: NIEHS and
other government pathways, grantee institutions, business and industry, and community. The model also
included the knowledge reservoir and contextual factors (Figure 3).
The various pathways allow a broader perspective to be developed than that of individual projects, for
example by the grantee institution pathway, and by focusing on streams of research from multiple funders.
Challenges identified in the initial case studies included ‘the lack of direct attribution of NIEHS-supported
work to many of the outcome measures’.63 The NIEHS put considerable effort into developing, testing and
using the framework. Orians et al.17 used it as an organising framework for a web-based survey of 1151
asthma researchers who received funding from NIEHS or comparison federal agencies from 1975 to 2005.
Although considerable data were gathered, the authors noted that ‘this method does not support
attribution of these outcomes to specific research activities nor to specific funding sources’.17
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Furthermore, Liebow et al.91 were funded to tailor the logic model of the NIEHS’s framework to inputs,
outputs and outcomes of the NIEHS asthma portfolio. Data from existing National Institutes of Health
databases were used and, in some cases, data matched with that from public data on, for example the
US Food and Drug Administration website for the references in new drug applications, plus available
bibliometric data and structured review of expert opinion stated in legislative hearings. Considerable
progress was made that did not require any direct input form researchers. However, not all the pathways
could be used and they found their aim to obtain readily accessible, consistently organised indicator data
could not in general be realised.
A further attempt was made to gather data from databases. Drew et al.90 developed a high-impacts
tracking system: ‘an innovative, Web-based application intended to capture and track short-and long-term
research outputs and impacts’. It was informed by the stream of work from NIEHS,17,63 but also by the
Becker Library approach118 and by the development in the UK of researchfish. The high-impacts tracking
system imports much data from existing National Institutes of Health databases of grant information, in
addition to text of progress reports and notes of programme officers/managers.
This series of studies demonstrates both a substantial effort to develop an approach to assessing research
impacts, and the difficulties encountered. The various attempts at application clearly suggest that the
full logic model is difficult and too complex to apply as a whole. Although the stream of work has,
nevertheless, had some influence on thinking beyond the NIEHS, apart from the in-house stream of work
no further empirical studies were identified as claiming that their framework was based on the NIEHS’s
logic model approach.
Medical research logic model (Weiss)
Anthony Weiss analysed ways of assessing health research impact, but, unlike many of the other
approaches identified, his analysis was not undertaken in the context of aiming to develop an approach for
any specific funding or any research-conducting organisation. He drew on the United Way model119 for
measuring programme outcomes to develop a medical research logic model. As with standard logic
models it moves from inputs, to activities, outputs, and outcomes: initial, intermediate, long term. He also
discussed various approaches that could be used, for example surveys of practitioners to track awareness
of research findings; changes in guidelines, and education and training; use of disability-adjusted life-years
(DALYs) or quality-adjusted life-years (QALYs) to assess patient benefit. He also analysed a range of
dimensions from the outputs, such as publications through to clinician awareness, guidelines,
implementation and overall patient well-being.120
Although this model was not developed for a specific organisation, it does overlap with the emphasis
given to logic models in various frameworks and studies, including the W.K. Kellogg logic model.121
Weiss’s account is included here because it has become quite high profile and is widely cited. It has
informed a range of studies rather than being directly applied in empirical studies.
National Institute for Occupational Health and Safety’s logic model
Williams et al.,92 from the RAND Corporation in the USA, with advice from colleagues in RAND Europe,
developed a logic model to assess the impact from the research funded by the National Institute for
Occupational Health and Safety (NIOSH). At one level the basic structure of the logic model was a standard
approach, as described by Weiss120 and as in the logic model from W.K. Kellogg.121 Its stages include
inputs, activities, outputs, transfer, intermediate customs, intermediate outcomes, final customers,
intermediate outcomes and end outcomes.
A novel feature of the NIOSH model was outcome worksheets based on the historical tracing approach,122
which reversed the order ‘articulated in the logic model and essentially places the burden on research
programs to trace backward how specific outcomes were generated from research activities’.92
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Research programmes could apply these tools to develop an outcome narrative to demonstrate and
communicate impact to the National Academies’ external expert review panels established to meet the
requirements of the US Government’s Performance Assessment Rating Tool.
The outcome worksheet was primarily designed as a practical tool to help NIOSH researchers think
through the causal linkages between specific outcomes and research activities, determine the data
needed to provide evidence of impact, and provide an organisational structure for the evidence.
Williams et al.92
The report stated that intermediate outcomes include adoption of new technologies; changes in workplace
policies, practices, and procedures; changes in the physical environment and organisation of work; and
changes in knowledge, attitudes and behaviour of the final customers (i.e. employees, employers). End
outcomes include various items related specifically to occupational health, including reduced work-related
hazardous exposures, and, in relation to morbidity and mortality, reductions in occupational injuries and in
fatalities within a particular disease- or injury-specific area.
The combination of historical tracing with a logic model is interesting because previously historical tracing
has been more associated with identifying the impact made by different types of research (i.e. basic vs.
clinical), irrespective of how they were funded, rather than contributing to the analysis of the impact from
specific programmes of research.
The Wellcome Trust’s assessment framework
The Wellcome Trust’s assessment framework has six outcome measures and 12 indicators of success.93
A range of qualitative and quantitative measures are linked to the indicators and are collected annually.
A wide range of internal and external sources is drawn on, including end-of-grant forms. The evaluation
team leads the information gathering and production of the report with contributions from many staff
from across the trust.
‘The Assessment Framework Report predominantly describes outputs and achievements associated with
trust activities though, where appropriate, inputs are also included where considered a major Indicator of
Progress.’93 To complement the more quantitative and metric-based information contained in volume 1
of the Assessment Framework Report, volume 2 contains a series of research profiles that describe the
story of a particular outcome or impact associated with Wellcome Trust funding. The Wellcome Trust
research profiles are agreed with the researchers involved and validated by senior trust staff.
Although there is no specific overall framework, it is a comprehensive approach. This is another example of
a major funder including impact in the annual collection of data about the work funded. On the one hand,
the importance of case studies is highlighted: ‘Case studies and stories have gained increasing currency
as tools to support impact evaluation’,93 but, on the other hand, the report described an interest in also
moving towards more regular data collection during the life of a project: ‘In future years, as the Trust
further integrates its online grant progress reporting system throughout its funding activities . . . it will be
easier to provide access to, and updates on grant-associated outputs throughout their lifecycle’.93
VINNOVA
VINNOVA, the Swedish innovation agency, has been assessing the impact of its research funding for some
time. The VINNOVA framework consists of two parts, an ongoing evaluation process and an impact
analysis, as described in the review for CAHS by Brutscher et al.37 The former defines the results and
impact of a programme against which it can be evaluated. It allows the collection of data on various
indicators. The impact analyses, the main element in the framework, are conducted to study the long-term
impact of programmes or portfolios of research. There are various channels through which impacts arise,
but each specific impact analysis can take a particular form.
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In Table 14 (see Appendix 3) we describe one example: the analysis of the impacts of a long-standing
programme of neck injuries research conducted at Chalmers University of Technology.94 This considered
the benefits to society through a cost–benefit analysis, the benefits to companies involved through an
assessment of the profits expected in the future as a result of the research and the benefits to the research
field through traditional academic approaches of considering the number and quality of articles and
doctorates, and peer review of the quality of the institute.
The aim has been, as far as possible to quantify the effects in financial terms, or in terms of other
physically measurable effects, and to highlight the contribution made by the research from the point
of view of the innovation system.
Eriksen and Hervik94
This approach is a hybrid in that it does relate to a stream of research funded by a specific funder, but it is
at a single unit.
Flows of knowledge, expertise and influence
Meagher et al.95 developed the ‘flows of knowledge, expertise and influence’ approach to assess the
impact of ESRC-funded projects in the field of psychology research. As part of a major analysis of the ways
in which research might make an impact, the authors pointed out that one limitation was that their study
was on a collection of responsive-mode projects and while they did have a common funder (i.e. the ESRC),
they had not been commissioned to be a ‘programme’. This again makes the example more of a hybrid,
and the study is described in more detail in Chapter 4, but this is the only application of the approach that
we identified in our search.
Research impact framework
The research impact framework (RIF) was developed at the London School of Hygiene and Tropical Medicine
by Kuruvilla et al.,123 who noted that researchers were increasingly required to describe the impact of their
work, for example in grant proposals, project reports, press releases and research assessment exercises for
which the researchers would be grouped into a department or unit within an organisation. They also
thought that specialised impact assessment studies could be difficult to replicate and may require resources
and skills not available to individual researchers. Researchers, they felt, were often hard-pressed to identify
and describe research impacts, but ad hoc accounts do not facilitate comparison across time or projects.
A prototype of the framework was used to guide an analysis of the impact of selected research projects at
the London School of Hygiene and Tropical Medicine. Additional areas of impact were identified in the
process and researchers also provided feedback on which descriptive categories they thought were useful
and valid vis-à-vis the nature and impact of their work.
The RIF has four main areas of impact: research-related, policy, service and societal. Within each of these
areas, further descriptive categories were identified, as set out in Table 3. According to Kuruvilla et al.,123
‘Researchers, while initially sceptical, found that the RIF provided prompts and descriptive categories that
helped them systematically identify a range of specific and verifiable impacts related to their work
(compared to ad hoc approaches they had previously used).’123
Although it is multidimensional in similar ways to the Payback Framework, the categories were broadened
to cover health literacy, social capital and empowerment, and sustainable development.
Another major feature of the RIF is the intention that it could become a tool that researchers themselves
could use to assess the impact of their research. This addresses one of the major concerns about other
research impact assessment approaches. However, while the broader categorisation has been used, on its
own or in combination, in an increasing number of studies124, we are not aware of any studies that have
used it by adopting the self-assessment approach envisaged. Nevertheless, it could be useful to researchers
having to prepare for exercises such as the REF in the UK.
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The Becker Medical Library’s model/the translational research impact scale
Sarli et al.118 developed a new approach called the Becker Medical Library model for assessment of
research. Its starting point is the logic model of the W.K. Kellogg Foundation,121 ‘which emphasises inputs,
activities, outputs, outcomes, and impact measures as a means of evaluating a programme’.118
For each of a series of main headings, it lists the range of indicators and the evidence for each indicator.
The main headings are research outputs knowledge transfer; clinical implementation; and community
benefit. The main emphasis is on the indicators for which the data are to be collected, and referring to the
website on which the indicators are made available the authors state: ‘Specific databases and resources for
each indicator are identified and search tips are provided’.118 The authors found during the pilot case study
that some supporting documentation was not available. In such instances, the authors contacted the
policy-makers or relevant others to retrieve the required information.
The Sarli et al.118 article includes the case study in which the Becker team applied the model, but the
Becker model is mainly seen as a tool for self-evaluation, with the suggestion that it ‘may provide a tool
for research investigators not only for documenting and quantifying research impact, but also . . . noting
potential areas of anticipated impact for funding agencies’.118 It is generating some interest in the USA,
including partially informing the Drew et al.90 implementation of the NIEHS framework described above,
and a UK application from Sainty.99
More recently, Dembe et al.124 proposed the translational research impact scale, which is informed not only
by a logic model from the W.K. Kellogg Foundation and by the RIF,123 but also by the Becker Medical
Library model.118
The authors identified 79 possible indicators, used in 25 previous articles, and reduced them to 72
through consulting a panel of experts, but further work was being undertaken to develop the requisite
measurement processes: ‘Our eventual goal is to develop an aggregate composite score for measuring
impact attainment across sites’.124 However, there is no indication provided about how a valid composite
score could ever be devised. Although as far as we are aware an application of it has yet to be reported,
from the perspective of our review it usefully illustrates how new models are being built on a combination
of existing ones.
TABLE 3 Research impact framework123
Research-related impacts Policy impacts Service impacts Societal impacts
Type of problem/knowledge Level of policy-making Type of services:
health/intersectoral
Knowledge, attitudes
and behaviour
Research methods Type of policy Evidence-based practice Health literacy
Publications and papers Nature of policy impact Quality of care Health status
Products, patents and
translatability potential
Policy networks Information systems Equity and human rights
Research networks Political capital Services management Macroeconomic/related
to the economy
Leadership and awards Cost-containment and
cost-effectiveness
Social capital and
empowerment
Research management Culture and art
Communication Sustainable development
outcomes
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Societal quality score
Mostert et al.100 developed the societal quality score using the theory of communication from Van Ark
and Klasen.125 Audiences are segmented into different target groups that need different approaches.
Scientific quality depends on communication with the academic sector and societal quality depends on
communication with groups in society; specifically, three groups: lay public, health-care professionals and
private sector.
Three types of communication are identified: knowledge production, for example papers, briefings,
radio/television services, products; knowledge exchange, for example running courses, giving lectures,
participating in guideline development, responding to invitations to advise or give invited lectures (these
can be divided into ‘sender to receiver’, ‘mutual exchange’ and ‘receiver to sender’); and knowledge use,
for example citation of papers, purchase of products, and earning capacity (i.e. the ability of the research
group to attract external funding). Four steps are then listed:
l Step 1: count the relative occurrences of each indicator for each department.
l Step 2: allocate weightings to each indicator (e.g. a television appearance is worth x, a paper is
worth y).
l Step 3: multiply 1 by 2 = ‘societal quality’ for each indicator.
l Step 4: the average societal quality for each group is used to get the total societal quality score for
each department.
It is a heavily quantitative approach and looks only at process, as the authors say that ultimate societal
quality takes a long time to happen and is hard to attribute to a single research group. The approach does
not appear to control for the size of the group but seems to be more applicable to research at an
institution rather than project level.
Research performance evaluation framework
Schapper et al.72 describe the research performance evaluation framework used at Murdoch Children’s
Research Institute in Australia. It is ‘based on eight key research payback categories’ from the Payback
Framework and also draws on the approach described in the RIF.123
The centre has an annual evaluation overseen by the Performance Evaluation Committee, with a nominee
from each of six themes and external member and chairperson. The evaluation ‘seeks to assess quantitatively
the direct benefits from research, such as gains in knowledge, health sector benefits, and economic
benefits’.72 Data for the Research performance evaluation are gathered centrally by the research strategy
office and verified by the relevant theme. The theme with highest score on a particular measure is awarded
maximum points; others are ranked relative to this. Each theme nominates its best three research outcomes
over 5 years, and is then interviewed by the research strategy team using detailed questionnaires to gain
evidence and verify outcomes. Research outcomes are assessed using a questionnaire based on the RIF.
There are three broad categories: knowledge creation; inputs to research; and commercial, clinical and
health outcomes. The six major areas of outcomes are development of an intervention; development of new
research methods or applications; communication to a broad audience; adoption into practice and
development of guidelines and policy; translation into practice; and impact of translation and on health.
Realist evaluation
The final approach described in this subsection, realist evaluation, is a relatively new generic evaluation
approach originally developed in the field of social policy. It has been applied to evaluating the impact
of the NIHR-funded Collaborations for Leadership in Applied Health Research and Care (CLAHRCs).
This evaluation by Rycroft-Malone et al.102 is described in Chapter 4 [see Co-production models
(e.g. multistakeholder research partnerships)]. Realist evaluation may be more widely applicable to other
programmes in the NIHR. The realist evaluation approach was also used in the evaluation of public
involvement in health research in England.101
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Generic approaches to research impact assessment developed and applied in
the UK, and parallel developments in other countries
In this final section considering conceptual frameworks we focus on two generic approaches that have
recently been introduced in the UK, namely researchfish and the REF, and in which the data collection
from individual projects or research groups, respectively, is brought together at a high level of aggregation.
Here we consider some of the accounts we gathered about them from reports and articles included in
our review.
Regular monitoring or data collection
Research funders became increasingly interested in moving beyond one-off impact assessments of the type
conducted through the Payback Framework and similar approaches. Of the various streams of work to
develop such approaches one emerged from the application of the framework to assess the impact of the
research funded by the Arthritis Research Campaign.104 Developed in consultation with members of the
research community, the RAND/Arthritis Research Campaign’s impact scoring system was loosely based on
the questions asked on previous payback surveys, but evolved thereafter, simplifying the questions and
increasing the number. According to Morgan Jones and Grant,126 this informed the development
of researchfish.
Researchfish (formerly MRC’s e-Val) is the system used to collect information on the outputs, outcomes
and impacts that have arisen from MRC-funded research. MRC’s e-Val was first launched in November
2009 and was used in three rounds of data collection. In 2011/12, the MRC worked with a group of
approximately 10 other funders on a ‘federated’ version of e-Val that works across funders so that
researchers can enter an output just once and then associate it with the relevant funder or funders.
Launched in 2012 as researchfish, by March 2014 there were more than 80 research organisations and
funders using it, including more than 50 medical research charities and 10 universities. The fourth
data-gathering period in 2012 – the first using researchfish – saw a 98% response rate.
The MRC plans to continue to co-ordinate use of researchfish closely with university support offices and/or
research unit. It sees the data being used in a variety of ways, from funders returning it to universities so
that they can be used for their REF submissions, to using data to inform funders’ strategic plans and as
evidence for the Government’s spending reviews.127
Researchfish is considered in the MRC’s report, Outputs, Outcomes and Impact of MRC Research.103
Although it could have been included in the list above, it might be seen more appropriately as a tool.
The researchfish web-based survey asks project principal investigators a series of questions under 11 major
headings ranging from publications through to impact on the private sector.
These headings have some parallels with some of the models considered above, although no conceptual
framework is made explicit. Given the nature of the requirements to complete the annual survey this
approach results in a high level of compliance, at least in terms of principal investigator’s supplying
some response.
A range of health research funders, including NIHR and the MRC, use researchfish. In addition to the
description in MRC reports,103 the results are also included as some of the data required in the reporting
for the BIS framework on economic impacts.76
Research Excellence Framework impact assessment (Higher Education Funding
Council for England) and the Research Quality Framework
The Research Quality Framework (RQF) was developed for the assessment of university research in
Australia.128 Owing mainly to a change of government, this framework was not actually used in Australia,
but it affected developments for research impact assessment in the higher education sector in the UK.
The Australian model proposed the use of narrative cases studies written by higher education institutes
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as the basis of expert peer review in national assessments of university research performance.128 The key
impacts to be assessed were wider economic, social, environmental and cultural benefits of research. The
study by Kalucy et al.65 piloted the expected introduction of the RQF and found the Payback Framework
would be likely to be a suitable framework to use to gather the data to submit to the assessment.
In preparing for the REF in the UK, the HEFCE commissioned RAND Europe to review possible frameworks that
might be adopted.38 RAND Europe reviewed four methods for evaluating impact of university research against
HEFCE criteria and recommended the adoption of a case study approach, drawing on the RQF from Australia.128
In the 2014 REF,33 the HEFCE required universities to submit impact case studies in the form of a four-page
description of a research project/programme and its ensuing impact, with references and corroborating
sources. In relation to medicine and life sciences the report identified the kind of impacts that were sought:
. . . benefits to one or more areas of the economy, society, culture, public policy and services, health,
production, environment, international development or quality of life, whether locally, regionally,
nationally or internationally.
And:
. . . manifested in a wide variety of ways including . . . the many types of beneficiary (individuals,
organisations, communities, regions and other entities).
p. 2633
The final report on the application of the REF to biomedical and health research from the REF 2014 Main
Panel A, which had overseen the assessment of some 1600 case studies, concluded that the case study
approach had been broadly successful.106 The report noted, ‘International MPA [Main Panel A] members
cautioned against attempts to “metricise” the evaluation of the many superb and well-told narrations
describing the evolution of basic discovery to health, economic and societal impact’.106 International
members of the panel also produced a separate section for the report and described the REF as:
To our knowledge, the first systematic and extensive evaluation of research impact on a national level.
We applaud this initiative by which impact, with its various elements, has received considerable emphasis.
p. 21106
The REF approach of assessing research impact through case studies prepared in institutions by groups of
researchers, and assessed and graded by peer reviewers in accordance with the criteria of reach and
significance, was adopted in Australia in a trial exercise by the Group of Eight and the Australian
Technology Network of Universities.105 Called Excellence in Innovation for Australia (EIA), this ‘replication’
of the REF approach was a small-scale trial, with 162 case studies, and was conducted much more rapidly,
reporting in 2012. This study also reported that the case study methodology ‘to assess research impact is
applicable as a way forward to a national assessment of impact’.105
Comparing frameworks
The various analyses of research impact assessment frameworks conducted by RAND Europe involved
making a series of detailed comparisons.9,37,38 These included the scoring of 21 frameworks (e.g. SIAMPI, REF,
CAHS/Payback) against 19 characteristics (e.g. formative, comprehensive, quantitative and transparency).9
Over half of the 20 frameworks we described above were included in one or more of the three
comparisons of frameworks noted here. Appendix 5 lists all the frameworks appearing at least once in the
main analyses in these reviews, and identifies those we have included in our list of 20 frameworks, those
for which we have included a later or alternative version, and those not included, with reasons, but some
of these are described in Table 14 (see Appendix 3). The additional ones we have included that were not
in the three reviews are generally more recent and have been applied specifically to assess the impact of
programmes of health research.
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In Table 4 we provide a brief analysis of the 20 frameworks described above. Much of the discussion of
strengths and weaknesses focuses on specific aspects of particular frameworks, with more generic analysis
in Chapter 4. The table of comparisons is intended to inform our assessment of options in Chapter 8.
Figure 4 locates the various frameworks on two dimensions in an attempt to identify clusters of
frameworks that might be attempting to do similar things. One dimension is the type of impact categories
assessed. We have abstracted the key impact categories described in the frameworks: multidimensional
(i.e. covers a range that can include health gains, economic impacts and policy impacts); economic impacts
(value of improved health and GDP); policy impacts (including clinical policies); and communication/
interactive processes. The other dimension is the level of aggregation at which the framework has primarily
been applied and whether the focus is on programmes of work from funders or on the portfolio of work
of individual researchers, groups of researchers or institutions. (We classed the REF as being in the
producers of research category because the work assessed was funded by multiple organisations and
conducted by institutions and their units, even though the assessment results will then be used to allocate
the future funds from the specific funding organisation conducting the assessment, i.e. the HEFCE.) Where
the focus is on programmes of funded research, the impact assessment is most likely to gather data from
individual studies, but these are then pulled together and reported on at an aggregate programme level.
Furthermore, there can be some data gathering about the whole programme.
Finally, in this section we draw attention to a very different approach: the balanced scorecard (BSC), which
is analysed in the CAHS report.7 Some studies describe health-care systems that include research as part of
a BSC approach to assessing performance of their system,130,131 but it is argued that the approach is not a
comprehensive impact assessment of research.7 If, however, a BSC approach is used to assess health-care
organisations, and includes research impact as one of the criteria, this could be a mechanism for
encouraging health-care organisations to foster research activity in their facilities.
Methods used in empirical impact assessment studies
Our updated review identified several studies that undertook important analysis of the methods used in
research impact evaluation. These include the UK Evaluation Forum,19 the CAHS report7 and the report
from RAND for the Association of American Medical Colleges.9 The last analysed 11 methods or tools used
in a range of six major research evaluation frameworks; most relate to the collection of data and others to
how data are presented. The authors provided a brief description of each with a suggestion of when and
how it is used. The 11 methods/tools were set out in alphabetical order: bibliometrics, cases studies, data
mining, data visualisation, document review, economic analysis, interviews, logic models, peer review, site
visits and surveys. The review by Boaz et al.5 of studies assessing the impact of research on policy-making
identified 16 methods as having been used, with semistructured interviews, case study analysis and
documentary analysis as the three most commonly adopted. Milat et al.129 reported that typically mixed
methods were used, which could include publications and citations analysis, interviews with principal
investigators, peer assessment, case studies and documentary analysis.
Our review of 110 empirical studies also found that a wide range of methods were adopted, but in various
combinations. Frequently used methods included desk analysis, surveys, interviews and case studies.
The full range of methods used in the studies listed can be found in Table 14 (see Appendix 3), and below
we note some interesting trends and show how our review provides further evidence on long-standing
issues about the range of methods available for impact assessments. In relation to surveys, for example,
there are concerns about the burden on researchers of completing them and on the accuracy of the data.
The burden is widely viewed as having increased with the introduction of the above annual surveys,
notwithstanding the attempts to reduce the burden by enabling the data entered to be attached to a
range of grants. This increased burden might result in incomplete data in the response to specific
questions within the overall survey, and might also have implications for the willingness of researchers to
complete voluntary but bespoke surveys that specific funders might consider commissioning.
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The survey response rates in the included studies varied enormously. The compliance requirements in a
survey such as researchfish result in very high formal response rate, but the rate has also been high in
other surveys; for example, it was 87% in a study in Hong Kong.66 The rate, however, was only 22% in a
pilot study assessing the impact of the EU’s international development public health programme,27 but
they did use a range of other methods as well.
In terms of the accuracy of the data from surveys of researchers, several studies report that, in general, the
findings from users were similar to those from researchers, for example Guinea et al.64 and Cohen et al.52
When comparisons have been made between the responses to surveys, and the data gathered in
subsequent case studies on the same project, researchers have been found not to routinely exaggerate.2
Indeed, Gutman et al.132 found that researchers interviewed claimed a higher level of impact on policy than
was reported by researchers in a web survey, although the questions were slightly different. Meagher
et al.95 also reported that while, ‘case studies were crucial in illuminating the nature of policy and practice
impacts . . . there were no evident contradictions between results obtained by different methods.’
Doubts have also been expressed as to how much researchers actually know about the impact their
research might have made. One trend that might provide some reassurance about this is that some of the
studies in Table 14 (see Appendix 3) report relatively small-scale research funding schemes in which much
of the claimed impact arises from the adoption of the findings in the researcher’s own health-care unit,
where researchers are well-placed to know the impact made. Some examples of this were reported by
Caddell et al.96
A balance must be found between coverage and resources. Several of the reported assessments relied on
the programme office and/or impact evaluators gathering the data from databases, for example in the
case of the evaluation of the impact from the EU’s public health programmes53 and in one of the NIEHS’s
studies.91 However, in both cases and others there were some doubts about whether or not sufficient
data could be collected in this way, but one of the advantages was that it did not place the burden on
researchers. Other attempts to increase practicality go in other directions. Individual researchers might be
encouraged to construct accounts of the impact from their own work. In particular, Kuruvilla et al.123
designed the RIF as a do-it-yourself approach, which prompts researchers to systematically think about the
impact of their work using descriptive categories. The Becker Medical Library model was also primarily seen
as a tool for self-evaluation.118
Case studies tend to provide a wider and more rounded perspective on how the impact might have arisen
and can address attribution. They tend to be resource intensive and usually conducted only selectively.
One dilemma is case study selection, for which a purposive approach is often adopted. However, a stratified
random selection has been used when applying the Payback Framework,2,36 and a recent study in Australia
conducted case studies on all the projects in which the respondents had completed two surveys and
an interview, thus avoiding any selection bias.52 Case studies can, however, be conducted through
self-assessment, perhaps based on desk analysis. They can then be evaluated by peers in an approach
that seems to be becoming increasingly important and broadly successful.33,105,106
There are also an increasing number of studies reporting attempts to score case studies. In addition to the
examples of scoring of self-assessment described above, this also includes scoring case studies produced
by impact assessors,36,52,89 or produced initially by central teams in the institution, including the cases
produced for the research performance evaluation framework used at Murdoch Children’s Research
Institute in Australia.72
Whatever the method of data collection, attention has been given in several studies to expected benefits.
We excluded studies that solely considered potential impact before research was commissioned, but some
studies are considering aspects of ‘expected’ impacts in several ways. Some make a comparison between
what was expected from a project and what had been achieved. Examples include studies from the EU
studies,53,133 from Catalonia/Spain56,58 and from Australia.70 Studies can also emphasise what impacts are
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expected from research that has already been completed, but which had not yet arisen at the time of the
impact study: such questions are, for example, often a feature of surveys in studies applying the Payback
Framework. This also includes the application of the framework to assess the impact of the funding
provided for biomedical research by the annual TV3 Telethon in Catalonia.58
Attempts are also being made to develop ways to consider the impact of programmes as a whole in
addition to the impact that might come from the collation of data on individual projects. This overlaps with
consideration of conceptual frameworks, where, for example, we discussed the role of realist evaluation in
assessing one of the CLAHRCs,102 but it can also relate to the methods used in other studies. For example,
in their assessment of the Austrian HTA programme, Schumacher and Zechmeister134 set out the methods
they had used and the issues that could be addressed by each one, including attempts to identify the
development of a HTA culture. Rispel and Doherty135 claimed that in their assessment of the impact of the
Centre for Health Policy in South Africa, their own experiences gave them an ‘insider–outsider’ perspective,
and that a rounded view of the Centre was provided by interviewing people with a predominantly ‘insider’
perspective, and others with an ‘outsider’ perspective.
Finally, in the 2007 report there was speculation regarding whether a conceptual framework was really
needed or whether it might be possible just to apply some of the methods. It was claimed, however, that a
conceptual framework could be most useful in informing the structure of a range of methods, such as
documentary analysis, surveys and case study interviews. This was seen to be the case with the Payback
Framework, and has remained so, as illustrated by the both the survey and the semistructured interview
schedule included in the article describing the assessment of the impacts from Asthma UK funding.51
This is also the case for newer frameworks such as the RIF.
Timing of assessments
Points about timing have sometimes been noted in the strengths and weaknesses column of Table 14 (see
Appendix 3). As much of the impact from research is likely to arise some time after the completion of the
research, any early one-off assessment is likely to capture less than regular monitoring that continues for
some time after the completion of the project. Some impact assessments, for example Oortwijn,69 explicitly
stated that they felt the early timing of the assessment had inhibited the level of impact that could have
arisen and thus be recorded.
However, even this issue is not clear-cut and partly overlaps with the nature of the research approach.
In the evaluation of the Africa Health Systems Initiative Support to African Research Partnerships, Hera136
reported that because the evaluation was before the end of the programme it was possible to observe the
final workshop and present preliminary findings. It may have been too early for some of the expected
impact to arise, but the interactive approach of the whole programme had led to some policy impact
during project, and there were some advantages in analysing it while project meetings were still occurring.
Nevertheless, the recent results from the UK’s REF clearly show that allowing up to 20 years for the impact
to occur can contribute to assessments that show considerable impacts have been achieved by a range of
research groups.106
In the future, regular monitoring of research outcomes and continuous monitoring of uptake/coverage
might provide ways of reducing at least some of the variations between studies in terms of the timing
of assessments.
Summary findings from multiproject programmes
The findings from the analysis of multiproject programmes reported in the 2007 review provide a context
for the current analysis. That review found that the six impact assessment studies that were focused on
HTA programmes reported that the number of individual projects making an impact on policy ranged
between 70% and 100%. The 10 impact assessment studies that were focused on ‘other health research
UPDATED SYSTEMATIC REVIEW
NIHR Journals Library www.journalslibrary.nihr.ac.uk
38
programmes’, claimed that the number of individual projects making an impact on policy ranged between
< 10% and 53%, and the number of projects making an impact on practice ranged between < 10% and
69%. These findings reflected the different roles of the two identified groups of programmes, but there
was also considerable diversity within the nature of the programmes within each group.
The study of the impact of the first decade of the NHS HTA programme was reported as the main part
of the 2007 report. However, the study was not included in the literature review chapter of that 2007
report because that review included studies published up to a cut-off point of mid-2005, and had been
conducted in order to inform the assessment that was undertaken of the NHS HTA programme. Therefore,
the findings below, from the survey of the lead researchers conducted as part of the assessment of the
HTA programme, were not referred to in the review chapter. They show a similar pattern to that identified
in the 2007 review, that is, an even higher level of impact being claimed for the Technology Assessment
Reports (TARs) than for the other types of HTA-funded research, which, in the case of trials, are nearer to
the research in the ‘other research programmes category’ than they are to appraisals that constitute the
work of most HTA programmes (Table 5).
In our current review a collation of the quantitative findings from studies assessing the impact from
multiproject programmes (such as the HTA programme) and published since the previous review
conducted in 2005 should provide a context for the results from the parallel study being conducted of the
impact from the second decade of the HTA programme.
The diversity of circumstances makes it difficult to be certain about which studies to include, but we
classified 26 studies as being empirical studies of the impact from multiproject programmes, and a further
two studies of the impact from research training have been included because the impact assessment
covered the wider impact made by the research conducted in each training award, as well as the impact
on the trainees’ subsequent careers (see Table 6 for the included studies). Even for these 28 studies there
is considerable diversity in a range of aspects, including:
l types of research and modes of funding of the programmes of research assessment
l timing of impact assessment (some while the programme was still continuing, some conducted
years afterwards)
l conceptual frameworks used for assessment (e.g. some ask about impact on policy, including
guidelines, and separately ask about impact on practice; but others ask about a combined
‘decision-making’ and have that as an impact category)
l methods used for collecting and presenting data in impact evaluations (e.g. some present percentage
of projects claiming each type of impact and some present the total number of examples of each type
of impact, making it impossible to tell how many projects are represented by the total number because
some projects might have generated more than one example of a particular type of impact).
TABLE 5 Opinion of lead researchers in the first decade of the NHS HTA programme about existing and potential
impact on policy and behaviour
Project type
Impact, n (%)
Policy Behaviour
Already Future Combineda Already Future Combineda
Primary 25 (66) 27 (71) 29 (76) 17 (45) 21 (55) 23 (61)
Secondary 27 (57) 27 (57) 36 (77) 10 (21) 22 (47) 25 (53)
NICE TAR 46 (96) 29 (60) 48 (100) 29 (60) 28 (58) 37 (77)
Total 97 (73) 82 (62) 113 (85) 56 (42) 70 (53) 85 (64)
a Combined= number in ‘already’ + number with no entry under ‘already’ claiming a future impact.2
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TABLE 6 Studies assessing the impact from programmes with multiple projects and training fellowships
Name and year
Location of original
research conducted Type of research/topicProjects
Adam et al., 201284 Catalonia Clinical and health services
Aymerich et al., 201256 Catalonia Epidemiology and public health
Catalan Agency for HTA and
Research, 200658
Catalonia Wide range
Bodeau-Livinec et al., 200682 France HTA
Brambila et al., 2007137 Guatemala Operational research in reproductive health
Caddell et al., 201096 Canada Women and children’s health
Cohen et al., 201552 Australia Intervention studies
Donovan et al., 201462 Australia Breast cancer research: wide range
Expert Panel, 201353 EU Public health
Gold et al., 2007138 USA Delivery systems: implementation
Gutman et al., 2009132 USA Active Living Research: transdisciplinary field
Hanney et al., 20072 UK HTA
Hanney et al., 201351 UK Asthma UK: wide-ranging portfolio
Hera, 2014136 Africa Research partnerships with users
Johnston et al., 200675 USA Stroke clinical trials
Kingwell et al., 2006139 Australia National Health and Medical Research Council: wide range
(grants ending in 2003 and 1997)
Kwan et al., 200766 Hong Kong Health and Health Services Research Fund
Milat et al., 201389 Australia New South Wales Health Promotion Demonstration Research
Grants Scheme
Oortwijn, 200869 The Netherlands Health Care Efficiency Research programme (HTA)
Poortvliet et al., 2010140 Belgium The Belgium Health Care Knowledge Centre, HTA, health
services research and GCP
Reed et al., 201170 Australia Primary care research
RSM McClure Watters et al.,
201271
Northern Ireland Northern Ireland Executive: Health and Social Care Research
Sainty, 201399 UK Occupational Therapy Research Foundation
The Madrillon Group, 201174 USA National Institutes of Health Mind Body Interactions and Health
Programme
Wooding, 2009104 UK ARC: wide range
Zechmeister and
Schumacher, 201283
Austria Institute for Technology Assessment and Ludwig Boltzmann
Institute for HTA: HTA
Research training
Action Medical Research,
200954
UK Fellowships: wide range
Zachariah et al., 2014141 International Structured operational research and training initiative of World
Health Organization/special programme for research and training
in tropical diseases: adopted an existing training initiative
ARC, Arthritis Research Campaign; GCP, Good Clinical Practice.
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It is likely that there will be different levels of impact on policy achieved, for example by a programme of
responsive mode basic research than by a programme of commissioned HTA research. However, studies
assessing impact from research do not necessarily fall into such neat categories because different funders
will have a different mix of research in their programmes and portfolios. Therefore, we have listed all
28 studies (Table 6), but do not include the figures for each study for the percentage of project principal
investigators claiming to have made various impacts.
All the data for the individual studies are available from Table 14 (see Appendix 3), but here in Table 7 we
show the average figures for the 23 of the 26 multiproject programmes in which the data were presented
in terms of the number, or percentage, of individual projects claiming to have made an impact in the
categories being assessed. Presenting it in this way allows the overall picture from the quantitative analysis
of multiproject programmes to be seen, but also allows a commentary to include some data from
individual projects, while at the same time describing key features of a particular research programme,
including sometimes the context in which it had been conducted. Table 7 presents the averages and the
range on each of the following criteria: impact on policy; impact on practice; a combined category,
for example policy and clinician impact, or impact on decision-making; and impact in terms of improved
care/health gain/patient benefit.
These are considered in turn.
Policy impacts
As in the 2007 review, the HTA programmes analysed generally showed the highest percentage achieving
or claiming an impact on policy, but various examples illustrate a range of issues. Although 97% of the
assessments from the Austrian HTA programme were classified by Zechmeister and Schumacher83 as
making some impact on coverage policies, other factors also played a role and in only 45% of reports
‘the recommendation and decision were totally consistent’.83 There is some uncertainty about whether or
not Bodeau-Livinec et al.82 included all the studies available, but, assuming that they did, 10 out of 13
recommendations from the French HTA body explored ‘had an impact on the introduction of technology in
health establishments’;82 in seven cases the impact was considerable and in three it was moderate.
In the case of the more mixed HTA programmes, we noted above the considerable impact made by the
NHS HTA programme, but with the TARs having a higher figure than the primary studies. For the Belgium
Health Care Knowledge Centre programme, Poortvliet et al.140 reported that within the overall figure of
58% of project co-ordinators claiming the projects had made an impact, the figure for HTAs was higher
than for the other two programmes. Finally, the Health Care Efficiency Research programme from the
Netherlands was classified as a HTA programme, but included a large responsive mode element and most
studies were prospective clinical trials. Furthermore, Oortwijn69 reported that the impact assessment was
TABLE 7 Analysis of quantitative data from studies assessing the impact from all 23 projects reporting on findings
from each project in a multiproject programme
Type of impact
Studies number
reporting on each
impact category
(n= 23)
Average achieving/claiming
this impact in the studies
reporting on it (%)
Range achieving/claiming
this impact in the studies
reporting on it (%)
Policy/organisation impact 18 36 5–97
Clinician change/informed
practice
10 31 10–43
A combined category, e.g.
policy and clinician impact, or
impact on decision-making
3 64 60–67
Health gain/patient
benefit/improved care
8 28 6–49
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conducted soon after many of the projects had been completed. These various factors are likely to have
contributed to the proportion claiming an impact on policy (in these cases mostly citation on a guideline)
being lower than other HTA programmes at 29%.
In four non-HTA studies,66,70,74,136 more than one-third of the projects appeared to make an impact on
policy, and generally interaction with potential users was highlighted as a factor in the impact being
achieved. Of the principal investigators in four studies, ≤ 10% reported that their research had made an
impact on policy, but three of these studies62,104,139 assessed the impact of wide-ranging research
programmes that, in addition to clinical and other types of research, covered basic research from which
policy impact would be much less likely to occur. However, some of these programmes also made an
impact in areas not reported on the table. For example, Donovan et al.62 reported that 11% of principal
investigators from the research funded by the National Breast Cancer Foundation in Australia claimed to
have made an impact on product development.
Informed practice
Of the 10 studies reporting on impact on clinical practice,2,53,62,66,69,84,96,99,139,140 the five highest were in a
narrow band of 37–43% of the principal investigators claiming such impact.2,66,84,96,99 The projects in these
programmes generally incorporated factors associated with achieving impact, including being funded to
meet the needs of the local health-care system and interaction with potential users. Two of the studies96,99
looked at small-scale funding initiatives, and found that the impact was often at the location where the
research was conducted.
Combined category
The three studies89,137,138 in which the impact seemed best reported at a combined level covering policy and
practice impact, all suggested considerable levels of impact from projects where partnerships with potential
users were a key feature.
Health gain/patient benefit/improved care
Only eight studies went as far as attempting to assess impact in terms of health gain or improved
care,51,53,66,70,71,74,75,96 and none of them reported a figure > 50%. Three studies66,74,96 were the only studies in
which over one-third of principal investigators claimed an impact on health care, and, as noted, all three had
features associated with impact being achieved. Also of note is Johnston et al.75 because although only eight
out of a programme of 28 RCTs (29%) were identified as having a measurable use, with six (21%) leading to
a health gain, these health gains were monetised and provide a major example of valuing the benefits from a
programme of health research. The study is fully reviewed and critiqued in Chapter 5.
Finally, both the studies assessing the impact of research training schemes54,141 indicate that between one-third
and three-quarters of the former trainees claimed that a wider impact had arisen from the research conducted
in each training award. Here, however, even more than with project funding, it can be difficult to discern
the impact from the specific research conducted and that from subsequent research that built on it.
Analysis of the findings from multiproject programmes
The picture emerging from Tables 6 and 7, plus the equivalent one in the 2007 review, is that many
multiproject programmes are being identified as resulting in a range of impacts, but levels are
highly variable.
An analysis of the findings from quantitative studies contributes to the overall review in various ways.
1. It is recognised there are many limitations in reducing issues of influence on policy and the other areas
to a tick-box survey, and recognition that case studies (externally conducted based on interviews and
documentary review, or self-assessment through desk analysis, etc.) are likely to provide a richer and
more nuanced analysis. However, we also noted above that a variety of studies that have used another
method in addition to surveying researchers suggest that, on average, researchers do not seem to be
making exaggerated claims in their survey responses. Therefore, surveys of researchers can play some
role in research impact assessment, and do allow wider coverage than is usually possible through more
resource-intensive methods such as case studies.
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2. There is an undoubted desire from some to improve survey methods, for example by computer-assisted
telephone interviews. Nevertheless, this portfolio of studies suggests impact assessment can be done to
some degree across multiproject programmes.
3. The findings indicate that different types of research programmes are likely to lead to different levels
and ranges of impact. With better understanding of the expectations of what might arise from different
programmes, it might be possible to tailor impact assessments to focus on appropriate areas for the
different types of research. Various studies of small-scale initiatives54,96,99 illustrate that there is now wide
interest in assessing the impact of health research funding, but also illustrate that conducting research
in a health-care setting can lead to impacts in that health-care setting.
4. Impact assessments are partly conducted to inform the approach to organising and managing research.
Therefore, collating these studies can add weight to the comments made in individual studies.
Quite frequent comments are made about impact being more likely when the research is focused on
the needs of the health-care system and/or there is interaction or partnership with potential
users.2,66,84,89,132,136–138,141 The particular circumstances in which HTAs are conducted to meet very specific
needs of organisations that are arranged to receive and use the findings as ‘receptor bodies’ are also
associated with high levels of impact.82,83,140 The qualitative study by Williams et al.,78 which included
observation of meetings, provides some verification of the finding in the assessment of the HTA
programme that the TARs do inform decision-making. Looking specifically at the economic evaluations
included in TARs they reported that, ‘economic analysis is highly integrated into the decision-making
process of NICE’s technology appraisal programme’.78
We looked for suitable comparators against which to consider these findings from assessments of
multiproject programmes. Potentially this could have come from a large-scale regular assessment that
could provide data about the proportion of projects claiming impacts in certain categories across a whole
research system. However, this is not the way researchfish operates and we could find no other
equivalent comparator.
Instead, the 2014 REF33 and the EIA105 offer illuminating comparators in that they show high levels of
impact were achieved from the small percentage of the total research that was described in the case
studies submitted by institutions for consideration through the REF and EIA. So, while the REF was based
on the research conducted by groups of researchers, rather than, in most cases, being based on the work
of a single funded programme, it is also of value as a comparator because of the amount of evidence
gathered in support of the exercise. The findings from our collection of studies in some ways reflect
aspects of the REF, for example in that the REF assumed only a minority of the research from groups over a
20-year period (in practice, 1993–2013) would be suitable for entry for using to demonstrate impact had
been achieved. As described, some of the studies of the whole portfolios of research funders included in
our review covered a wide range of projects, and usually, in such cases, the percentage of principal
investigators reporting impacts on policy and practice was lower than in other studies. However, such
studies often identified examples of research within the portfolio that had made major impacts, although
these were best explored in depth through case studies. This reinforces the point that in most research
programmes only a minority of research should be expected to make much impact, but the impact from
that minority can sometimes be considerable.
Furthermore, the nature of some of the major impacts claimed in the impact assessments from around the
globe are similar to those reported in REF cases, even if the impacts in the REF are generally the more
substantial examples. For instance, the report on the impacts from the Main Panel A suggests that in the
REF many cases reported citations in clinical guidelines as an impact, and this is frequently a focus of
the impacts reported in the assessments of multiproject programmes.
Overall, therefore, the quantitative analysis of studies assessing multiproject programmes can contribute to
understanding the role impact assessments might play, and the strengths and weaknesses of the
methods available.
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Discussion
The considerable growth of interest in assessing the impact from health research was captured in our
review. We identified an increasing number and range of conceptual frameworks being developed and
applied, and included 110 new empirical applications (see Appendix 3), in comparison with the 41 reported
in the review published in 2007.2 In particular, we described and compared 20 frameworks or approaches
that had been applied since 2005, some of them having also been described in the previous review. Quite a
few of the 20 frameworks, and others, built on earlier frameworks, and sometimes combine elements from
several. This partly reflects the need to address the various challenges identified as facing attempts to assess
the impact from research.
The Payback Framework39 remains the most widely used approach for evaluating the impact of funded
research programmes. It has been widely applied, and sometimes adapted and refined, including in the
CAHS framework115 and Banzi’s research impact model.4 Other robust models that show promise in
capturing the diverse forms of health and non-health impacts from research include the RIF123 and various
approaches to considering the economic impacts of health research. A comparison of the 20 frameworks
indicates that while most, if not all, could contribute something to the thinking about options for future
assessment of impact by NIHR, some are more likely than others to be relevant for assessing the impact of
the bulk of the portfolio.
There is considerable diversity in terms of the impacts measured in the studies examined. Some of them
make no attempt to move beyond the assessment of impact on policy to consider whether or not there
has been any health gain. Others that adopt a multidimensional categorisation often recognise the
desirability of identifying health gains, but, in practice, lack the resources to make much progress in
measuring the health gain even in those cases (usually a small minority) where some links can be
established between the research being assessed and the eventual health gains. Finally, some studies, at
least in a few of the case studies included in an overall assessment, do go on to attempt to assess the
health gains that might be at least partially associated with particular research. The variations depend
on combinations of (1) the type of research portfolio that is being assessed, for example if it is a
commissioned programme; (2) the type of framework being used for the assessment; (3) the resources
available; and (4) the actual outcomes from the particular examples of research assessed. The
multidimensional categorisation of impacts, and the way it is applied in approaches such as the Payback
Framework and CAHS framework, allows considerable flexibility. In each case study, for example, it might
be appropriate to take the analysis as far along the categorisation as it is practical to go. So, for some it
might be possible to show an impact on clinical policies, such as guidelines or screening policies, and then
for a minority of those there might be opportunities to take the analysis further and explore whether or
not there is evidence from databases of practice change, screening uptake rates, etc. that could feed into
an estimate of possible health gain.
Although interviews, surveys, documentary analysis and cases studies remained the most frequently used
methods to apply the models, the range of methods and ways in which they were combined also
increased. The purpose behind a particular study often influenced the frameworks and methods adopted.
We identified 28 studies that had reported the findings from an assessment of the impact from all the
projects in multiproject programmes. We were able to compare the findings from 25 of these studies, and,
as in the previous review, they varied markedly in the percentage of projects within each programme that
seemed to make an impact on health policy and practice. Generally, the programmes with the highest
levels of impact were HTA-type programmes in which the projects were primarily reviews or appraisals that
fed directly into policy-making processes. Other programmes in which quite high proportions of projects
were seen to be making some impact were ones in which there had been one or more of the following:
thorough needs assessments conducted beforehand; frequent interactions with potential users; and the
existence of ‘receptor’ bodies that would receive and potentially use the findings. A key conclusion from
this is that impacts from such programmes were best assessed by frameworks devised to capture data
about the context and interactions related to research programmes.
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The consideration of the findings from studies and the role of the different possible frameworks and
methods have to take account of the major recent developments in impact assessment described in the
chapter, namely the introduction of regular monitoring of impact, for example through researchfish,76 and
the major, and largely successful, REF exercise in the UK.33 Both of these developments mean that any
future additional assessment of impact by NIHR will take place in an environment in which there is already
considerably more data available about impacts than was ever previously the case. Both developments also
demonstrate that impact assessment can be conducted in ways that identify that a wide range of impacts
come from health research and, therefore, provide a degree of endorsement of the previous smaller
exercises. However, many challenges remain in assessing research impact and further consideration of the
most appropriate approaches is highly desirable.
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Chapter 4 Towards a broader taxonomy of
impact models
This chapter attempts to make sense of the expanding array of impact models by offering a preliminarytaxonomy based on two questions: (1) ‘who is the model for?’ and (2) ‘what are its underlying
assumptions?’.
Different philosophical roots: five ‘ideal types’
Different approaches to measuring research impact also rest on different (usually implicit) assumptions
about the nature of knowledge. To understand impact and measure it in a valid way, we need to clarify
questions of ontology [what is (research) knowledge?], epistemology (how might we come to understand
that knowledge), the purpose of scientific inquiry and the mechanism by which research is assumed to link
to practice. The philosophical assumptions of different approaches to understanding scientific inquiry are
summarised in Table 8.
Traditionally, HTA’s focus has been on experimental studies of drug treatments or surgical interventions
from a positivist ‘hard science’ perspective. Mostly outwith HTA’s terms of reference, but within the wider
scope of health services research [see, for example, the NIHR CLAHRC programme (www.clahrcprojects.co.uk/),
the Wellcome Trust’s ‘Society and Ethics’ programme (https://wellcome.ac.uk/) or some elements of the
European Commission’s Horizon 2020 programme (https://ec.europa.eu/programmes/horizon2020/)],
are research designs such as collaborative codesign, policy analysis, health systems analysis and
organisational case study that are built (variously) on constructivist, critical or performative assumptions
(see Table 8). HTA has occasionally commissioned overviews of qualitative research from a constructivist
perspective,142,143 systematic reviews with a realist component144 or a systematic review of action research
that acknowledged (although it did not prescribe) a critical perspective.145 However, even considering
HTA’s main focus on clinical trials, few, if any, models of research impact assume a direct, linear and
unproblematic link between a trial and its subsequent impact. Most begin with a basic logic model and
enhance it with an interpretive account of the different relationships, interactions and contextual
influences that affect the research–impact link.
In this chapter, we will outline some research approaches and models of research impact that draw on the
wider range of philosophical assumptions set out in columns 3–6 in Table 8.
Different readers will have different views on the ‘correct’ or ‘preferred’ approach to research or the
measurement of impact. However, it is important to note that these different philosophical positions tend
to be linked to very different research topics and questions. Positivist assumptions tend to underpin
quantitative and experimental studies (especially the question of if and for whom a particular intervention
‘works’, and what magnitude of benefit can be expected). In contrast, studies with a strong explanatory
component (e.g. those that seek to build theory about a complex social intervention) may reject the
positivist assumption that there is a transferable ‘effect size’ and focus instead on describing interactions
and/or drawing out theoretical mechanisms of change. Studies that are driven by a passionate
commitment to improve the lot of a marginalised or underserved group, such as refugees or the homeless,
may find a critical perspective (and an action research study design) more appropriate and feasible than a
randomised trial.
The literature on impact in health services research is increasingly philosophically diverse, attempting to
combine the outputs of (positivist) evidence-based medicine (e.g. quantitative findings on the efficacy of
tests and treatments) with a broader (constructivist, realist, performative), epistemology of research
utilisation that incorporates various social science disciplines (notably, social psychology, organisational
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sociology, social policy, and science and technology studies). Some of these extended models sit more
comfortably in a social policy paradigm than in implementation science.146 In the following section (see
‘Logic models’ of research impact: strengths and limitations), we summarise these contrasting philosophical
ideal types and suggest how the different models of research impact align with them, and the implications
this has for assessing research impact in an increasingly diverse health research system.
Given that many of the models reviewed in this report draw on multiple philosophical assumptions,
it is worth introducing a composite philosophical position (not shown in Table 8), which is pragmatism.
Ontologically and epistemologically eclectic pragmatism proposes that when combining scientific and
practical knowledge (e.g. when attempting to link a body of research with its application in the real
world), the relevance of each competing position should be judged in terms of how well it addresses the
problematic situation or issue at hand.147
It should be noted that positivism is the only philosophical position that strongly supports a ‘model’ with
‘tools’ to apply it. Hence the perspectives in other philosophical schools might best be thought of as
‘approaches’ rather than as ‘models’.
‘Logic models’ of research impact: strengths and limitations
Most, although not all, approaches to assessing research impact in the health sciences include some kind
of ‘logic model’ – defined as a depiction of the logical (implicitly, causal) relationships between the
resources, activities, outputs and outcomes of a programme. However, few, if any, of these approaches
assume that the link between research and impact is as linear and direct as the logic model implies.
Different approaches enhance the logic model in different ways. In this section we summarise the
approaches that include a logic model and review the strengths and limitations of the logic model.
Chapter 3 described a number of widely used approaches from the mainstream health services research
(or ‘research on research’) literature, including the Payback Framework and its variants,39 the monetary
value approach, the Quebec HTA approach,43,44 the CAHS approach,7 Banzi’s research impact model,4 the
NIEHS logic model,63 the medical research logic model,120 the NIOSH logic model,92 the Wellcome Trust’s
assessment framework,93 the VINNOVA framework,37 the RIF,123 the Becker Medical Library model,118 the
research performance evaluation framework,72 the UK REF and the Australian RQF.128 All these examples
consist partly or wholly of a logic model (although Chapter 3 also includes some examples of constructivist,
realist and performative approaches).
Similarly, all the models described in Chapter 5 on the monetary value are essentially logic models,
whether ‘top down’ or ‘bottom up’, which link inputs (research funding) with the research process and
then outputs and (monetised) impacts. Chapter 6 (the impact of RCTs via their role in systematic reviews
and meta-analyses) and Chapter 7 (the impact of RCTs on stopping ineffective interventions) also relate
exclusively to logic models.
The strengths of logic models are the way in which the links between inputs, processes, outputs and
outcomes are carefully drawn out, and the fact that mediating and moderating variables can be added to
the model to account for successes, failures and partial successes. A robust logic model, systematically
applied, should produce valid and reliable statements about the relationship between these variables.
However, in the real-world application of research evidence, it is widely recognised that not all research
impact links can be predicted or reliably quantified. Part of the elegance of many frameworks that include
a logic model is the sophistication of the caveats and nuances they accommodate to explain, for example
how, why, by whom and influenced by what historical and contextual factors the impact unfolded as it
did. In the Payback Framework, for example, the basic logic model is enhanced by a narrative account of
factors and influences, including the context within which the research takes place and the interactions
between potential users and the researchers. These are widely viewed as key features of the framework.
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Although logic models are only ever an approximation of reality, they can be extremely helpful as
conceptual tools. They generally cover a range of impacts considered important to stakeholders, and the
various elements of the models provide a framework for organising data collection, analysis and data
presentation consistently, taking account of inevitable variations between projects or programmes.
A robust basic model, while being rigorously applied, can also be refined further in collaboration with
the funders of particular studies and other stakeholders (e.g. patient organisations) to ensure that the
assessment of impact focuses on the categories important to those stakeholders. Such models can often
be applied flexibly in a way that is compatible with the values of the research funders and researchers,
who are usually concerned to show that they are contributing to improved health care.
Even when they include such scope for flexibility and caveats, logic models may be criticised by social
scientists who question their value for assessing research that is inherently non-linear (e.g. the evaluation
of real-world social programmes that follow the non-linear dynamics of complex systems). We list below
the alleged downsides of logic models as described by their critics.5,6,14,95,115,116,148–151
1. Assumption of linear causality: to a greater or lesser extent (e.g. depending on the degree of
‘permeability’ acknowledged by their architects), logic models reflect a deterministic, research-into-
practice mind set that is incapable of fully capturing the messiness and non-linearity of the relationship
between research, practice and policy. The epistemological assumption behind unenhanced logic
models is that with careful measurement and synthesis of input, process and context variables,
it is possible to draw meaningful conclusions about the link between a research programme and
subsequent impact, and predict comparable impact in the future. Critics say that this assumption is
highly questionable in certain circumstances, notably when the context is complex and multiple input
variables are rapidly changing.
2. Disciplinary bias: logic models are said to privilege ‘hard’ research, such as trials and epidemiological
studies, over ‘soft’ research, such as qualitative or developmental studies, and to valorise easily
monetised impacts such as licensing and start-up creation. Furthermore, the quest to measure the
measurable in a rational, ‘objective’ way creates perverse incentives to overlook the unmeasurable
elements in any research discipline.
3. Temporal bias: different kinds of research achieve impact over different time scales, and hence an overly
rigid logic model will miss impacts at extremes of these scales. In general, the longer the time scale,
the more diffuse the chain of causation. As Kok and Schuit stated: ‘pathways from research to
”impacts” are very diverse: sometimes short and traceable, but often long, through multiple reservoirs,
and via utilization at untraceable times and places’.116
4. Attribution: the extent to which an impact can be attributed to a particular research project is a matter
of judgement. In reality, attribution is often an inexact science in which accuracy attenuates with each
stage in the logic model.
5. Additionality: return on investment models are not designed to address whether or not the claimed
impact would still have occurred had the research not been done. There is also the related question of
opportunity costs – might the research budget have been spent differently, with greater benefit to the
public good?
6. Excessive abstraction: according to critics, logic models are elegant and parsimonious in the abstract
and convey the impression of rigour through ‘hard’ analytics, but (depending on how rigidly they are
applied) they bear little relation to the messier real-world use of knowledge by human actors and how
knowledge is interpreted, negotiated and valued by wider society.
7. Impracticality: application of logic models (which tend to be multimethod, multilevel and seek to build a
rich picture of the numerous interacting influences on impact) is resource intensive, hence not a
practical or affordable option in most situations. Reducing the rich, multimethod case study approach
intended by the original authors to a crude inventory based on tick-box surveys and a handful of
standardised interviews will not produce valid or reliable data.
8. Ethical issues: the impact of research may be significant and far-reaching but morally questionable
(e.g. if it is achieved at the expense of environmental damage) or even harmful (e.g. if it distorts rather
than informs decision-making). It has even been argued that the dominance of economic models of
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impact reflects a sinister development in which key moral questions about the public good (what kind
of science is morally right) are downplayed in favour of instrumental practices aimed at a narrow range
of utilitarian goals, especially innovation and economic growth.
The validity of all the above arguments will, of course, depend on context and specifics, but, as noted
above, the crude and unenhanced logic model that depicts a naive and deterministic relationship between
research and impact has long been rejected in favour of more pragmatic and flexible hybrids. As the range
and diversity of research expands, the models reviewed in the next section should perhaps be viewed not
as substitutes for (or competitors of) more widely used approaches based on logic models, but as
complementary approaches that might prove fit for purpose in particular circumstances.
Alternatives to the logic model approach
Different models of research impact are more or less appropriate for different study designs and research
themes – a finding that was evident in the previous HTA review.2 Similarly, the CAHS panel commissioned
separate analyses of how which approaches might work best for each of three of the four ‘pillars’ of research
used to categorise health research in Canada: pillar II, clinical research;152 pillar III, health services research;113
and pillar IV, population and public health research.114 (Pillar I, basic biomedical research, was excluded on the
grounds that it ‘is the area where most has been said on understanding the impacts of health research’.)
Some Australian studies have also considered this issue. Cohen et al.52 found that ‘single intervention
research studies can and do have concrete and measurable post-research real-world impacts . . . on policy
and practice’.52 This recent study adds to the view that the degree of impact identified and reliably
attributed (at least over relatively short time scales) might vary depending on the type or research, and
context in which it is conducted and its findings presented. Kalucy et al.65 used the Payback Framework to
assess the impact of primary care research and reported that the ‘logic model’ of the framework worked
better for a RCT than it did for an action research study.
Impact assessments are conducted for a variety of audiences (Table 9) and purposes [the ‘four As’ of advocacy
(for research), accountability, analysis (of why and to what extent research is effective) and allocation].2,9
TABLE 9 Different audiences for impact assessments
Audience/stakeholder Main concern
Research funder/donor Was the money we invested in (donated to) research well spent? Were the benefits anticipated
in the application actually realised? The audiences and purposes clearly overlap to a degree, but
of course a major audience is likely to be the organisation funding the original research, who,
according to our analysis, are the most likely to be funding the assessment. Research funders as
an audience are likely to hope an assessment study would contribute to several purposes.
Indeed, they might hope an assessment study would inform both analysis and allocation,
but as shown above it is unlikely a single assessment approach would be best for both tasks
Patient/carer/research
participant
Did the research address things of concern to people with the illness?
Are we better off as a result of the research, and, if so, how?
Researcher Who used the findings of my research and what benefit resulted?
Treasury/taxpayers Is/was this programme of research a good use of public money?
Were there cash-releasing or non-cash-releasing benefits elsewhere in the system?
Higher education
institution
Was the research excellent (i.e. world-leading)?
Did it lead to high-impact publications, reputational benefits, rise in university ranking, etc.?
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Guthrie et al.9 examined six impact frameworks in detail and suggested that all six could be used if the
purpose was advocacy or accountability. However, if the purpose were analysis, only three of the six
frameworks would be fit and if the purpose were allocation, a different three would be fit. They applied
the four As to inform a decision tree for developing a research evaluation framework.
Audiences and purposes clearly overlap to a degree. A major audience is likely to be the organisation
funding the original research, who may also be funding the impact assessment. Research funders might
hope a single impact assessment will inform both analysis and allocation, but may be unaware that
different assessment tools are more or less suited to different purposes.
Bearing in mind the consistent evidence in favour of different models for different types of research,
different audiences and different purposes, the next few sections address alternatives to the logic model
for assessing research impact. Although many are only marginally relevant to the current remit of the HTA
programme, they are nevertheless important components of a broader toolkit.
Constructivist models of impact (developed in social sciences)
As column 3 in Table 8 shows, constructivist (sometimes called interpretivist) research focuses on people’s
interpretations of the world. This is important for the study of research impact because policy-makers,
clinicians and patients interpret the world they inhabit – and they also interpret research evidence in ways
that may not align with researchers’ perspectives.
This misalignment was systematically documented in a detailed ethnographic study undertaken in the
1970s,49 and more recently updated,153 of the interactions between national policy-makers and the
university-based researchers from whom they commissioned research (the so-called ‘Rothschild experiment’
in the English Department of Health and Social Security). Kogan and Henkel’s49 landmark study
demonstrated a number of key principles that are still relevant to the measurement of research impact
today. First, science and government are from different cultural worlds; interaction between them is a
‘contact sport’, in which success depends on sustained linkage and exchange with ‘knowledge brokers’
playing a key role.154
Second, despite the ubiquity of simple, linear models of research-into-policy, scientific research and the
business of government is, in reality, highly complex. Simplistic models fail to capture their important
nuances. In particular, science and government are interdependent and mutually shaping, hence even
commissioned research does not follow a simple, customer–contractor logic.
Third, research priorities, even in applied fields, are rarely self-evident, partly because different stakeholders
view the world differently and have competing vested interests.
Finally, the different perspectives within each ‘multimodal’ group of scientists and users can have major
consequences; for example, if the chief scientist took a narrow, positivist and quantitative view of what
science should look like, this would limit the scope for university researchers and research users to develop
more emergent partnerships to address highly complex real-world problems.
In 1979, sociologist Carol Weiss34 challenged the prevailing assumption that research impact is direct and
linear (and hence that it can be meaningfully summarised in logic models). Drawing on empirical studies
in the social sciences, she argued that the assumed knowledge-driven mode of impact, along with
problem-solving mode (research commissioned directly to solve particular policy problems – as in the
Rothschild experiment) were rare, not least because the findings of social science research tend to
illuminate the complexity and contingency of phenomena rather than providing simple and universal
solutions to them.
TOWARDS A BROADER TAXONOMY OF IMPACT MODELS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
52
Weiss and others have shown that research in the social sciences (which includes much applied health
research) is generally characterised by an interactional mode of impact in which researchers and
policy-makers, through repeated interaction over time, come to understand each other’s worlds and
develop shared goals and approaches.34 Impact may also occur by other non-linear mechanisms
including enlightenment – as Hanney et al.35 stated, drawing on the work of Thomas,155 ‘the gradual
“sedimentation” of insight, theories, concepts and perspectives’, as a result of continuing exposure to
research insights and ideas. Finally, research findings may be used by policy-makers symbolically (either
politically to support a particular course of action or tactically to delay a decision, perhaps commissioning
new research in order to buy political breathing space).34,35,156
Knowledge in the social sciences has complex properties. It is fluid, context dependent, embodied by
individuals and embedded in organisational routines and norms. Hence social scientists are uncomfortable
with models of impact that rest heavily on the ‘transfer’ or ‘implementation’ of an assumed fixed body of
knowledge. Conversely, they are often keen to explore the processes by which knowledge, which is
assumed to take multiple forms, is interpreted, negotiated, transformed and applied in practice, and how
context may profoundly affect these processes.149
Meagher et al.,95 for example, applied a model with some parallels to the Payback Framework, but resting
on interpretivist assumptions and placing more emphasis on processes and activities, to study the impacts
of ESRC-funded research in a number of detailed case studies. They found that conceptual (e.g. indirect,
enlightenment based) impacts were more common than instrumental (e.g. direct, knowledge driven) ones.
They also found that most principal investigators had a naive and linear view of the research–impact link
(e.g. few knew about interactive or enlightenment mechanisms or the need for ongoing linkage and
exchange with policy-makers). They questioned the value of tracking impacts in the absence of specific
activities aimed at facilitating uptake. Indeed, they felt it might be inappropriate to try to measure
something that one has not expressly tried to bring about. They commented:
It was extremely difficult to attribute with certainty a particular impact to a particular project’s research
findings. It was often more feasible to attach an impact to a particular researcher’s full body of
research [. . .] Changes in practice or policy often appear to stem from a general ‘awareness-raising’ or
conceptual shift.
p. 17095
The ‘full body of research’ referred to in the above quote has been described by RAND as a ‘research
cloud’ and explored using electronic bibliometrics.157
Brambila et al.137 used a rare longitudinal case study methodology to demonstrate Weiss’s ‘incremental’
mechanism of impact in a sample of 44 community-based health care projects in Guatemala between
1988 and 2001. Like Meagher et al.,95 they found few linear impacts directly attributable to single projects.
Rather, policy change occurred through ‘a gradual process of information sharing, where researchers
influence decision-makers through a continual stream of information rather than a single set of findings’.137
de Goede et al.158 developed a three-phase framework for capturing the complexity of research utilisation:
(1) describe the research network and the policy network; (2) describe the types of research utilisation
(classified as instrumental, conceptual and symbolic); and (3) describe the (reciprocal) interactions between
researchers and policy-makers. Barriers to the effective uptake of research may occur at the level of
expectation (are policy-makers ‘ready’ for these findings?), transfer (how effectively and appropriately are
findings communicated?), acceptance (are findings seen as credible and true?) and interpretation (what
value do policy-makers place on them?). Using three detailed case studies, these authors showed, like
Meagher et al.,95 and Kogan and Henkel earlier,49 that most research utilisation was conceptual and that
non-uptake could often be explained by a mismatch of world view and problem definition between
researchers and policy-makers.
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de Jong et al.159 developed a model for incorporating context into impact assessment (Figure 5), as
different fields of inquiry provide very different contexts for research and impact. (This finding resonates
with Nicolini et al.160 on the different nature of knowing in different clinical specialties.)
Step 1 considers ‘research field context’: nature and range of research, how quality is defined, and
implications for agenda-setting, collaboration, knowledge dissemination and impact. Steps 2–4 consider
missions of the research group, audiences and outputs within this wider context. Contrasting examples of
architecture and law illustrate that attempts to assess research impact make little sense without preliminary
contextualisation of the field.
A study from Australia based on five case studies in contrasting disciplines found similarly that ‘disciplinary
and methodological context matters when it comes to understanding the translation, dissemination,
and utilization of academic social research.’161
More recently, Lemay and Sá162 depict research utilisation as having the non-linear dynamics of a complex
adaptive system, composed of multiple interacting entities, coevolving, locally adaptive, self-organising,
path-dependent and sensitive to initial conditions. They view research users as active problem-solvers and
generators of knowledge, not passive receptacles. They propose that impact may (theoretically at least)
be modelled using computational techniques such as agent-based modelling, data mining or socionics.
Such approaches would require a shift in the policy mind set.
Normative policy development and implementation are about directing, controlling and minimising
uncertainty about outcomes. Taking into account the contingent, emergent and unpredictable nature
of research use would imply acknowledging and accommodating unpredictable outcomes that might
emerge over time.
p. 480162
In a widely cited systematic review of knowledge utilisation, Contandriopoulos et al.163 depicted
knowledge in two essential forms: individual, that is, held in people’s heads and translated (or not) into
action by human will and agency (a conception of knowledge that rests largely on positivist assumptions);
and collective, that is, socially shared and organisationally embedded (a conception that rests on more
constructivist assumptions). They reviewed the mechanisms by which knowledge may become collectivised,
including efforts to make it relevant, legitimate and accessible and to take account of the values and
priorities of a particular audience. If there is broad agreement on what the problem is and what a solution
FIGURE 5 de Jong et al.’s framework for assessing impact in context. Reproduced from de Jong SP,
van Arensbergen P, Daemen F, van der Meulen B, van den Besselaar P. Evaluation of research in context: an
approach and two cases. Res Eval 2011;20:61–72, by permission of Oxford University Press.159
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would look like, arguments can proceed through logic models along the lines of conventional scientific
inquiry (e.g. strength of research evidence). If not, the research impact challenge must take account of
people’s interpretations, and hence enters the more fluid and subjective realm of political science in which
research use is, in Weiss’s taxonomy, instrumental and/or tactical rather than knowledge driven.34
In summary, whereas the natural sciences can be thought of as trading in more or less universal truths,
knowledge in the social sciences (including the study of how individuals interact and how organisations
and communities operate) is more fluid, dynamic and value-laden. The uptake and use of knowledge
depend heavily on context; impacts may be diffuse, subtle, diverse and unpredictable; and causality tends
to be explanatory rather than probabilistic.
Realist models: impact as ‘theory of change’
The studies described in the previous sections applied an interpretivist lens to explore the research–impact link
in (mostly) single case studies without making predictions about other cases. A different approach, realist
evaluation, uses case study methodology but through abductive theorising about context–mechanism–outcome
configurations, seeks to make generalisable statements about what tends to work for whom in what
circumstances. A preliminary paper purporting to apply realist methods to the study of impact has been
published, although this monograph would more accurately be described as an introduction to realist
methodology in general.164 The principles of the realist approach are summarised below.
Realist evaluation was developed by Pawson and Tilley in the 1990s for the evaluation of ‘what works for
whom in what circumstances and how?’165 This early work made the following points.
l Complex interventions (what Pawson and Tilley call ‘social programmes’, e.g. an intervention to
encourage people to consult their general practitioner rather than attend the emergency department)
are an attempt to create some level of social change.
l These interventions ‘work’ by enabling participants to make different choices.
l Making and sustaining different choices requires a change in a participant’s reasoning (e.g. in their
values, beliefs and attitudes or the logic they apply to a particular situation) and/or the resources
(e.g. information, skills, material resources, support) they have available to them. This combination of
‘reasoning and resources’ is what enables the intervention to ‘work’ and is known as a ‘mechanism’.
l Complex interventions ‘work’ in different ways for different people because contexts (social, economic,
organisational, interpersonal) have different influence on different people, triggering different
mechanisms: context +mechanism = outcome.
l As complex interventions work differently in different contexts and through different change
mechanisms, programmes cannot simply be replicated from one context to another and automatically
achieve the same outcomes (i.e. impacts). Theory-based understandings about ‘what works for whom,
in what contexts, and how’ are, however, transferable.
l Therefore, one of the tasks of evaluation is to learn more about ‘what works for whom’, ‘in which
contexts particular programmes do and don’t work’, and ‘what mechanisms are triggered by what
programmes in what contexts’.
In summary, a realist approach to research impact is centrally concerned with looking at how different
research programmes may have different impacts in different settings. Empirical studies applying realist
methodology to the evaluation of research impact are currently sparse,166 but the approach is rapidly
growing in popularity in the health-care field, and hence we flag it here as a potential (if largely
untested) option.
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Participatory and critical emancipatory models of impact
One of the most striking developments in UK health services research since the publication of the 2007
HTA report has been the increased emphasis on patient and public involvement as a contributory factor in
research impact.167 User involvement on grant applications and study steering groups is widely promoted
and an important criterion against which studies are evaluated. However, this involvement is sometimes
under-theorised, depicted as instrumental (aimed at increasing recruitment to clinical trials) and couched
in strongly positivistic terminology, with an emphasis on standardisation and formal measurement of
variables. One study, for example, was entitled Involving Service Users in Trials: Developing a Standardised
Operating Procedure.168 Another offered a 31-point checklist to ensure uniformity in this aspect
of research.169
An alternative approach to public involvement in research has been presented in the critical social science
literature.170 From this perspective, research impact is centrally concerned with achieving social justice and
improving the lives of disadvantaged groups. Action research, sometimes known as community-based
participatory research (CBPR), seeks to redress the adverse influence of social determinants of health
(e.g. poverty, sex, ethnicity, education/literacy, citizenship status and access to services) through
collaborative, multistakeholder activity.171
A key challenge of CBPR is ensuring that the research process should remain democratic despite
imbalances of resources and power, so some tools have been designed to measure the extent of power
sharing. White,172 for example, writing in the CBPR literature, distinguishes nominal involvement of the lay
public (undertaken to confer legitimacy on a project), instrumental involvement (to improve its delivery
and/or efficiency), representative involvement (to avoid creating dependency) and transformative
involvement (to enable people to influence their own destiny).
Additional dimensions of the CBPR process may also be assessed to estimate the level of democratic
decision-making, such as the extent to which research designs are culturally and logistically appropriate;
the extent of measures to develop capacity and capability in stakeholder groups; how, and to what extent,
conflicts are managed; and the extent to which mutual trust builds over time.173
Martin174 classifies involvement of practitioners (e.g. clinicians) in collaborative research on a five-point
scale: informant (‘type 1 co-production’ – supplying data for a mode 1 research study but no other
involvement); receiver (‘type 2 co-production’ – involved at the end of a mode 1 study to receive the
findings, usually on terms set by the researchers); endorser (‘type 3 co-production’ – involved from an early
stage to endorse, but not influence, priority setting and research programmes); commissioner (‘type 4
co-production’ – involved from the outset to conceive and initiate studies that are taken forward by
researchers); or co-researcher (‘type 5 co-production’ – working democratically alongside researchers at
every stage in the research).
Macaulay et al.171 applied CBPR to health care. They proposed some indicators of whether or not a
community–campus partnership was truly democratic, including (1) ‘Were the research goals, objectives
and methods negotiated among all partners?’; (2) ‘Were the terms of the community–researcher
partnership made explicit and agreed?’; (3) ‘Who evaluated the project and how?’; (4) ‘Where were the
data filed and who had control over their subsequent analysis and publication?’; (5) ‘What were the
arrangements for resolving disagreements?’; and (6)’ How and to whom were the findings disseminated?’.
In CBPR, partnerships succeed largely through partnership synergy – defined as combining people’s
perspectives, resources and skills to ‘create something new and valuable together – a whole that is greater
than the sum of its individual parts’.175 Partnerships are often characterised, at least initially, by conflict, but
synergy may increase as cogoverning partners work together, leading to convergence of perspectives by
progressive alignment of purpose, values and goals and growth of mutual understanding and respect.173
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Cacari-Stone et al.176 linked the CBPR approach to policy-making by linking CBPR contexts (political–societal
and specific collaborative histories) and partnership processes (e.g. equitable decision-making or leadership)
to intermediate research and system or capacity outcomes, and more distally to health outcomes (Figure 6).176
They depict the policy process as iterative, non-linear and characterised by windows of opportunity. CBPR
may influence this both instrumentally (by generating evidence) and interactively (through civic engagement).
Community-based participatory research depicts sustainability of research impact in synergistic terms as
progressive strengthening of the community–campus partnership for further collaborative knowledge
production (hence the feedback arrows from the outcomes of one project to the context for the next
project in Figure 6).
The literature on CBPR, and on ‘socially engaged’ research more generally, uses the language of critical
sociology and critical public health. It is a world away from most clinical research, which remains dominated
by the language and logic of epidemiology and RCTs. However, while the RCT is predicated on the positivist
assumption that knowledge is fixed and stable and political issues lie beyond the analytic frame (see Table 8),
the use of evidence from RCTs requires attention to the policy process and hence to interpretation (see the
‘constructivist’ column in Table 8) and the balance of power (see the ‘critical’ column in Table 8).
In 2011, Kessler and Glasgow177 famously called for a 10-year moratorium on RCTs to allow the health services
research community to learn and apply the concepts of a more applied and socially engaged approach. They
subsequently drew the disparate paradigms of RCTs and CBPR together in an evidence integration triangle
designed to ‘[marry] rigorous design focused on internal validity and theory-driven hypotheses with an
increased focus on external validity, contextual considerations, and stakeholder relevance’.178
Glasgow et al.’s ‘evidence implementation triangle’ (Figure 7)178 is an example of how the research
tradition of knowledge translation has sought to embrace a wider range of paradigms. The triangle
comprises an evidence-based intervention or policy (perhaps tested in a RCT), a participatory
implementation process (perhaps using CBPR or some other developmental approach), and practical
FIGURE 6 Conceptual model for illustrating the link between CBPR and policy-making. Cacari-Stone L, Wallerstein N,
Garcia AP, Minkler M. The Promise of Community-Based Participatory Research for Health Equity: A Conceptual
Model for Bridging Evidence With Policy. Am J Public Health 2014;104:1615–23, with permission from The Sheridan
Press (on behalf of The American Public Health Association).176
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(i.e. feasible, affordable, actionable and sensitive to change) progress measures, all studied with attention
to context. Although this is a worthy attempt to link the different cultural worlds of clinical trials and
real-world implementation, the depiction of CBPR as an ‘implementation process’ for the findings of
mode 1 research spectacularly misses the central emancipatory principle of this approach.
Many writers in social science traditions consider that a focus on ‘translation’ or ‘dissemination’ of
pre-existing research knowledge offers only limited purchase on the phenomenon of impact. In this
section, we review approaches that focus instead on knowledge production.
Co-production models (e.g. multistakeholder research partnerships)
In 1994, a book entitled The New Production of Knowledge: The Dynamics of Science and Research in
Contemporary Societies introduced a new taxonomy: ‘mode 1 scientific discovery’ and ‘mode 2 knowledge
production’.179 This centred on the practices through which knowledge is produced rather than the
mechanisms by which it was subsequently disseminated. The book had much influence in the social
sciences, but less so in health-care fields. However, with the emergence of complex organisational forms
(such as Academic Health Sciences Networks,180 funded by the NHS, and CLAHRC, funded jointly by the
NHS and NIHR181–186) oriented towards the collaborative production of research knowledge between
universities, the NHS and other partners, the literature on mode 2 research is increasingly relevant for the
UK research community – though perhaps less so for the HTA programme in which the commissioning
model remains largely mode 1.
Multilevel context
Participatory 
implementation process
(e.g. stakeholder engagement, 
CBPR, team-based science, 
patient centred)
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 longitudinal measures)
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FIGURE 7 Glasgow et al.’s evidence implementation triangle.178 Reprinted from Glasgow RE, Green LW, Taylor MV,
Stange KC. An evidence integration triangle for aligning science with policy and practice. Am J Prev Med
2012;42:646–54, with permission from Elsevier.178
TOWARDS A BROADER TAXONOMY OF IMPACT MODELS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
58
Mode 1 research equates to traditional academic science, led by university researchers and then
disseminated to stakeholders beyond higher education. In contrast, mode 2 knowledge is generated within
its context of application – what Gibbons et al.179 refer to as a ‘multi-stakeholder transaction space’ –
embracing state, economy, culture and the wider public sphere, as well as academic institutions (of which
Academic Health Service Networks and CLAHRCs are good examples). In this ‘transaction space’ (the
formal board meetings of AHSNs and CLAHRCs, as well as the informal interactions that go on behind the
scenes to keep these shows on the road), problems are identified, questions debated, methodologies
developed and outcomes disseminated. There are many players, many experts (of different kinds) and an
evolving collective view (though rarely a consensus) on what the questions and challenges are.
Gibbons et al.179 emphasise that in mode 2 research, a range of theoretical perspectives and practical
approaches – including, but not limited to, specialist scientific techniques – is mobilised and managed,
often for only a limited period, to address a particular set of problems. The planning, execution,
dissemination and implementation of research are not separate and linear phases but interwoven, and the
relationship between scientists and research users (industry, policy-makers, citizens, patients) is one of
Co-production rather than ‘producer’ and ‘consumer’ or ‘commissioner’ and ‘contractor’. The authors of
the mode 2 hypotheses depicted the process as highly reflexive.
The research process can no longer be characterised as an ‘objective’ investigation of the natural (or
social) world, or as a cool and reductionist interrogation of arbitrarily defined ‘others’. Instead it has
become a dialogic process, an intense (and perhaps endless) ‘conversation’ between research actors
and research subjects.
p. 4187
The emergence of complex forms for mode 2 research in health care in the UK is mirrored in other
countries, for example the Canadian Community–University Research Alliances,188 the Dutch Academic
Collaborative Centres for Public Health189 and the Australian Accreditation Collaborative for the Conduct of
Research, Evaluation and Designated Investigations through Teamwork.190 One recent publication coined
the term ‘multi-stakeholder health services research collaborations’ to describe the increasingly complex,
intersectoral and networked structure of contemporary medical and health services research.190 These
complex forms should be seen as part of the wider emergence of ‘health research systems’ – organised
networks of researchers, knowledge intermediaries, policy-makers and others who provide a context for
health sciences research and its uptake and application.35,191 We include brief mention of them here, as
even though the HTA programme is not directly linked to such forms, it must take account of their indirect
influence on the UK research landscape.
While logic models tend to centre on demonstrating more or less causal connections in the temporal
sequence of inputs (research funding), processes (execution of discrete projects or programmes of
research, usually following a predefined protocol), outputs (e.g. publications and presentations) and
outcomes (impacts on end-users of research), the study of knowledge production has emphasised the
non-linearity, messiness and unpredictability of the collaborative knowledge production process. It has also
surfaced the importance of power relations and governance for the success of such partnerships, as each
partner brings different expectations and goals and the generation of robust and useful research will
inevitably depend on managing these conflicts. Evaluations of multistakeholder research collaborations
have consistently found that ‘colliding institutional logics’,192 ‘ambiguous loyalties . . . different interests . . .
competing goals’193 and ‘multiple accountabilities’.189 Hinchcliff et al.190 distinguish between the sanitised
written accounts of multistakeholder interactions (‘draped in the formal collaborative language and
procedures prescribed by funding agency protocols’) and the reality in which ‘participants . . . view each
other pragmatically as consultants, clients or even competitors, rather than partners’.190
The analysis of developments such as CLAHRCs has (rightly) drawn on a range of different perspectives,
approaches and models. Although they are empirically diverse and philosophically heterogeneous, they
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have in common recognition that the logic model approach is inadequate to capture the multiple (and
bidirectional) interactions occurring within the system. These include:
l approaches based on an in-depth case study that emphasised the formative role of real-time evaluation
findings in shaping the emergence of CLAHRC activities185
l approaches based on a complex adaptive systems perspective, including that proposed by the World
Health Organization Alliance for Health Policy and Systems Research194 and Shepherd’s model of the
evidence ecosystem in health and social care195
l adaptation of complex systems theory that focus specifically on conflict, including Bennet et al.’s196
metaphor of collaborative entanglement (depicting the conflict-ridden, messy, unpredictable and
evolving interactions among stakeholders in contemporary mode 2 activity), explored further by
Phipps et al.197,198
l Kislov et al.’s199 theorisation of CLAHRCs as communities of practice
l Caldwell and Mays’ application of sociological ‘frame analysis’ (Goffman200) to analyse a CLAHRC from
macro (policy context), meso (organisational activities and interactions) and micro (individual
behaviour) perspectives182
l Currie et al.’s201 application of neo-institutional theory to explore the interplay between knowledge
brokering and professional power dynamics in CLAHRCs (‘Professional hierarchy means that some
change agents or knowledge brokers are accorded greater legitimacy than others’) and question the
level of policy commitment to the CLAHRC model
l Rycroft-Malone et al.’s102,166 adaptation of realist evaluation to look at context–mechanism–outcome
configurations in a CLAHRC.
Critics have questioned if, and to what extent, mode 2 knowledge production (in which multiple
stakeholders negotiate a research agenda that may not meet scientists’ standards of rigour) counts as
science at all.202 These reservations might be partially assuaged by Van de Ven and Johnson’s paper on
engaged scholarship,203 in which they apply the concept of mode 2 to organisational academics working
alongside managers. Using the philosophical lens of pragmatism, they argue that mode 2 is essentially a
dialectical process of bringing competing perspectives (academic and practical) to bear on a problem –
a task they term arbitrage and others have called ‘bricolage’.204 They explain:
By exploiting multiple perspectives, the robust features of reality become salient and can be
distinguished from those features that are merely a function of one particular view or model.
p. 810203
Such an approach is invariably conflict ridden; the key to its success is encouraging task-oriented conflict
(which is creative and productive) while managing the potentially destructive influence of interpersonal
conflict.
Discussion
In summary, the landscape of applied health research in the UK is changing. A great deal of research
remains unambiguously university led, university based and funded (in either ‘responsive’ or ‘commissioned’
mode) from research councils, NIHR and the Department of Health (e.g. via the HTA programme). However,
such mode 1 research (in which impact can often be effectively evaluated through logic models) increasingly
coexists with mode 2 programmes of activity that are jointly led and governed by multiple (university and
non-university) stakeholders, organised in a more neutral transaction space and characterised by organic,
non-linear dynamics and focus on the ‘production’ rather than ‘translation’ of knowledge.
These findings are discussed further in Chapter 8.
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Chapter 5 Estimating the monetary value of the
impact of health research
Introduction
The economic impacts from medical research form a subset of many of the logic models presented in
Chapter 3. A section of the literature has addressed the specific issues relating to undertaking exercises to
determine economic impacts or the returns on investment from medical research and development spending.
Previous reviews of the literature, which form a starting point for this review, have highlighted work that has
been done to advance the field.2,205 The methods used to assess these impacts or returns on investment are
born from the economic evaluation literature, and the difference in approaches lies largely in the scope of
the cost and benefits assessed, and the valuation methods for seemingly non-monetary components of the
impact. As stated in Chapter 2, the purpose of this review was, using Buxton et al.28 as a starting point, to
identify studies since 2004 that have used any methods to attempt to value (in monetary terms) the benefits
(health and cost savings) of a body of health research and link that with an investment in the body of
research. Articles were included only if they contained a component that attempted to value the impact of
research and development investment on population health.
The article in the Bulletin of the World Health Organization by Buxton et al.28 attempted to learn from
previous studies that had estimated ‘monetary values for the societal benefits obtained from health
research, especially those studies that have attempted to link (and value) benefits to a specific society from
a specified (and costed) body of research’.
The authors characterised the identified methods into four categories:
1. valuing direct cost savings to the health-care system
2. valuing benefits to the economy from a healthy workforce
3. valuing benefits to the economy from commercial development
4. measuring the intrinsic value to society from health gain.
Studies were identified that had considered the benefit of medical research and development as direct cost
savings to the health-care system, brought about by a reduced number of people requiring treatment or
reductions in per patient treatment costs. This approach had been predominant in estimating the benefits
of vaccination research, which had the potential to eradicate subsequent disease and associated treatment
costs.205–208 Cost savings could be included as part of cost–benefit analysis, but these studies did not always
link this to an investment period or country-specific research.
One of the earliest studies to attempt to calculate a rate of return from medical research was conducted by
Mushkin and Landefeld.209 A human capital approach (equating the value of life to market values, i.e.
wages) was used to value gains from US biomedical research, characterised by a healthier workforce.
The limitations of such an approach were acknowledged by the authors and others28,209,210 and tend to
overstate benefits when lost labour can be replaced, while understating benefits for those sections of the
population not of working age.
Buxton et al.28 drew largely on a review conducted by Salter and Martin,211 which explored the commercial
economic benefits from basic research. Salter and Martin noted progress made by Mansfield212,213 that
estimated a worldwide social rate of return (benefits accrued to the whole of society, as opposed to one
firm or funders of one project) of 28% for research undertaken 1975–78. Studies have also demonstrated
the economic benefits of medical research through industrial applications to other industries.214
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An emerging field highlighted by a number of studies in the Buxton et al.28 review had measured the
intrinsic value of health gains brought about by research and development. A US initiative of the Mary
Woodard Lasker Charitable Trust, Funding First,215 produced a series of papers that formed a subsequent
book.216 An informal approach used willingness-to-pay methods to value the increased longevity of life
experienced by the US population, attributing a fraction of these gains to medical research. The results
suggested ‘exceptional returns’ of nearly 20 times the investment in US medical research. This type of
analysis was performed in a more systematic fashion in an Australian study, taking a similar ‘top-down’
approach to valuing health gains, to produce an estimate of the annual rate of return to investment in
research and development.217 They estimated a favourable benefit-to-cost ratio of 2.40 (i.e. AUS$1
invested creates an additional AUS$1.40 benefit); however, this work has been subsequently criticised
because the time for investment in medical research to produce health gains was not considered.218
Buxton et al.28 noted that there is significant scope for these methods to be extended and refined to
allow more robust estimation of the economic benefits from medical research. In particular, a widely
acknowledged central challenge that must be addressed in this kind of analysis relates to the attribution
problem; the relationship between investment in research and health outcomes.15,22,28,115 This manifests
itself as several related issues regarding the contribution of health research in improving health outcomes
and what would have happened without research, that is the unobservable counterfactual. Assumptions
must be made regarding the share of health gains attributable to health research, and given there is an
international pool of health research, the contribution of any particular country to particular health gains.
Finally, assumptions must be made regarding the temporal relationship between a period of investment
and a period of health gains. Different approaches face somewhat different problems in dealing with
attribution, but methods have continued to be developed to address these issues.
Review findings
The search of databases produced 413 articles, which were initially screened by a reviewer by title (Figure 8).
After initial screening and deduplication, 102 articles were screened by abstract. Seventeen articles were
reviewed in full, with five included.22,26,75,218,219 Two of these articles were included in the main literature
review.26,75 One additional report that was not picked up by the supplementary search was included from the
main literature review.25 One additional article and one report known to the authors was also added.24,220
One in-press article that the authors kindly gave us access to was also included.27 In total, the review
produced nine articles/reports. The studies and methods of assessing return on investment, that included a
component that attached a monetary value to health gains, are summarised in Table 16 (see Appendix 6).
Records screened
(n = 419)
Records excluded
(n = 396)
Full-text articles
assessed for eligibility
(n = 23)
Studies included 
in review
(n = 9)
Full-text articles
excluded, with reasons
(n = 14)
Records identified through
database searching
(n = 413)
Additional records identified
through other sources
(n = 6)
FIGURE 8 Flow diagram of included studies.
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The nine studies identified in the review can be split into two categories in terms of how health gains are
measured: those taking a top-down approach and those taking a bottom-up approach. There are several
other important issues that must be addressed in quantifying the returns; this simple taxonomy allows us
to explore the different methodologies. Figure 9 depicts the basic methodologies.
Studies have been compared on a number of key facets of the analysis and assumptions that have to be
made regarding measuring and valuing net health gains and how to attribute a proportion of health gains
to a body of research as follows: How were health gains measured? How were health gains valued?
Were health gains ex post or ex ante? Were the costs of delivery accounted for? Was the lag between
investment and health gain considered? How was the attribution problem addressed?
Top down
A stream of work undertaken by Access Economics (now Deloitte Access Economics) assessed the benefits
of medical research in terms of the intrinsic value of the health gains to society. Two studies were
conducted to estimate the returns on investment from Australian research and development.24,25 Access
Economics considered all Australian health research and development spending both public and private
between 1992 and 2005.24 Building on their approach in an earlier report,217 they used projections from
the Australian Institute of Health and Welfare to estimate DALYs averted in the period 2033–45 relative to
1993 levels and calculate a return on investment of 117%.24 The authors assume that the lag between
investment and realisation of health gains is 40 years, although the rationale for this figure is unclear.
To calculate the return on investment the authors considered the proportion of DALYs averted attributable
to research and development, as opposed to other factors claimed not to be a result of research and
development. The authors state that other factors include ‘public health awareness and preventive programs
such as ‘Slip Slop Slap’ or ‘Quit’, screening and early intervention initiatives, the public subsidy of drugs and
interventions through the Pharmaceutical Benefits Scheme and the Medicare Benefits Schedule, and so on’.24
The extent to which these examples are not research and development-based interventions could be heavily
debated, especially screening programmes; however, the premise that external factors other than research
and development are responsible for health gain has been widely acknowledged.221 They attributed 50% of
health gains to research, as they had in their previous study, but have acknowledged that this was not
robust.217 The return was highly sensitive to the value of this parameter. The authors take account of research
and development conducted in others countries and its contribution to Australian health gains by using
bibliometric techniques to estimate a proxy, based on Australia’s share of publications in the clinical sciences.
They estimated that 3% of health gains could be attributed to Australian research and development. The
DALYs averted were monetised using a willingness-to-pay methodology, attaching the value of a statistical
life-year [AUS$266,843 – £124,300 (converted at 2015 purchasing power parity exchange rate)].222
Total health gains R&D-led interventions health
% attributable to R&D Total health gains
% attributable to investment % attributable to investment
A ‘top-down’ approach A ‘bottom-up’ approach
FIGURE 9 Approaches to identifying health gains from research. R&D, research and development.
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A further study estimated the returns from National Health and Medical Research Council (NHMRC) funding
in five disease areas (cardiovascular disease, cancer, sudden infant death syndrome, asthma and muscular
dystrophy) using the same methodology.25 They estimated that the return on investment ranged from 509%
in cardiovascular research to –30% for muscular dystrophy. These returns also included the value of
avoiding direct health system expenditure, the value of avoiding indirect costs (through productivity losses),
the value of direct commercial gains from the NHMRC-funded research and development, and benefits of
NHMRC-supported commercialisation. Neither of the Deloitte Access Economics studies considered
potential increased costs borne by the health-care system from expensive new technologies.24,25
Health gains were measured using DALYs averted in 2040–50 relative to 2000 levels.25 The time between
investment (2000–10) and health gains (2040–50) was again assumed to be 40 years. It was assumed that
the proportion of gains as a result of research and development was 50%, and 3.14% of these gains were
assumed to be attributable to Australian research and development (re-estimated using bibliometric
techniques). However, the authors were presented with an additional necessary estimation; the proportion
of health gains that were a result of this programme of NHMRC research, rather than the whole body of
Australian health research and development. Using bibliometric techniques they found that 25.04% of
Australian research publications were funded through the NHMRC and used this as a proxy. The DALYs
averted were monetised using a willingness-to-pay methodology (based on individual’s valuation of
avoiding mortality/morbidity) attaching a value of a statistical life-year [AUS$168,166 – £78,300 (converted
at 2015 purchasing power parity exchange rate)].222
Roback et al.218 used a broadly similar approach to value Swedish gains from all public and private research
and development spending on clinical and health research in the year 2005. In this tentative modelling
exercise, average annual increases in life expectancy (population utility adjusted) were used to estimate
QALY gains in 2015. This implies a lag of 10 years, but the authors did not explicitly discuss this. QALY gains
were valued using the value of a statistical life-year [SEK500,000 – £37,900 (converted at 2015 purchasing
power parity exchange rate)].222 The returns were estimated at a socioeconomic level, including a whole
range of non-health benefits where they could be quantified, resulting in a return on investment of 1.08
(8%). In making this estimate, the authors did account for ‘more expensive healthcare due to new methods’.
They assumed that 50% of health gains were attributable to research and development, referencing
estimates made by various authors that suggest the range may be between 25% and 67%.216,223–225
The proportion of health gains attributable to Swedish research and development was assumed to be 3%
based loosely on an estimate of Sweden’s share of global expenditure and global medical publications.
A significant drawback of Roback et al.218 and the Access Economics24,25,217 work is the ex ante nature of
health gains: the reliance on predictions based on previous trends in population health improvement.
This assumes the impact of as of yet unobserved future usage of interventions and hence improvements in
health. Ex post studies use retrospective data, either by directly observing population health gains or by
compiling data on observed uptake and modelled per patient incremental net health benefits. Although
many of these studies require pragmatism in assumption making, the reliance on unknown unknowns
requires a leap of faith.24,25,217,218
Lakdawalla et al.220 assessed the social surplus arising from the ‘war on cancer’ in the USA from all public
cancer research and development spending between 1971 and 2000. An upper bound of this investment
was estimated to be US$300B, based on National Cancer Institute spending (which was assumed to make
up approximately one-quarter of cancer research and development spending). Ex post life-year gains in
survival between 1988 and 2000 were identified and valued at individual willingness-to-pay [US$30,737 –
£21,300 (converted at 2015 purchasing power parity exchange rate)].222 This produced an estimate of the
net gains at US$1.6T. Lakdawalla et al. acknowledge the likely lag between investment and health gain
and suggest that they may have overestimated the size of investment and hence conservatively estimate
social surplus, but did not explicitly investigate the lag. The survival gains were estimated based on
cancer-specific improvements in detection and treatment, although the potential for non-research and
development contributions to these improvements was not considered.
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Bottom up
Informed by methodological frameworks, such as the Payback Framework, studies have used a different
approach to build the benefits up from individual interventions to estimate the sum of the health gains,
rather than starting from an estimate of overall health gains.39 It, in part, theoretically deals with the
attribution problem presented when trying to estimate the contributions of research and development and
non-research and development factors in producing health gains, although it produces a different
challenge in identifying only those interventions that are known to have been research driven.
Johnston et al.75 applied such an approach to the US National Institute of Neurological Disorders and
Stroke’s funding of 28 Phase III RCTs prior to 2000. They estimated a return on investment of 46% per
year based on 10-year estimates of post-funding QALYs. Available cost–utility analyses were used to
estimate the per-patient QALY gains for eight interventions, and data on use were gathered to estimate
population gains. Implicitly, it was assumed that all changes in use post trial were a result of that clinical
research. Although the examination of the use of the eight interventions suggests some lag, with use fairly
stable for at least 2 years after the completion of funding, it might be considered shorter than other
estimates.226 Data presented by the authors suggest that use is not zero during the period when funding
ends, which might be indicative that other research not funded by the National Institute of Neurological
Disorders and Stroke could have played a role in health gains. By using cost per QALY utility data, the
authors were able to present monetised health gains [valued at GDP per head of US$40,310 – £27,900
(converted at 2015 purchasing power parity exchange rate)]222 net of costs of delivery (net monetary
benefits) for each intervention. The study was able to find adequate data for only 8 of the 28 Phase III
trials, which highlights the data-heavy nature of this exercise and the reliance on published literature.
In some instances, a paucity of data may limit the ability for such a study to be undertaken or at least limit
the generalisability of findings.
Two studies published by authors of the Payback Framework have adopted an approach that is similar
with respect to the identification of health gains to the work of Johnston et al.,75 but have focused on
quantifying the returns in different disease areas.22,26
Buxton et al.22 estimated the return on investment [presented as an internal rate of return (IRR) that
considers the flow of cost and benefits] from publicly and charitably funded cardiovascular research in the
UK to be 9% per year (£1 investment yields health gains equivalent to £1.09). They estimated the health
gains between 1986 and 2005 and linked this with a period of investment between 1975 and 1988,
based on a lag of 17 years. The lag was estimated based on citation analysis of UK guidelines, using mean
time between citation and guideline publication (‘knowledge cycle time’) as a proxy for the time between
investment and health gain. Research-led interventions in the cardiovascular field were identified and a
timeline of usage assembled. For each of the interventions, per-patient QALY gains and net costs
(increases from delivery and potential savings from reduced sequelae) were identified through published
cost–utility analyses. QALY gains were valued at the health-care service opportunity cost based on implied
cost-effectiveness thresholds of NICE (£25,000) and presented net of costs, to produce an estimate of the
net monetary benefits produced per year. The NICE threshold value was chosen to reflect the competing
nature of funding of health research over provision of existing technologies. It was assumed that 17% of
the health gain was attributable to UK research, based on bibliometric analysis of cardiovascular guidelines
that identified the proportion of cited work that contained a UK corresponding author. Buxton et al.22
combined this IRR with the wider GDP spill over effects of research and development, estimated to be
30%, to give an overall IRR of 39%.
Glover et al.26 applied the same methodology to publicly and charitably funded cancer research in the UK,
re-estimating the lag between investment and health gain and the proportion of health gains attributable
to UK research based on cancer guidelines. An IRR of 10% was estimated, based on the monetised net
health gains for 1991–2010 for research-driven interventions, linked to cancer funding between 1976 and
1995 (15-year lag). This work highlighted the difficulty in identifying all of the important research-driven
interventions. An additional publication227 used accompanying case studies to highlight the complex and
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heterogeneous relationship between research and health gains. There is a need in a field such as cancer to
narrow the scope to complete such a resource-intensive exercise, where there have been widespread
improvements in detection and treatment brought about by research, and where the benefits are realised
across a heterogeneous patient population (for instance there are over 200 types of cancer). Although
developing a method that used changes in incidence and survival gains as a predictor of which cancer
types were likely to have contributed largely to overall gains, the authors assumed that interventions not
represented in the analysis produced zero net benefit.
A study by de Oliveira et al.219 largely replicated the methods presented in Buxton et al.22 to assess the
return from Canadian publicly and charitably funded cardiovascular research, which they estimated to be
21% per year based on QALY gains in 1994–2005. Using similar bibliometric techniques, a time lag of
13 years was estimated and 6% of overall health gains were attributed to Canadian research and
development. They also argued that an additional component should be considered as part of the
attribution problem, assuming that 70% of the health gains were attributable to medical research.
However, if the identified interventions were research led and studies used to estimate per patient health
gains produced incremental differences brought about by the specific intervention, it is not clear why
non-research and development factors ought to be considered in this context.
Guthrie et al.27 estimated the benefits of the NIHR HTA programme funding from 1993 to 2013. They
selected 10 key HTA studies, which were largely made up of randomised trials but also systematic reviews.
They identified the per-patient QALY gains associated with the interventions. QALY gains were monetised
at the health-care opportunity cost (£20,000 and £30,000) net of health service costs, but total actualised
gains were not estimated. Instead, a net monetary benefit associated with a hypothetical 1 year of full
implementation for the patient population of the interventions was calculated; therefore, the lag between
investment and gains was not considered. The HTA studies were considered to be responsible for all
post-HTA research implementation, as they were seen to constitute ‘definitive’ evidence. The authors
suggest that only 12% of potential net benefit would cover the £367M invested by the NIHR HTA
programme. Although indicative of potential gains, this analysis does not adequately address the
attribution problem and makes no consideration of when benefits accrue. It also raises the interesting
problems posed when the research takes the form of systematic reviews and the role of such a study in
changing clinical practice and hence leading to health gain.
Discussion
There have been contributions to the literature that estimate the impacts of health research using methods
to attach a monetary value to health gains. Approaches have attempted to estimate the resultant health
gains from investment in bodies of research, and, in doing so, must deal with several problems relating
to attributing health gains to particular investments. Techniques that attempt to deal with the problems
of attribution have been established. However, authors have acknowledged a simplification of the
relationship that is required and the reliance on a logic model view of research impacts. Some of these
contributions also consider non-health sector benefits falling on the wider economy, although the scope of
the benefits considered often differs, as does the valuation.
Only a few studies specifically considered programmes of health research.25,27,75 Guthrie et al.27 estimated
the gains of the NIHR HTA programme, but made cautious conclusions on the returns based on
hypothetical uptake of a subset of HTA-funded research.27 Clearly there is scope for these types of
methods to be applied to estimate returns from programmes such as NIHR HTA, but several additional
considerations need to be taken into account. Conversely, there are advantages to having a well-defined
unit of analysis.
It would appear that assessing monetised impact at a programme level is conducive to the bottom-up
approach, when the set of interventions is well defined and the task of identifying those that are
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‘important’ could be avoided. To an extent, data feasibility issues that limit the bottom-up approach should
be mitigated by programmes such as NIHR HTA in that most of its research includes cost–utility estimates.
However, issues of scale are present if the number of studies undertaken by a programme is large, such as
in the NIHR HTA programme. This might be mitigated to an extent by the need to consider only those
trials that showed a significant effect, but this makes a bold assumption about the nature of evidence
being used in clinical practice.
When attempting to measure health gains from a programme of research, the attribution problem
manifests itself as an added layer of uncertainty regarding the proportion of total health gains that should
be attributed to the specific programme. Using a top-down approach, Deloitte Access Economics25 dealt
with this by using the percentage of total citations in clinical sciences that were studies funded by the
programme as a proxy. This additional attribution problem is not circumvented by the bottom-up approach
and a consideration must be still be made. The view taken in Johnston et al.75 and Guthrie et al.,27 that
National Institute of Neurological Disorders and Stroke’s trials and HTA studies are definitive in terms of
changes in uptake, is insufficient, especially in developed countries with multiple funding streams and
complex and evolved research ecosystems. The use of the weights attached to particular RCTs in
meta-analyses could provide a more systematic way of considering the relative impact of different clinical
research supported by multiple funders. Regarding the proportion of health gains that should be attributed
to world research and development, this could be used as an intervention-specific replacement for
guideline analysis or used as an adjunct. Although time lags must be included, it is not clear how best to
estimate these.
An additional problem for programmes that fund only clinical research is dealing with the role of basic
research in health gains. This is unclear and constitutes a major potential limitation in these methods.
No study looking at a programme has yet encompassed these kinds of considerations into the approach
dealing with attribution of health gains to a programme, using either top-down or bottom-up methods.
Although it would clearly be possible to estimate the returns on investment from the NIHR HTA
programme, significant challenges remain.
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Chapter 6 Assessing the impact of trials on
systematic reviews
Introduction
This chapter considers how the impact of a randomised trial might be measured in terms of its
contribution to a subsequent systematic review. After an introduction, the results of the literature search
are presented. The results of a search of The Cochrane Library for systematic reviews that include
randomised trials funded by the HTA programme are then presented and the implications of these findings
are discussed.
The HTA programme aims to fund research on technologies that matter to the NHS. In doing so, it funds
mainly systematic reviews and randomised trials. Given the widely used hierarchy of evidence, which
privileges randomised trials, most systematic reviews are composed of only randomised trials. Meta-analysis
provides a synthesised estimate of the effectiveness of the technology. Results from systematic reviews are
seen as more robust than those from particular trials and are the preferred basis of decisions by NICE and
similar bodies. The two relate in that new trials are rarely funded without a prior systematic review about
what current evidence exists. Many of these identify weaknesses in the body of research and recommend
new research, usually randomised trials.
Systematic reviews can also provide a way of retrospectively assessing the impact that such trials made to
the evidence on the clinical effectiveness and cost-effectiveness of the technology involved. Systematic
reviews and their linked meta-analyses provide quantitative measures of the quality and impact of
individual trials. Trials are assessed for quality to be included. The included trials indicate not only how
many have reported but also the contribution (weight) of each. The resulting synthesised effect size may
be statistically significant even though none of the contributing trials was, or, despite some trials showing
statistically significant differences, the synthesised effect may not be statistically significant.
Although the HTA programme uses systematic reviews to identify topics for randomised trials, it does not
review the impact that those trials have on any subsequent systematic reviews. To some extent it relies on this
happening automatically, as the programme partly funds the Cochrane Collaboration, which has pioneered
impartial, thorough systematic reviews that are in the public domain. However, the HTA programme keeps
no record on the extent to which relevant systematic reviews include trials it has funded (whether new or
updates). Updating systematic reviews varies widely, reflecting developments in science. Some HTA journal
reports include updated systematic reviews by the triallists and others take a long time to be updated. Some
updates adopt slightly different, narrower foci. No guarantee exists that a trial funded by the programme in
response to an earlier systematic review will be included in that review’s update, if and when it is updated.
The HTA programme’s early adoption of the process whereby systematic reviews preceded new trials
implied a cycle in which new RCTs would contribute to the updated meta-analysis so that uncertainty was
reduced if not eliminated. Although methods of measuring such progress were not available when the
programme started, this chapter explores if that has remained the case.
Many of the early projects commissioned by HTA were systematic reviews, all recommending further
research (usually RCTs), some of which the programme went on to commission and fund. Of 109 projects
that included a randomised trial to March 2011, 62 (57%) were recorded as quoting a prior systematic
review in its monograph report.228 Most [109/125 (87%)] of the RCTs funded by the HTA programme
were superiority, not equivalence (non-inferiority), trials. Superiority trials also made up the bulk of
systematic reviews.
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Owing to the time lag between identification of topic and publication in HTA Journal, almost all trials
published to 2011 had been commissioned pre-2006 when researcher-initiated bids began to be funded.
Therefore, almost all were on topics identified and prioritised by the programme. For RCTs that are
‘commissioned’ (i.e. defined) by HTA, the research question, the existing evidence and the need for a trial
are specified.
To explore the scope for measuring the impact of randomised trials through their contribution to
systematic reviews, one needs to know what the literature offers in terms of methods and the extent to
which systematic reviews that include trials funded by the HTA programme exist.
Literature searches
The methods used in the literature search were, as outlined in Chapter 2, supplemented by the team’s
knowledge. The search of The Cochrane Library of Systematic Reviews was based on the relevant
technology and disease. Reviews that included both the technology and disease were searched to locate
randomised trials funded by the HTA programme, using the lead author as the link. For each review
including a trial funded by the programme, the following items were extracted: technologies compared,
whether or not the difference was statistically significant and the weight attached to the trial.
Results
The results of the literature search were divided into descriptive studies, those that explored the use of
systematic reviews in designing trials, those regarding VOI [and its York/Patient-Centered Outcomes
Research Institute (PCORI) variant] and those assessing systematic reviews in relation to their use in
clinical guidelines.
Descriptive studies
Gouldie et al.229 showed that a minority of trials published in leading journals cited previous RCTs (6/27)
or systematic reviews (10/27) in determining their target sample size.
Jones et al.,230 in a review of randomised trials funded by the HTA programme between 2006 and 2008,
found that 77% (37/48) cited a previous systematic review. A follow-on of this study231 found that almost
all of those that lacked a prior systematic review did so for good reasons. Some were new topics (first in
class), in which case a formal systematic review might not be necessary. In other instances, the previous
trials were judged to be of low quality.
Use of systematic reviews in designing new trials: literature
Sutton et al.232 employed simulation methods to estimate the trial sample size linked to probability of
conclusive result in meta-analyses. Their results favoured several small RCTs, rather than a single large
conclusive trial.
Roloff et al.233 used a random-effect meta-analysis to estimate conditional power, which is needed to
detect a specified mean effect size for a given meta-analytic result. This work showed that, in the presence
of heterogeneity, no trial could be large enough to be conclusive. Instead, several separate trials would
be needed.
Heterogeneity was defined as relating to genuine differences underlying the results of RCTs (heterogeneity)
as opposed to variation as a result entirely of chance (homogeneity). The degree of heterogeneity has
become widely used in Cochrane reviews.
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Value of information literature
Value of information, a concept from decision analysis, relates to the extent of uncertainty and the types of
information that would reduce that uncertainty relative to perfect information. Wikipedia provides an
entertaining definition: ‘Value of Information is sometimes distinguished into value of perfect information,
also called value of clairvoyance, and value of imperfect information. They are closely related to the widely
known expected value of perfect information and expected value of sample information’. More formal
accounts of VOI have recently been puplished.234–236
Cost-effectiveness acceptability curves, an element of the VOI approach, have been used in almost all the
economic analyses in HTA-funded trials. They have also been adopted by NICE in its technology
appraisal programme.
The HTA programme has made use of the VOI approach. It decided not to fund a trial based on a form of
VOI from the preliminary assessment of technology for health services model.237 It funded a review of the
‘role of modelling in planning trials’,238 which favoured VOI. It also reported the results of a pilot study of
the use of VOI by the programme.239 This was successful according to the authors, a University of York
team that carried out the relevant analyses. A more recent review240 found that 25 of approximately
500 studies (≈5%) published by the programme had used VOI method(s).
Overall, VOI appears more useful in assessing the gaps in research than in assessing the impact of RCTs.
Projects that are developed on the basis of VOI should produce less uncertain estimates of the
cost-effectiveness of particular technologies. The extent to which this results in greater impact, however
measured, is unknown. Research on this forms one of PCORI recommendations below.
Patient-Centered Outcomes Research Institute
The PCORI was authorised by the US Patient Protection and Affordable Care Act of 2010241 to conduct
research to provide the best available evidence to help patients and those who care for them to make
better-informed health-care decisions.
The PCORI was explicitly prohibited from using QALYs and cost-effectiveness in determining research
priorities.242 Instead of using VOI, which implies use of cost per QALY, it developed (along with Claxton
et al.234 from the University of York) an amended version that relies on cumulative meta-analysis and
minimum clinical difference. This, combined with incidence/prevalence, can be used to assess the worth
of funding new research. It involves asking if the expected net health benefits of additional evidence are
sufficient to regard a particular research proposal as worth prioritising.
The scale of uncertainty is assessed from systematic reviews and meta-analysis, combined with baseline risk
and incidence. These are used to express the expected consequences of uncertainty in terms of health
outcomes. The approach also assumes degree of implementation.
The York/PCORI package was offered as a software package to the HTA programme in 2013, which has
been exploring its use. No formal evaluation appears to be taking place.
This approach shares the VOI emphasis on prospectively prioritising elements of research. Whether or not
reduced uncertainty leads to greater impact remains unknown.
Literature on systematic reviews and clinical guidelines
A different approach for valuing trials considers the scope for basing clinical guidelines on systematic reviews.
The Grading of Recommendations Assessment, Development and Evaluation (GRADE) group provides tools
to assess the quality of information in relation to its use in guidelines. GRADE ‘is a well-developed formal
process to rate the quality of scientific evidence in systematic reviews and to develop recommendations in
guidelines that are as evidence-based as possible’.243
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The GRADE tool is used by NICE along with many similar organisations elsewhere. Given the aim of the
HTA programme in relation to meeting the needs of the NHS with high-quality evidence, GRADE provides
a tool for assessing the extent the usefulness of that evidence for clinical guidelines.
The GRADE tool recommends that:
l The strength of recommendations should be expressed using two categories (weak/conditional and
strong) for or against a management option and the definitions for each category should be consistent
with those used by the GRADE Working Group.
l Decisions about the strength of the recommendations should be transparently reported.
However, an evaluation of GRADE suggests that it has had little impact on which systematic reviews are
included in clinical guidelines.244
Results of search of The Cochrane Library for systematic reviews that included
trials funded by the Health Technology Assessment programme
The Cochrane Library was searched to explore the extent to which systematic reviews that included
randomised trials funded by the HTA programme existed. This section provides preliminary results.
As shown in Table 10, 28 (around one-quarter) out of the 121 eligible trials (excluding four feasibility or
pilot trials) published up to 2011 featured in a subsequent Cochrane systematic review. This indicates that
subsequent systematic reviews cannot be assumed.
TABLE 10 Trials published by the HTA programme to 2011 that featured in subsequent Cochrane
systematic reviews
First author
(volume:issue)
Subsequent
Cochrane review Comparison Disease Superior
Weight
(%)
Simpson et al.238
(4:36)
Bower et al.245 Counselling Depression No 32
Suri et al.246
(6:34)
Wark and
McDonald247
Daily rhDNase vs.
alternate-day rhDNase vs.
hypertonic saline
Cystic fibrosis Yes 64
Garry et al.248
(8:26)
Nieboer et al.249 Laparoscopic vs. abdominal
hysterectomy
Menorrhagia Yes 36
No 40
Vickers et al.250
(8:48)
Linde et al.251 Acupuncture vs. treatment
as usual
Migraine Yes (short and
long term)
Ozolins et al.252
(9:1)
Garner et al.253 Antimicrobials Acne Yes (short and
long term)
100
Cochrane et al.254
(9:31)
Bartels et al.255 Hydrotherapy short term Osteoarthritis Yes (short and
long term)
100
Thomas et al.256
(9:32)
Furlan et al.257 Acupuncture/control Lower back pain Yes (short and
long term)
40
Hobbs et al.258
(9:40)
Moran et al.259 Atrial fibrillation detection Atrial fibrillation Yes 100
Dennis et al.260
(10:2)
Gomes et al.261 Percutaneous endoscopic
gastrostomy vs. nasogastric
feeding
Post stroke No
Kennedy et al.262
(10:19)
Zijdenbos et al.263 Cognitive–behavioural
therapy+ treatment as
usual, short term
Irritable bowel
syndrome
Yes (short and
long term)
52
Nixon et al.264
(10:22)
McInnes et al.265 Pressure mattress vs.
underlay
Pressure ulcers No 100
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TABLE 10 Trials published by the HTA programme to 2011 that featured in subsequent Cochrane
systematic reviews (continued )
First author
(volume:issue)
Subsequent
Cochrane review Comparison Disease Superior
Weight
(%)
O’Dowd et al.266
(10:37)
Price et al.267 Cognitive–behavioural
therapy vs. treatment as
usual
Chronic fatigue
syndrome
No 24
Hewison et al.268
(10:50)
Mujezinovic
et al.269
Communication strategies Amniocentesis Yes 100
Jolly et al.270
(11:35)
Taylor et al.271 Home vs. hospital Cardiac
rehabilitation
No 9
Fader et al.272
(12:29)
Fader et al.273 Absorbent pads
comparison 1
Incontinence Yes 100
Absorbent pads
comparison 2
No 100
Grant et al.274
(12:31)
Wileman et al.275 Medical vs. surgical
management
Gastro-
oesophageal
reflux disease
Yes 96
Potter et al.276
(13:9)
Bath and
Krishnan277
Hypertension control vs.
treatment as usual
Post stroke No
Morrell et al.278
(13:30)
Dennis and
Dowswell279
Psychological intervention
vs. treatment as usual
Postpartum
depression
Yes 39
Grey et al.280
(13:33)
Vital et al.281 Non-invasive ventilation
methods (continuous
positive airway pressure vs.
non-invasive positive-
pressure ventilation)
Cardiogenic
pulmonary
oedema
Yes 31
Williamson et al.282
(13:37)
Simpson et al.283 Steroids: intranasal Otitis media No 100
Sullivan et al.284
(13:47)
Salinas et al.285 Corticosteroids/control Bell’s palsy Yes 18
Jeffcoate et al.286
(13.54)
Dumville et al.287 Dressings Diabetes foot
ulcer
Yes 46
Michaels et al.288
(13.56)
O’Meara et al.289 Antimicrobial silver
dressings vs. non-adherent
control dressings
Venous leg
ulcers
Yes (short and
long term)
77
Lock et al.290
(14.13)
Burton et al.291 Tonsillectomy Tonsillectomy Yes 25
Peek et al.292
(14.35)
Tramm et al.293 No meta-analyses possible N/A
Lamb et al.294 Williams et al.295 Not included as insufficient
psychotheraptic content
Chronic pain
Sharp et al.296
(14.43)
Molyneaux
et al.297
Antidepressant drug
therapy vs. psychosocial
intervention
Postnatal
depression
No 100
Antidepressant drug
therapy vs. treatment as
usual
Yes 100
Cockayne et al.298
(15.32)
Kwok et al.299 Cryotherapy vs. salicylic
acid
Verruca warts No 16
N/A, not applicable; rhDNase, recombinant human deoxyribonuclease.
Note
By superiority means that the meta-analytic effect size had a 95% confidence interval that excluded no difference.
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Caveats relate to the limited nature of the search and its restriction of the search to The Cochrane Library.
Although a more thorough search might reveal a few more instances, we are confident the results
presented here indicate the limited extent to which trials funded by the HTA programme feature in
systematic reviews.
Only around half of the meta-analyses in these systematic reviews indicated that the intervention was
superior, in that the 95% confidence interval for the primary outcome excluded no difference.300 For the
rest of the comparisons, the difference was not statistically significant. Non-superiority cannot be
interpreted statistically as proof of no difference (whether non-inferiority or equivalence). However,
although some authors claimed non-inferiority, this was not strictly justified. The policy implications
resulting from systematic reviews that do not demonstrate superiority deserve separate attention, if only
because such results are so common.
Several other points are worth noting from Table 10. First, the weight of the HTA trials in the meta-analysis
varied widely. For some comparisons in eight reviews,252,254,258,264,269,273,283,297 the trial funded by the HTA
programme had a weight of 100%, indicating that it provided the only evidence for that particular
comparison. For the others in Table 10,252,254,258,264,268,272,282,296 the weight was much lower, indicating a
lower contribution of that trial to the synthesised result. This is partly because of other trials reporting after
the HTA trial was funded.
Second, the HTA-funded trials tended to have higher weights for comparisons relating to patient-related
outcomes and/or longer time frames. This indicates that the contribution of a trial to a systematic review
can take many forms, some of which may be more relevant to those commissioning health services
than others.
Given that only around one-quarter of HTA-funded trials are included in a subsequent systematic review,
more work is required on their contribution to knowledge.
Discussion
The chapter has shown that the HTA programme contributes only one side of the loop linking systematic
reviews and trials. Although it usually carries out a systematic review before funding a trial, it does not
follow up with any analysis of the contribution that trial makes to any subsequent systematic review.
The York/PCORI approach used in 2015 by the HTA programme for deciding when to fund trials is
important and deserves to be evaluated. However, without subsequent analysis of the trials funded, this
will not help with assessing the contribution any trial funded makes to the body of evidence.
The GRADE tool offers a way to assess how complete the evidence in systematic reviews is for the purpose
of drawing up clinical guidelines. This may offer a way for the HTA programme to assess the extent to
which a particular trial has contributed and if another is required.
The finding that only around one-quarter of HTA-funded trials are included in a subsequent systematic
review shows that a contribution by a trial to systematic reviews cannot be assumed. Furthermore, the fact
that around half of the Cochrane systematic reviews to which a trial contributes do not demonstrate
superiority prompts questions as to how to assess the value of these.
Research recommendations
There is merit in using existing systematic reviews to assess the impact of trials funded by the programme.
When systematic reviews of important topics are lacking, the programme should consider funding them.
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When the topic of a trial may become part of a clinical guideline, GRADE should be employed to assess
the completeness of the evidence. The exploration by the HTA programme of the PCORI/York approach of
assessing the need for a trial in relation to existing systematic reviews should be evaluated.
Research on the extent to which projects and programmes that employ either VOI or the PCORI approach
achieve greater impact would be valuable. As the HTA programme has made some use of both VOI and
PCORI, the relevant projects might be considered for case studies as well as for bibliometric analysis.
Work is also required on the policy implications of non-superiority results in systematic reviews of
superiority trials.
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Chapter 7 The impact of randomised trials on
stopping the use of particular health technologies
Introduction
This chapter was prompted by the suggestion that the impact of some RCTs funded by the HTA
programme were mainly concerned with stopping new technologies.30 The two cases cited were water
softeners for eczema and larvae for wound healing.31,32 Both were novel technologies, funded by the HTA
programme. Both were negative in the sense that neither demonstrated that the technology added value
to current treatments. Subsequently, neither technology appears to have been used much by the NHS,
although no formal evaluation has been carried out.
To discredit or stop the diffusion of a technology, a randomised trial must be definitive; being one of the
first and biggest in the field can do this. The water softener trial was both the first and biggest, whereas
the larvae healing trial was the biggest but not the first.
This chapter explores the related literature and briefly reviews the HTA portfolio of randomised trials in
terms of how many were ‘first in class’. In brief, it finds little of relevance in the literature on trials stopping
technologies. It found that, of the 121 eligible trials published up to 2011, 30 could be considered first in
class. A further 10 projects had three or fewer prior randomised trials (see Table 10 for these references).228
Literature searches
Two searches were carried out, the terms of which are provided in Chapter 2. The first focused on terms
such as ‘randomised controlled trials’ and ‘disinvestment/rationing’ and the second widened the terms to
include The Lancet article,30 which included the water softening and larvae cases. Between them they
identified 78 articles, of which 38 were deemed relevant. Of these:
l 16 were descriptive or discursive83,301–315
l six were on programme budgeting and marginal analysis316–321
l six were surveys of attitudes to disinvestment302,322–326
l five related to NICE327–331
l one analysed a RCT in terms of discontinuation of a particular drug.332
Four systematic reviews were identified, three of which were concerned with disinvestment. Leggatt et al.333
found that eight countries had some evidence of such work but no clear findings. Polisena et al.’s334 review
of case studies of disinvestment found 14 cases, with programme budgeting marginal analysis used in six.
Neilsen et al.335 reviewed HTA in European countries, indicating the priority many attached to disinvestment.
The final systematic review, by Watt et al.,336 reviewed the use of safety and effectiveness in a single service,
assisted reproduction.
Points arising from the descriptive papers included: the asymmetry between existing and new services in
terms of assessment and scope for disinvestment,318 and the importance of safety concerns in decisions to
stop use of particular technologies.336 Stepped-wedge trials were advocated as a means of evaluating new
technologies before/during implementation.304
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Overall, with the exception of the advocacy of the stepped-wedge design, the literature review offered
little on the scope for using trials to prevent the diffusion of new technologies. The literature was focused
on disinvestment and was concerned mainly with the removal of older, less effective technologies.
First in class
A term usually referring to the first pharmaceutical in a class to be authorised for marketing, the term
acquires a gradation of meanings applied to HTA programme trials. The interventions are often complex
packages, parts of which differ from trial to trial. Furthermore, such interventions can often be provided in
different settings (hospital or community) or by different people (doctor or nurse). All those randomised
trials with a reasonable claim to be first in their class, based on the background provided in each HTA
journal, were included.
Forty-four out of a total of 121 trials involving a RCT that did not have a preceding systematic review were
identified from the metadata database228 and examined in terms of preceding evidence. Twenty-two could
be considered ‘first in class’. Systematic reviews that had a weight of 100% were added to these. As
discussed in Chapter 6, eight fell into this category. Therefore, 30 out of 121 (around one-quarter) eligible
trials could be considered first in class.
Few of these were novel technologies such as water softeners or larvae. The nearest to a new technology
was a befriending service for people with dementia.337 Many interventions were new only in the sense of
being the variants of existing procedures. In surgery, these included different methods for performing
tonsillectomy290 and for reconstructive surgery for limb ischaemia.338 Some were the first in a particular
setting, mainly in general practice, while others were new diagnostic tests,339 referrals for pain and for
lumbar spine radiography,340,341 and screening for atrial fibrillation.258
A further 10 had three or fewer preceding randomised trials. These were usually small trials, most of which
were deemed of poor quality.
Discussion
The role of randomised trials in stopping the diffusion of particular technologies has received almost no
attention in the literature. To have scope to prevent diffusion, any such trial needs to be definitive: this
implies being either the first or the largest trial. Given the paucity of literature, a preliminary search was
carried out to establish how many HTA trials could be considered first in class. This search showed that
around 30 trials funded by the HTA programme could be titled ‘first in class’. However, many of these
involved small variations on existing treatments. Very few were studies of completely new types of
technology. The programme may wish to consider identifying trials that might be considered first in class
and on the extent to which they can be considered definitive.
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Chapter 8 Discussion
This chapter discusses the findings of each element of the work reported above, exploring theirimplications for the HTA programme. Recommendations are made for research priorities.
Updated systematic review
This updated systematic review identified and described 161 publications on research impact (see
Appendix 3, Table 14). Most of these were published since the previous original review that included
studies published up to 2005.2 The earlier review2 described 46 publications from the period from 1990 to
2005 and hence the number of studies has grown, as has the range of approaches used (please refer to
the original Hanney et al.2 report for a full list of these references).
Continuities exist between this and the previous review.2 Some older frameworks continued to be used,
but with variations, particularly the Payback Framework and the monetary valuation of benefits. Additional
frameworks have been developed and applied, often drawing on and combining earlier approaches.
Major work building on previous frameworks was conducted by the CAHS,7 summarised in Frank and
Nason.115 This was further developed and built into the performance measurement system by the Alberta
health research system.85
The scale of application varied enormously, with some frameworks using small-scale approaches designed
for use by individual researchers, such as the RIF developed by Kuruvilla et al.97 At the other end of the
spectrum national schemes continue in the Netherlands,79 and have developed with the UK’s REF.106
This reflects the growing interest by research funders from national governments through to small funding
organisations. For example, the Addenbrooke’s Charitable Trust commissioned a study to assess the impact
of its fellowship scheme, which invested less than £1M.67
Much of the literature comes from the English-speaking nations of Australia, Canada, the UK and the
USA, perhaps partly reflecting the search restriction to English on pragmatic grounds. However, we also
include ongoing work conducted in many other countries, including the Netherlands and Austria, and
published in English. We also identified assessments of the impact of health research in international
development programmes, including programmes of research training.
Some core methods continue to be widely used: interviews, surveys, documentary analysis and case studies.
Case studies are of interest for several reasons. They have confirmed responses to surveys suggesting that
researchers do not generally exaggerate the impact they report in surveys.2,51,52,62,95 Case studies have
enabled the capture of the wider impacts from research training programmes, such as that funded by the
National Institutes of Health Fogarty International Centre.57 Case studies have also incorporated qualitative
findings in mixed-method approaches such as that adopted by the Wellcome Trust.93 Finally, although the
2014 REF and the EIA exercises were based on the outputs of groups of researchers rather than funded
programmes, they too demonstrated the advantages of using case studies. Those conducting the REF
warned of the danger of excluding case studies in favour of metrics in future such exercises.33
We also noted attempts to develop the methods used, owing, in part, to the recognition of limitations with the
existing methods. One limitation frequently noted is that most of the studies have been funded by the same
organisations that funded the original research. Potential for conflicts of interest can also arise owing to the
involvement in impact assessments of members of the research organisation whose research is being assessed.
The impact assessment studies reported in our review (see Table 14, Appendix 3) generally start with
specific pieces of research and work forwards to identify impacts. Many of them suggest that research has
made a larger impact on policy than is often reported in reviews of studies that start with policy-making
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and work backwards to consider how far research might have impacted on those policies.13 This might
reinforce the suggestion that the best way to identify research impacts is to start from a body of research
and work forwards to trace any impact that it might have had.2 Tracing forwards provides a different focus
from studies that start from impacts, such as on policy, and work backwards. For example, a researcher
interested in their research being used might have better recall about how, and to whom, the findings
were disseminated than a busy policy-maker would have of which research influenced him or her. The
growing portfolio of case studies supports the claims that a range of impacts can be identified as coming
from research. Sensitivity analyses have generally indicated the robustness of these estimates. On balance,
differences in method rather than conflicts of interest seem to account for the high impact reported in
some studies included in our review.
Not all types of programmes have the same potential for delivering impact. There is considerable evidence
that programmes based on a prior assessment of needs by funders, or which have been commissioned by
an authoritative ‘receptor body’, are likely to have more impact than programmes driven by researchers’
interests. This was, of course, the rationale for establishing the HTA programme in which the commissioning
of research was linked to the needs of the NHS.2,49 It is also seen internationally. This suggests that the
frameworks to assess the impacts from these programmes should take account of the context within which
the research occurs.
Many studies indicate that the impacts of research are often slow and incremental, and that many factors
impinge on potential users.137 Some highlight the importance of personal interactions between actors to
achieve impact. We have shown that the programmes with the strongest interactions are among those
reporting highest levels of impact. Does this suggest that a greater emphasis on interactions might be
having some successes? Some of the studies described might indicate this is the case.66,89,132,136–138,141 More
detailed assessments might play a useful role in understanding the processes involved. However, initiatives
informed by concepts such as linkage and exchange342,343 do not necessarily make an impact if, for
example, there is a high turnover among the government officials.344 Iteration at an organisational level
may be required for interactions to be successful. Impact assessment requires attention to scale and
context. The validity and reliability of different data sources also needs to be assured.
Taxonomy of approaches
The extended review of the social sciences literature revealed a wide variety of approaches which reflected
a range of philosophical positions: positivist (e.g. the unenhanced logic model), constructionist
(interpretative and interactionist), realist (context–mechanism–outcome–impact models), critical
(participatory models) and performative (or Co-production models). However, these ‘ideal type’ positions
are often used eclectically in combination. For example, the Payback approach is a hybrid, including a
central logic model but enhanced by a focus on case study methods, reflecting the importance of an
interpretative narrative and paying attention to context.
Approaches that emphasise ‘co-production’ of research findings are becoming more popular, particularly in
Europe. These approaches may be less appropriate for the HTA programme than for some types of NIHR
programmes such as CLAHRCs and Academic Health Science Networks.
Monetary value on the impact of health research
The literature on the economic returns from medical research has also expanded since 2005. Health gains
have been monetised by putting a value on each QALY gained, net of the cost of delivery to produce
estimates of net monetary benefit and linked to specific investments in research. Some of these analyses
have also considered wider non-health benefits from research investments. These analyses have been
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performed at various levels from programmes to specific diseases. All these analyses required major
assumptions relating to attribution, first of the contribution of research to health over specified time
periods and then attribution by country. Each analysis has provided its own challenges in finding estimates
to meet these assumptions.
A new method for identifying health gains has used a ‘bottom-up’ as opposed to a ‘top-down’ approach,
building the totality of health gain based on individual research-led interventions.22,26,27,75,219 Most of these
assessed health gains ex post. The ‘top-down’ approach that formed much of the earlier work in the field
has also continued to develop.24,25,218,220
The bottom-up approach has produced more conservative returns and helps deal with some of the
research/health attribution problems specific to the top-down approach, in that only research-driven
interventions need be included in the analysis. In the latter, it is clear that estimates rely heavily on the
fraction of health gains that are attributed to research and development, for which robust estimates do
not exist. Although the bottom-up approach may be better able to address this attribution problem, it
struggles with the issue of scale. This has often narrowed its scope because of the richness and level of
data required.
Most of the identified studies acknowledge the time lag between the investment and health gains but
based on different assumptions. The most robust estimates have been informed by guideline analysis,22,26,219
but even these share uncertainties about time lags and implementation.
Assessing the impact of trials on systematic reviews
The HTA programme contributes one side of the loop, from a systematic review to the need for new
trials but not vice versa. The impact of a new trial on the subsequent systematic review is not routinely
examined. Only by completing this side of the loop can it be established if further research is required.
Clinical guidelines are the main ‘customer’ for systematic reviews. Both the York/PCORI (which is being
used by the programme) and the GRADE toolkit consider systematic reviews and guidelines to assess if
further research is required.
However, it remains the case that many trials funded by the HTA programme do not show statistically
significant differences in their primary outcomes. When included in systematic reviews, these often also fail
to show superiority of the intervention in question. Non-superiority, however, cannot be interpreted
statistically as non-inferiority. A preliminary search showed that around only one-quarter of trials funded by
the HTA programme were included in subsequent systematic reviewed by Cochrane; of these reviews,
around half showed superiority. For the rest, the 95% confidence interval included a measure of
no difference.
Although each trial has value in contributing to a meta-analysis, the policy implications are unclear when
the meta-analysis fails to indicate superiority of any compared intervention. Work is required to assess what
further research might indicate if non-superiority can reasonably be taken as indicating non-inferiority.
The implications can be considerable. For instance, if two interventions had no difference in efficacy, a
choice might be offered if the cost was similar. If the costs are materially different, the less costly might be
preferred. More generally, funding trials and systematic reviews on the basis of hypothesised differences but
being unwilling (or unable) to draw conclusions when such differences are not proven amounts to waste.
Cost-effectiveness modelling, such as that funded by the HTA programme, to support NICE’s technology
appraisal programme, goes beyond systematic reviews to synthesise data on costs and effectiveness often
projected to cover patients’ lifetimes. Such models can have a major impact on decisions made by NICE.
Although we have not considered these models, we believe that assessment of their impact should be
included in future.
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Impact of randomised trials on stopping the use of particular
health technologies
Although disinvestment has attracted considerable interest in the literature, it has been largely concerned
with existing rather than new technologies. The literature provides no instances of a randomised trial
playing a major role in stopping the diffusion of a new technology. A few trials funded by the HTA
programme related to water softeners and larval healing may have played such a role.31,32 One was first in
class and both were the biggest trials of each topic. Around one-quarter of trials funded by the HTA
programme can be considered first in class, but many of these were concerned with small changes in
existing treatments. The term ‘first in class’ is usually used in discussing pharmaceuticals where ‘class’ may
be defined more rigorously than for other interventions.
Limitations of the Health Technology Assessment review
In conducting this review we faced various challenges, and, although we attempted to address them,
some limitations remain. The precise inclusion/exclusion criteria were difficult to define and apply,
especially around issues such as what is meant by a ‘programme’ of research. For many programmes from
specific funders they were, of course, clear-cut. However, the boundaries were less clear in relation to the
collective work supported by multiple funders and conducted by a group of individual researchers at one
end of the spectrum, and a large part of the research system at the other.
The nature of the review was also complex because we wished to not only update the earlier 2007
review,2 but also extend the focus of the review to include a wider range of analysis and address issues of
particular (policy) relevance to the HTA programme. Therefore, inevitably, there were some issues in which
the boundaries became fuzzy. At the same time, we wanted to maintain a degree of coherence by
presenting just one main list of included studies before delving into the more specialist areas covered by
Chapters 5–7. In addition, to ensure as wide a range of papers as possible was included in the main list,
we drew on the knowledge of the team and snowballing to a considerable extent. These methods
provided over one-quarter of the papers (43/161 included studies), a higher proportion than for many
reviews. Although this might create some difficulties for any replication of the review, and the diversity of
papers did present challenges for the analysis, the importance of these limitations was reduced because
there was no possibility that a meta-analysis could have been meaningfully conducted in a field such as
this. Nevertheless, the scope of the review remained challenging, especially in view of the resource
constraints within which we operated.
Finally, as discussed below (see Options for the National Institute for Health Research/Health Technology
Assessment to take research impact assessment forward), we were aware that the whole field has become
increasingly controversial in recent years. Furthermore, there have been major developments at the system-
wide level that, while they have not been fully evaluated, are having an increasing impact on what
assessment might be undertaken at the level of specific funded programmes.
Options for the National Institute for Health Research/Health
Technology Assessment to take research impact
assessment forward
What do the findings of our review tell us about approaches to assessing
the impact of multiproject programmes such as the Health Technology
Assessment programme?
Our findings strongly support the recommendation that the HTA programme should continue to assess the
impact of its research. The findings of this review support the use of the Payback Framework. The fact that
the programme’s funding, like the rest of NIHR, comes from the funds allocated to the Department of
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Health, means that a major part of the impact must concerned with meeting the needs of the NHS. The
HTA programme has succeeded in meeting the research needs of some key NHS bodies, such as the
National Screening Committee and NICE. Changes in the structure of the NHS, the development of NHS
England and changes in NICE’s remit pose new challenges relating to identifying and meeting current and
future research needs.
In recent years, the NIHR has supplemented its focus on trials by embracing an explicitly interdisciplinary
and mixed-method approach to the study of health policy and health services delivery (drawing on the
assumptions and methods of the social sciences). The literature highlights the importance of building and
maintaining relationships between different stakeholders in the research process (including, sponsors,
researchers, the public and policy-makers) in order to build a shared understanding of research priorities
and create interest and engagement in a programme of work (hence, improve dissemination and impact
after it is complete). Sponsors of complex programmes of research with a strong social science element
and/or those that emphasise collaborative Co-production of research may find this wider literature helpful.
However, enhanced logic models that assume a broadly direct and linear link between a programme of
work and its impact, but which include scope for interpretive case study to explain unique and/or
non-linear influences, may be appropriate for the bulk of HTA-funded research, especially systematic
reviews and trials. These models may be less applicable to the study of organisational change or
collaborative research such as CLAHRCs. Although many promising alternative models now exist in the
social science literature, further work is needed to determine the most appropriate models and tools to use
for different research programmes and study designs.
What might be the consequences of the introduction of the Research Excellence
Framework, and what might it contribute to impact assessments for National
Institute for Health Research programmes?
Future assessments of the impact of the HTA programme will have to take account of wider changes in
research policy, notably the REF. The REF has become more important as a major and regular quality
assurance mechanism. Its extension in 2014 to include impact appears to have been a success and hence
likely to continue, possibly using a similar case study approach to that employed in 2014.106,345 Besides
learning from the REF case studies, the HTA programme should consider how these should be structured
in the future. The selection of topics for case studies is often ad hoc, different methods are used and data
are often either unavailable or retrospective. The selection of case studies, such as in the REF but also more
generally, tends to be biased towards ‘good news’ stories. Other fields indicate that much can be learnt
from failures. Appendix 7 gives brief details of some early research studies on impact case studies from the
2014 REF, which were published after the cut-off date for our census.
What might be the consequences of the introduction of researchfish, and what
might it contribute to impact assessments for National Institute for Health
Research programmes?
This review did not identify any independent evaluations of the use of researchfish in impact assessment.
The adoption of researchfish by all major UK research funders also has implications for future assessments
of impact. While the routine capture of indexed research publications has merit, the degree to which
researchfish will succeed in collecting other, non-indexed outputs and activities remains to be established.
Further, the focus on individual projects means the more macro aspect of the impact of research projects
may receive less attention. These higher levels include the overall impact of the HTA programme on both
the NHS and on the universities. The evolution of NIHR to be the main funder of most late-stage health
research has plausibly changed how it is perceived by universities, not least in relation to REF. How this
might affect how the NHS sees the programme remains to be established.
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Options for the National Institute for Health Research/Health
Technology Assessment for health research impact and
research recommendations
One option for the HTA programme is to plan how best to meet the data requirements of future impact
assessments, both by the programme but also in external assessments such as any future REF exercises.
The data on the management of the HTA programme, held by NIHR Evaluation, Trials and Studies
Coordinating Centre, focus on administration and management of the programme. Development of its
electronic management information system has been slow and uneven. The programme has invested in
projects that quality assures the data, and enables comparisons and trends to be analysed,228 but these
have applied only to the randomised trials. The likely data requirements of future assessments of impact
and of the REF need to be planned for and included either in management information systems or in
special projects.
Research recommendations
We recommend research prioritised as ordered below.
1. Given the importance of case studies and the criticisms that can be levelled against them (selection and
methods bias), research on the extent to which case studies in general and the REF impact case studies
in particular provide sufficiently rich, complete, accurate, honest stories of the impact of a team’s
research is required. We recommend a review of case studies and their application to health research,
including the 2014 REF, combined with independent selection and preparation of case studies of
HTA projects.
This should include both successful and unsuccessful projects. It should also include cases focusing on
the monetisation of impact and on linking trials to systematic reviews and guidelines. Particular case
studies might contrast the tracing forward/backward methods of linking particular research projects to
policy changes. The aim should be the development of evidence-based case studies, as well as
appropriate frameworks and examples of good practice. As case studies have importance in other
NIHR research programmes, the remit of the proposed research should include the relevant NIHR
research programmes.
2. Research is required on the role of ongoing electronic data collection of the sort involved with
researchfish. This should assess the strengths and weaknesses of this approach, the extent of bias, such
as towards indexed publications, and the extent of researchers’ compliance and support. A careful
assessment of the completeness, accuracy, technical properties, usability and user experiences of
researchfish is needed. Researchers’ responses on researchfish might be compared with previous studies
(typically based on semistructured interviews) of principal investigators to ascertain their views on the
impact of their research.
3. Research is also required on optimal methods for assessing the impact of randomised trials on
systematic reviews and guidelines. The York/PCORI methods currently being piloted by the HTA
programme should be evaluated along with the scope for use of GRADE. This research should also
address ways of assessing the value of randomised trials and meta-analyses that indicate the non-
superiority of particular interventions.
4. Research would be valuable on the extent to which projects and programmes that employ either VOI or
the PCORI approach achieve greater impact, as discussed in Chapter 6. As the HTA programme has
made use of both VOI and PCORI, the relevant projects might be considered for case studies as well as
for bibliometric analysis.
5. Research might also usefully explore the impact of cost-effectiveness models, such as those used by
NICE’s technology appraisal programme.
6. With regard to NIHR, research is required on the appropriate measures of impact for research
programmes other than the HTA programme.
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Chapter 9 Conclusions
We concluded that the HTA programme should continue to monitor and evaluate the impacts of thestudies it funds. Such analyses should be informed by considering, in parallel, the assessment of the
impact of the first decade of the HTA programme by Hanney et al.2 and the findings from the RAND
review of the second decade.27 It should consider the scope for building on the analysis in the RAND
Europe report of the wider, overall impact of the HTA programme as a long-standing programme. It
should also consider the findings of this current review of methods and frameworks for assessing research
programmes, including the analysis that the HTA programme contains several key features that increase
the likelihood of impact arising.
Although it is important to consider the impact of a programme by gathering opinions from stakeholders
about its overall impact, it is also desirable to collate data from a range of individual studies funded by the
programme. For this, we recommend a review of case study methods and their application to health
research, including the 2014 REF, combined with independent preparation of case studies of new HTA
projects. They should include both successful and unsuccessful projects. They should include cases focusing
on the monetisation of impact and on linking trials to systematic reviews and guidelines. Particular case
studies might contrast the tracing forward/backward methods of linking particular research projects to
policy changes. The aim should be to develop better, deeper case studies as well as appropriate
frameworks and examples of good practice. As case studies have importance in other NIHR research
programmes, the remit of the proposed research should include these.
The HTA programme should continue to expand its work on linking trials to meta-analyses and to
guidelines. The York/PCORI methods currently being piloted by the HTA programme should be evaluated
along with the scope for use of GRADE. This research should also address ways of assessing the value of
randomised trials and meta-analyses that indicate the non-superiority of particular interventions.
The range of NIHR research programmes should consider the relevance of the broader literature, which
suggests a range of approaches are appropriate in different circumstances. The menu of approaches
should be taken into account in assessing the impact of NIHR research programmes and projects,
particularly those that can be seen as involving ‘co-production’ of research.
The HTA programme should continue to support routine collection of data from researchers, such as
researchfish, on aspects of impact but should be cautious of its effects. It should research researchers’
perceptions of this tool including what they include and exclude. Periodic case studies that provide a more
detailed analysis of the impacts achieved and a greater understanding of the factors that contribute to
achieving impact should support the routine collection of data by researchfish.
Financial constraints on health services mean that health research must demonstrate societal impact and
value for money. Methods for doing so have developed significantly in the last few years. While not
without caveats, these methods should be applied routinely to help safeguard the effectiveness and
cost-effectiveness of research programmes.
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Appendix 1 Literature search strategies
Search strategy for the update to the 2007 systematic review
(impact of Health Technology Assessment research)
Search date: August 2014.
TABLE 11 Search strategy for the update to the 2007 systematic review (impact of HTA research)
Database Search strategy Download file
Ovid MEDLINE(R) without
Revisions
Search range: 1996 to
August, week 2 2014
Saved as med-impact-final-
strategy
1. Health Services Research/ (21,575)
2. ((health technolog$ adj3 assessment$) or hta).mp. (2254)
3. (NHS adj6 research$).mp. [mp=title, abstract, original title, name
of substance word, subject heading word, keyword heading
word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier] (316)
4. exp *Technology Assessment, Biomedical/ (2993)
5. *Biomedical Technology/ec, mt, og, sn, td [Economics, Methods,
Organization & Administration, Statistics & Numerical Data,
Trends] (848)
6. Health Policy/ (35,849)
7. 1 or 2 or 3 or 4 or 5 or 6 (60,818)
8. (payback or pay back).ti,ab. (239)
9. ((“benefit$” or “utili#ation” or “impact” or “gains” or “returns”)
adj5 (research or evidence or health technolog#)).ti,ab. (18,997)
10. *“diffusion of innovation”/ (6104)
11. *Information Dissemination/mt [Methods] (1903)
12. *Program Evaluation/ (5976)
13. *Policy making/ (3089)
14. *Cost-Benefit Analysis/mt, sn, td [Methods, Statistics & Numerical
Data, Trends] (607)
15. 8 or 9 or 10 or 11 or 12 or 13 or 14 (36,356)
16. 15 and 7 (2923)
17. limit 16 to (english language and yr=“2005 -Current”) (1842)
18. limit 17 to (evaluation studies or “review” or systematic
reviews) (494)
494
Ovid MEDLINE(R) In-Process &
Other Non-Indexed Citations
Search date: 13 August 2014
1. Health Services Research/ (0)
2. ((health technolog$ adj3 assessment$) or hta).mp. (524)
3. (NHS adj6 research$).mp. [mp=title, abstract, original title, name
of substance word, subject heading word, keyword heading
word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier] (43)
4. exp *Technology Assessment, Biomedical/ (0)
5. *Biomedical Technology/ec, mt, og, sn, td [Economics, Methods,
Organization & Administration, Statistics & Numerical Data,
Trends] (0)
6. “research and development”.mp. (975)
7. Health Policy/ (0)
8. 1 or 2 or 3 or 4 or 5 or 6 or 7 (1531)
9. (payback or pay back).ti,ab. (31)
10. ((“benefit$” or “utili#ation” or “impact” or “gains”) adj5
(research or evidence or health technolog#)).ti,ab. (2857)
11. ((implement$ or disseminat$) adj2 (benefit$ or impact or gain)).ti,ab.
(167)
12. exp *“diffusion of innovation”/ (0)
13. *Information Dissemination/mt [Methods] (0)
14. *Program Evaluation/ (0)
15. *“Costs and Cost Analysis”/ (0)
17
continued
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TABLE 11 Search strategy for the update to the 2007 systematic review (impact of HTA research) (continued )
Database Search strategy Download file
16. 9 or 10 or 11 or 12 or 13 or 14 or 15 (3035)
17. 16 and 8 (50)
18. limit 17 to (english language and yr=“2005 -Current”) (43)
19. limit 18 to (evaluation studies or meta analysis or “review” or
systematic reviews) (17)
EMBASE
Search range: 1996 to 2014
week 33
1. Health Services Research/ (21,291)
2. ((health technolog$ adj3 assessment$) or hta).mp. (4277)
3. (NHS adj6 research$).mp. [mp=title, abstract, subject headings,
heading word, drug trade name, original title, device
manufacturer, drug manufacturer, device trade name,
keyword] (584)
4. Biomedical technology assessment/ (9191)
5. Health Care Policy/ (119,074)
6. *“medical research”/ (44,171)
7. 1 or 2 or 3 or 4 or 5 or 6 (192,702)
8. (payback or pay back).ti,ab. (333)
9. ((“benefit$” or “impact*” or “influenc$” or “gain$” or
“utili#ation” or “returns”) adj8 (research or evidence or health
technolog$)).ti,ab. (68,728)
10. ((implement$ or disseminat$) adj4 (benefit$ or impact* or
gain$)).ti,ab. (4188)
11. program impact/ (73)
12. 8 or 9 or 10 or 11 (72,921)
13. 7 and 12 (4868)
14. *“diffusion of innovation”/ (4800)
15. *“conceptual framework”/ (909)
16. *“empirical research”/ (455)
17. *“cost benefit analysis”/ (3972)
18. *theoretical study/ (278)
19. post hoc analysis/ (9899)
20. *data analysis/ (2544)
21. *process model/ (493)
22. *practice guideline/ (35,560)
23. program evaluation/ (1301)
24. *information dissemination/ (3309)
25. 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or
24 (63,178)
26. 13 and 25 (157)
27. limit 26 to (english language and yr=“2005 -Current”) (120)
120
Cochrane Methodology
Register, issue 3 of 4,
July 2012
Impact AND research 61
HMIC
Search range: 1979 to present
Records from The King’s Fund
and Department of Health
(August 2014)
(impact AND “health research”).ti,ab
Limited from 2005 to date
67
CINAHL (impact AND “health research”).ti,ab [Limit to: Publication
Year 2005-2014]
188
Total records downloaded 947
Total records after duplicates removed and initial screening 297
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Search strategy for monetary value on the impact of research
Search date: October 2014.
TABLE 12 Search strategy for the monetary value on the impact of research
Database Search strategy Download file
Ovid MEDLINE(R) without
Revisions
Search range: 1996 to
September, week 4 2014
1. *Biomedical Research/ec [Economics] (1270)
2. *“Health Policy”/ec (962)
3. *“Health Services Research”/ec (241)
4. *“Public Health Administration”/ec (207)
5. 1 or 2 or 3 or 4 (2636)
6. “Cost-Benefit Analysis”/ (44,900)
7. “Health Status”/ (49,980)
8. “Investments”/ (4192)
9. *“Social Values”/ (3351)
10. (health gain* and (value or research or return*)).ti,ab. [mp=title,
abstract, original title, name of substance word, subject heading
word, keyword heading word, protocol supplementary concept
word, rare disease supplementary concept word, unique
identifier] (282)
11. (health gain* and research).m_titl. (3)
12. (research adj5 return*).ti,ab. (400)
13. *Randomized Controlled Trials as Topic/ec, sn [Economics,
Statistics & Numerical Data] (1578)
14. *“Research Support as Topic”/ec, sn (1025)
15. “return on investment* ”.m_titl. (149)
16. *“Models, Econometric”/ (929)
17. moneti?ation.ti,ab. (16)
18. (economic adj3 return*).ti,ab. (266)
19. (payback or payoff).m_titl. (140)
20. (“health gain*” and return).ti,ab. (8)
21. “value of research”.mp. (300)
22. 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17
or 18 or 19 or 20 or 21 (105,665)
23. 5 and 22 (591)
24. limit 23 to (english language and yr=“2003 -Current”) (453)
25. limit 24 to (evaluation studies or “research support, american
recovery and reinvestment act” or research support, nih,
extramural or research support, nih, intramural or research
support, non us gov’t or research support, us gov’t, non phs or
research support, us gov’t, phs or “review” or systematic
reviews) (178)
178
EMBASE
Search range: 1996 to 2014
week 40
1. “Cost-Benefit Analysis”/ (51,907)
2. “Health Status”/ (76,129)
3. “Investments”/ (10,912)
4. *“Social Values”/ (15,223)
5. (health gain* and value).m_titl. (4)
6. (health gain* and research).m_titl. (3)
7. (health gain* or return*).ti. (8565)
8. “return on investment* ”.m_titl. (201)
9. *“Models, Econometric”/ (13,644)
10. moneti?ation.ti,ab. (26)
11. (economic adj3 return*).ti,ab. (356)
12. (payback or payoff).m_titl. (156)
13. (“health gain*” and return).ti,ab. (16)
14. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or
13 (174,045)
15. “value of research”.mp. (445)
16. 14 and 15 (34)
17. *medical research/ (44,423)
18. 15 and 17 (49)
19. 16 or 18 (76)
76
continued
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TABLE 12 Search strategy for the monetary value on the impact of research (continued )
Database Search strategy Download file
Ovid MEDLINE(R) In-Process &
Other Non-Indexed Citations
Search date: 7 October 2014
1. (health gain* or return*).ti. (1028)
2. “return on investment* ”.m_titl. (14)
3. moneti?ation.ti,ab. (2)
4. (economic adj3 return*).ti,ab. (41)
5. (payback or payoff).m_titl. (21)
6. (“health gain*” and return).ti,ab. (4)
7. “value of research”.mp. (50)
8. (“health gain*” and value).ti,ab. (18)
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 (1152)
10. research.m_titl. (14,752)
11. 11 9 and 10 (47)
47
The Cochrane Library
including NHS EED and
Methodology
Monetisation or “value of research” or payback or payoff No additional
records identified
HMIC Monetisation or “value of research” or payback or payoff 112
Total records identified 413
Total records downloaded after initial screening and duplicates removed 102
Search strategy for randomised trials impact on systematic reviews
Search date: October 2014.
TABLE 13 Search strategy for randomised trials impact on systematic reviews
Database Search strategy Download file
Ovid MEDLINE(R) without
Revisions
Search range: 1996 to
October, week 1 2014
1. “cumulative meta-analysis”.m_titl. (48)
2. *Meta-Analysis as Topic/ (3706)
3. *Randomized Controlled Trials as Topic/ (14,912)
4. *Research Design/ (24,605)
5. (sufficiency or stability).m_titl. (48,059)
6. 2 and 5 (4)
7. from 6 keep 2 (1)
8. find similar to Sufficiency and stability of evidence for public
health interventions using cumulative meta-analysis (3)
9. from 8 keep 1-2 (2)
10. *data interpretation, statistical/ (11,447)
11. 2 and 3 and 10 (32)
12. from 11 keep 1-7 (7)
13. 7 or 9 or 12 (10)
14. (meta-anaylysis and RCT design).mp. [mp=title, abstract, original
title, name of substance word, subject heading word, keyword
heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier] (0)
15. (meta-analysis and RCT design).mp. (16)
16. 2 and 10 (235)
17. 3 and 4 (1807)
18. 16 and 17 (2)
19. *Statistics as Topic/st, td [Standards, Trends] (264)
20. 2 and 19 (5)
21. 5 and 19 (0)
22. 15 and 19 (0)
23. 1 and 4 (1)
40
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TABLE 13 Search strategy for randomised trials impact on systematic reviews (continued )
Database Search strategy Download file
24. from 23 keep 1 (1)
25. 13 or 24 (11)
26. (before or prior).ti. (57,012)
27. 2 and 3 and 26 (3)
28. (before or prior).ti,ab. (1,210,214)
29. 2 and 4 and 28 (17)
30. from 29 keep 4 (1)
31. Sample Size/ (9612)
32. Clinical Trials as Topic/mt, st, sn, td [Methods, Standards, Statistics
& Numerical Data, Trends] (18,904)
33. 31 and 32 (752)
34. meta analysis.mp. or Meta-Analysis/ (78,317)
35. 33 and 34 (29)
36. from 35 keep 19 (1)
37. 3 or 32 (33,668)
38. 4 and 37 (3527)
39. 34 and 38 (160)
40. find similar to The use of systematic reviews in the planning,
design and conduct of randomised trials: a retrospective cohort of
NIHR HTA funded trials. (1)
41. from 39 keep 4,12,15,20 (4)
42. from 39 keep 10,20,48-49 (4)
43. Meta-Analysis as Topic/ (14,488)
44. 31 and 37 and 43 (54)
45. from 44 keep 1-6,8,10-12,14-15,17,19,25-26,30-31,34,36-
37,41,45 (23)
46. 7 or 9 or 12 or 24 or 30 or 36 or 41 or 42 or 45 (40)
47. “Cumulative meta-analysis”.fc_titl. (48)
48. from 64 keep 9,18,25,41,44,48 (6)
49. 63 or 65 (11)
50. 68 or 71 or 72 (14)
51. 73 or 75 (15)
52. “first in class”.ti,ab. (664)
53. Meta-Analysis as Topic/ (14,488)
54. *Randomized Controlled Trials as Topic/ (14,912)
55. 79 and 82 (4)
56. 79 and 81 (3)
57. 83 or 84 (7)
58. first in class.mp. (664)
59. (first adj2 class).ti,ab. (2217)
60. 81 and 87 (3)
61. first-in-class.ti,ab. (664)
62. 81 and 89 (3)
63. *Research Design/ (24,605)
64. 89 and 91 (1)
65. from 78 keep 1-16 (16)
66. from 92 keep 1 (1)
EMBASE
Search range: 1996 to 2014
week 41
1. “cumulative meta-analysis”.ti,ab. (251)
2. “meta analysis (topic)”/ (15,619)
3. *methodology/ (10,073)
4. *“randomized controlled trial (topic)”/ (2815)
5. *“clinical trial (topic)”/ (6699)
6. 4 or 5 (9463)
7. 1 and 6 (2)
8. 2 and 6 (256)
9. 3 and 8 (19)
8
Cochrane methodology cumulative meta-analysis 6
Total records identified after initial screening and duplicates removed 54
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Search strategy for impact of randomised trials on stopping
health technologies
Database: Ovid MEDLINE(R) without Revisions
Search date: March 2015.
Search range: 1996 to week 2 March 2015.
Search strategy
1. disinvestment.mp. (86)
2. discontinue.mp. (3569)
3. (disinvest and technology).mp. [mp=title, abstract, original title, name of substance word, subject
heading word, keyword heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier] (1)
4. (discontinu* and technolog*).mp. [mp=title, abstract, original title, name of substance word, subject
heading word, keyword heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier] (522)
5. 1 or 3 or 4 (608)
6. *“Efficiency, Organizational”/ (6431)
7. “Biomedical Technology”/ (3230)
8. 6 and 7 (15)
9. from 8 keep 5,11 (2)
10. from 1 keep 1-2,7-8,11,16-18,20,22,27-29,33-34,40,43,45,50,52,56-57,61,64,68 (25)
11. optimization.mp. (50,487)
12. 7 and 11 (10)
13. from 12 keep 1-3 (3)
14. Technology Assessment, Biomedical/ec, og [Economics, Organization & Administration] (1048)
15. 7 or 14 (4203)
16. 1 and 15 (17)
17. from 16 keep 1-8,12-16 (13)
18. impact.mp. (422,537)
19. 5 and 18 (45)
20. 10 or 15 (38)
21. 19 or 20 (52)
Database: Ovid MEDLINE(R) without Revisions
Search date: March 2015.
Search range: 1996 to week 2 March 2015.
Search strategy
1. larval therapy in the management of leg ulcers.m_titl. (1)
2. “Treatment Outcome”/ (626,908)
3. water softening for eczema.m_titl. (0)
4. (water softening and eczema).mp. [mp=title, abstract, original title, name of substance word, subject
heading word, keyword heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier] (6)
5. ((impact adj5 RCTs) or trial*) and (stop* adj5 technolog*)).mp. [mp=title, abstract, original title, name
of substance word, subject heading word, keyword heading word, protocol supplementary concept
word, rare disease supplementary concept word, unique identifier] (3)
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6. (impact adj5 (RCTs or trial*)).mp. [mp=title, abstract, original title, name of substance word, subject
heading word, keyword heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier] (2608)
7. (impact adj2 (RCTs or trial*)).mp. [mp=title, abstract, original title, name of substance word, subject
heading word, keyword heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier] (396)
8. (impact adj2 (RCTs or trial*)).ti. (131)
9. Decision Making, Organizational/ (7820)
10. exp Resource Allocation/og, td [Organization & Administration, Trends] (1228)
11. 9 or 10 (8959)
12. 6 and 11 (0)
13. evidence.mp. (814,371)
14. 11 and 13 (889)
15. from 4 keep 3-4 (2)
16. from 8 keep 10-11,30,32 (4)
17. from 14 keep 1,11,16 (3)
18. (evidence and disinvestment).mp. [mp=title, abstract, original title, name of substance word, subject
heading word, keyword heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier] (34)
19. from 18 keep 1-2,5,8,11-15,18-19,21,27-28,30 (15)
20. “Disinvestment”.kw. (2)
21. 9 or 10 (8959)
22. 2 and 21 (67)
23. *“Diffusion of Innovation”/ (6307)
24. 9 or 10 or 23 (15,112)
25. (trial* and disinvest*).mp. [mp=title, abstract, original title, name of substance word, subject heading
word, keyword heading word, protocol supplementary concept word, rare disease supplementary
concept word, unique identifier] (4)
26. from 22 keep 30 (1)
27. from 25 keep 1-4 (4)
28. (trial* and (technolog* adj4 discontinu*)).mp. [mp=title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol supplementary concept word, rare
disease supplementary concept word, unique identifier] (0)
29. (trial* and (technolog* adj4 stop*)).mp. [mp=title, abstract, original title, name of substance word,
subject heading word, keyword heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier] (3)
30. (against technolog* and trial*).mp. [mp=title, abstract, original title, name of substance word, subject
heading word, keyword heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier] (0)
31. (technolog* and (against or stop* or reject*)).mp. [mp=title, abstract, original title, name of substance
word, subject heading word, keyword heading word, protocol supplementary concept word, rare
disease supplementary concept word, unique identifier] (11,240)
32. (RCT* or trial).mp. [mp=title, abstract, original title, name of substance word, subject heading word,
keyword heading word, protocol supplementary concept word, rare disease supplementary concept
word, unique identifier] (620,530)
33. 31 and 32 (566)
34. 24 and 33 (4)
35. from 34 keep 3 (1)
36. 26 or 27 or 35 (6)
37. 2 and 24 (139)
38. from 37 keep 2,15,17-18,22,36,48,71,75 (9)
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39. *“Technology Assessment, Biomedical”/ (2925)
40. *“Decision Support Techniques”/ (6218)
41. “Randomized Controlled Trials as Topic”/ (86,973)
42. 40 and 41 (163)
43. from 42 keep 2 (1)
44. 11 and 41 (29)
45. from 44 keep 1,8,13,16 (4)
46. discontinu*.mp. (54,765)
47. 41 and 46 (1359)
48. 39 and 47 (0)
49. 39 and 41 (117)
50. from 49 keep 1-2,15,20-22,25,49 (8)
51. 2 and 41 (20,759)
52. 39 and 51 (18)
53. from 52 keep 5 (1)
54. 31 and 39 and 41 (7)
55. from 54 keep 7 (1)
56. from 22 keep 30 (1)
57. 32 and 39 and 41 (43)
58. from 57 keep 6-9 (4)
59. 15 or 16 or 17 or 19 or 27 or 35 or 38 or 43 or 45 or 50 or 53 or 55 or 56 or 58 (53)
60. (disuse adj3 technolog*).mp. [mp=title, abstract, original title, name of substance word, subject
heading word, keyword heading word, protocol supplementary concept word, rare disease
supplementary concept word, unique identifier] (1)
61. (disuse or cancel*).mp. [mp=title, abstract, original title, name of substance word, subject heading
word, keyword heading word, protocol supplementary concept word, rare disease supplementary
concept word, unique identifier] (13,164)
62. 2 and 61 (1199)
63. 39 and 62 (0)
64. 41 and 62 (13)
65. “raftery$”.fc_auts. and “lancet$”.fc_jour. (7)
66. “Program Evaluation”/ (40,717)
67. 39 and 66 (72)
68. from 59 keep 1-53 (53)
69. from 67 keep 5-6 (2)
70. 59 or 69 (55)
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Appendix 2 Data extraction sheet
Number
Authors
Title of paper
Journal (journal, year, volume, etc.)
Source summary
Type of study or description of method/application/both
Country
Programme/specialty
Conceptual framework used in impact assessment
Methods used in impact assessment
Brief description of aspects/dimensions of impacts assessed and found
Attempts to assess the impact from each of the projects in a multiproject programme
Conflicts of interest
Meeting inclusion criteria
Strengths and weaknesses
Factors associated with impact
Other comments (reviewer) and quotes
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The papers listed below are ones that were identified but either did not meet inclusion criteria for theupdated review or they were reports or other publications covering the same material as publications
that were included either in the current review or in our review conducted in 2005 and published in
2007.2 Some papers on monetised health gains were excluded from the update, as they did not assess the
value of the health gain from specific programmes of research. However, these were included in Chapter 5
on the monetary value of health research because that provided a broader analysis. The list below is only
a selection of the potentially relevant papers that we reviewed but were not included in the final 161
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Appendix 5 Frameworks included in previous
analyses by RAND Europe
Below we set out a range of conceptual frameworks or approaches that were included in the maincomparative analysis described in at least one of the three studies from RAND Europe: Brutscher
et al.,37 Grant et al.38 and Guthrie et al.9 In each case we note if the framework was included in the list
of frameworks in Chapter 3, and if it was not we briefly describe the reason(s).
TABLE 15 Frameworks included in previous analyses by RAND Europe
Framework for assessing impact
from health research (country)
Description of whether or not it was included in account of frameworks in
Chapter 3, or the reason for not including framework in list of those
described in detail and compared in Chapter 3
CAHS (Canada) Included in the list of frameworks in Chapter 3
Congressionally directed medical
research programme (USA)
Designed to track the annual progress of projects conducted for the US Army
Medical Research and Material Command. Perhaps it was too specific for wider
application. The ‘research product’ is a central element:
One rationale is that the pressure on the CDMRP (as a military command) is
even higher to develop products
Brutscher et al. 2009, p. 6237
Department for Innovation,
Universities and Skills (UK)
Included in the list of frameworks in Chapter 3 as part of the background to
the current approaches to monetary value approaches; specifically the previous
version of the data collection undertaken by the MRC (2013)
EU FPs Several studies included in Table 14 describe approaches previously used to assess
EU FPs (e.g. Arnold et al.;133 Hansen et al.111) but the Court of Auditors criticised
the lack of information on impacts from FPs’ health research and several studies in
Table 14 describe work to develop new approaches (Expert Panel;53 Guinea
et al.64). Hence, the position seems uncertain, and we have not included this
ERiC (the Netherlands) While this was not directly included in the list of 20 frameworks in Chapter 3,
some of the team conducting this Dutch study also led a parallel EU FR7 project
that produced the Productive Interactions (SIAMPI) framework that is included in
Chapter 3 (see also an account of ERiC in Spaapen et al.140 in Table 14)
ERA (Australia) The criteria for the ERA framework are described in a report by the Australian
Research Council,411 but ERA is not comprehensive in terms of impacts, and
has an academic focus (Guthrie et al.9), which is why the EIA was developed
to complement it (Group of Eight and Australian Technology Network of
Universities105)
Leiden University Medical Centre
(the Netherlands)
Included in the list of frameworks in Chapter 3 as the Societal Quality Score
MOIRA and NHMRC (Australia) MOIRA was reported in Brutscher et al.37 2009 as an approach developed at the
Australian NHMRC as a possible way of introducing impact into ex ante
assessment of proposals. Of potentially more relevance to our review, it was
thought it might inform the development of a new NHMRC end of grant form.
While a new form was developed, and applied 6 months after project
competition, as described in one of our included studies, i.e. Kingwell et al.,139 it
was not included in the recent review from Australia by Milat et al.129
NIHR Dashboard (UK) Although developed for use by NIHR and has comprehensive coverage of financial
data and internal and external processes, it is not designed to capture data for
impact assessments (see Guthrie et al.)9
continued
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TABLE 15 Frameworks included in previous analyses by RAND Europe (continued )
Framework for assessing impact
from health research (country)
Description of whether or not it was included in account of frameworks in
Chapter 3, or the reason for not including framework in list of those
described in detail and compared in Chapter 3
PART (USA) Partially included in the list of frameworks in Chapter 3, in that the NIOSH
logic model described by Williams et al.92 was developed in order to gather data
for an assessment under PART. However, PART is used widely to assess publicly
funded programmes in general, and covers many issues such as programme
design, so it takes a somewhat different form in relation to research than to most
other areas
Payback Framework (UK) Included in the list of frameworks in Chapter 3
Productive Interactions (the
Netherlands)
Included in the list of frameworks in Chapter 3 as SIAMPI
RAND/Arthritis Research Campaign
Impact Scoring System (UK)
Included in the list of frameworks in Chapter 3, but as part of the background
to regular monitoring
REF (UK) Included in the list of frameworks in Chapter 3
RQF (Australia) Included in the list of frameworks in Chapter 3 but as part of the background
to the REF
STAR METRICS (USA) Developed for regular monitoring of US publicly funded research but not fully
developed. The Scientific Management Review Board of the NIH said in relation to
STAR METRICS and other developments:
NIH’s data infrastructure was built primarily to manage grants and contracts
during their life cycle, not to track outcomes
Scientific Management Review Board, NIH, p. 19399
VINNOVA (Sweden) Included in the list of frameworks in Chapter 3
ERA, Excellence in Research for Australia; FP, Framework Programme; NIH, National Institutes of Health; MOIRA, Measure
of Research Impact and Achievement; PART, Program Assessment Rating Tool.
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Appendix 6 Summary of methods for estimating
the monetary value of the impact of health research
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Appendix 7 Studies of impact assessment in the
2014 Research Excellence Framework
The census date for this systematic review (2005–15) meant that our search just captured the reportsfrom the HEFCE on the 2014 REF, but not evaluations published soon afterwards that assessed
the success of that exercise. As the approach to impact assessment in the 2014 REF is widely viewed
as an important innovation (e.g. other countries are looking to emulate the REF model for impact
assessment105,412), we include an account of the REF and brief description of the published evaluations here.
The 2014 REF was an extensive exercise to assess UK universities’ research performance with a view to
informing the allocation of a central budget (‘quality in research’ funding). It built on similar exercises held
in 2008, 2001 and earlier years. Unlike previous exercises, in which scores had been allocated on the basis
of publications, infrastructure and ‘prestige’, the 2014 REF introduced an additional category: 20% of the
total score (and hence funding) was awarded for research impact.106
Accordingly, as part of its REF submission, each higher education institution submitted an ‘impact template’
describing its strategy and infrastructure for achieving research impact, along with a sample (between 2
and 49, depending on the size of the submission) of impact case studies. Each case study was four pages
long and described a programme of research along with the claimed impacts from that programme and
supporting evidence. Impact case studies were required to follow a sequential and time-bound structure
(describe research undertaken between 1993 and 2013 and then describe impact occurring between
2008 and 2013). In the REF, impact templates and case studies were peer reviewed by an intersectoral
assessment panel representing academia and research users (industry and policy-makers).106
The final report from the Medicine Panel in the 2014 REF106 concluded that the impact assessment
component had been very successful – in that it had been possible to undertake a systematic evaluation of
research impact using a structured case study format (although it also expressed the panel’s reservations
about the usefulness and discriminatory ability of the impact template).106 One important reason why the
approach worked appears to have been the strong financial and reputational incentive to higher education
institutions to engage with the REF, including putting significant effort into writing the case studies and
linking them to externally verifiable evidence of impact. Whether or not such an exercise would work
equally well if the financial component of that incentive were not present (e.g. in countries where the
ranking would be purely reputational) is questionable.
The cost to HEFCE of the REF was high in absolute terms (£55M), though relatively modest as a proportion
of quality in research funding (1.3%); however, these figures may not fully take account of the full costs to
institutions of preparing their submissions.
An independent evaluation of the REF impact assessment process by RAND Europe (based on focus
groups, interviews, survey and documentary analysis) concluded that panel members perceived it as fair
and robust and valued the intersectoral discussions, though many felt the somewhat crude scoring system
(in which 84% of case studies in medicine were awarded 3, 3.5 or 4) lacked granularity.413
The 6679 non-redacted impact case studies submitted to the REF (1594 in Main Panel A, which covered
medically related fields) have been placed in the public domain (see http://results.ref.ac.uk) and provide a
unique data set for further analysis (around 4% of case studies, deemed commercial-in-confidence or
otherwise sensitive, remain unpublished). The final report from Main Panel A commended the richness of
the impact case study narratives and noted that ‘International Main Panel A members cautioned against
attempts to “metricise” the evaluation of the many superb and well-told narrations describing the
evolution of basic discovery to health, economic and societal impact’.106
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A preliminary analysis of all 6679 REF impact case studies, based mainly, but not exclusively, on automated
text mining, identified 60 different kinds of impact and 3709 ‘pathways to impact’ through which these
had been achieved; every country in the world was mentioned in the data set at least once, suggesting
wide geographical spread of at least some UK research.345 The authors of that analysis felt that attempts in
the case studies to monetise health gains (using QALYs, for example) and other impacts from research
were, by and large, crude and speculative, though in some cases the evaluation team were able (with
additional efforts) to produce monetised estimates of return on investment. They commented that ‘the
information presented in the [REF impact] case studies was neither consistent nor standardised’, and that
there is probably considerable potential to improve the data collection and reporting process for
future exercises.
A reviewer of this report, who is leading the ongoing analysis of impact case studies from 2014 REF,
commented that, in his view, one of the most significant emerging findings was the difference between
the great diversity of impacts and mechanisms for achieving it described in the REF impact case studies and
the much more limited range and mechanisms of impact implicit in the frameworks covered in this report.
He commented:
I wonder if we have over simplified our understanding of impact through the use of these frameworks
and that as we apply more sophisticated empirically driven text mining methods (which I stress are not
without limitations) we will radically rethink the way we need to conceptualise impact.
Professor Jonathan Grant, Director of the Policy Institute at King’s College London,
personal communication, 2015
While text mining holds considerable promise for generating ‘big data’ on this important data set, there is
likely to be a trade-off between breadth and depth, as automated analysis of several thousand documents
would be unable to explore the detail of impact narratives or the complex and sometimes non-linear
mechanisms through which impact may be achieved. A complementary approach, involving manual
content and interpretive analysis of a smaller sample of REF impact case studies, has recently
been published.414
In summary, the impact case study as used in the 2014 REF, peer reviewed by mixed panels that included
both academics and research end-users, is widely considered to have effectively captured the impacts of
research at UK higher education institutions. The main limitation may have been lack of granularity in the
scoring system used. As this exercise generated a large data set that has been placed in the public domain,
it is also now methodologically innovative approaches to analysis, including (but not limited to) automated
text mining. The future for research impact assessment is to include developments in this subfield.
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